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CHAPTER 1 
INTRODUCTION 
 A positive blood alcohol concentration is detected in nearly half of burn 
patients admitted to the emergency room. The combined insult of being intoxicated at the 
time of burn injury results in more clinical complications, in comparison to non-
intoxicated burn patients.  Severe burn, with or without inhalation injury, is a common 
predisposing factor for the development of acute respiratory distress syndrome (ARDS).  
Exacerbated pulmonary inflammation and a net result of insufficient gas exchange 
underlie the large percentage of burn fatalities due to pulmonary complications.   
Previous studies in our laboratory indicate a drastic elevation in pulmonary inflammation 
in a mouse model of intoxication and burn injury.  This was characterized by heightened 
levels of alveolar wall thickening, neutrophil accumulation, neutrophil chemokines KC 
and macrophage inflammatory protein 2 (MIP-2), and pro-inflammatory IL-6.  Reducing 
levels of pulmonary inflammation and restoring the lungs to homeostasis is essential to 
prevent lung complications and failure. 
 Alveolar macrophages (AMs) are the lungs first line of defense against inhaled 
particles or pathogens and elegantly coordinate the on-set and resolution of inflammation.  
The transition from steady-state healthy conditions to a pro-inflammatory state is a result 
of macrophage plasticity to readily activate into a reversible pro- or anti-inflammatory 
profile, depending on mediators present within the microenvironment. Importantly, AM 
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efferocytosis of apoptotic cells stimulates anti-inflammatory mediator release and 
promotes the resolution of inflammatory responses, while a disruption in this function 
can result in drastically increased levels of inflammation. 
A common feature of both ARDS and burn injury is an increase in apoptosis in 
lung tissue.  Specifically, ARDS has been associated with the apoptosis of lung epithelial 
cells. Since the removal of apoptotic cells by AMs is important for the termination of 
inflammation, a dysregulation in the activation state or survival of AMs can result in 
prolonged pulmonary inflammation.  Thus, the role of AMs in pulmonary inflammation 
after intoxication and injury is extremely important.  With this knowledge, we 
hypothesize that intoxication at the time of burn injury leads to an increase in AM 
apoptosis, resulting in exacerbated pulmonary inflammation and impaired lung function. 
To test this hypothesis, three aims are proposed: 1) to determine if pulmonary 
inflammation after intoxication and burn injury affects physiological parameters of lung 
function, 2) identify the role of alveolar macrophages in post-burn pulmonary 
inflammation, and 3) to determine if exogenous mesenchymal stem cell treatment will 
attenuate pulmonary inflammation after intoxication and burn injury. 
 Lung function will be measured using non-restrained whole body 
plethysmography. AMs will be isolated and their activation profiles will be assessed 
using flow cytometry, immunofluorescent staining, and cytokine assays.  Multiple 
apoptosis identification methods, including TUNEL, Annexin V/PI, and caspase-3/7 
staining, will be used to evaluate apoptosis in lung tissue and alveolar macrophages.  The 
role of alveolar macrophages in pulmonary inflammation after intoxication and injury 
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will be determined by selectively depleting alveolar macrophages from the lungs with 
clodronate liposomes.  Finally, the ability of mesenchymal stem cells to attenuate 
pulmonary inflammation will be assessed.  
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CHAPTER 2 
REVIEW OF RELATED LITERATURE 
Alveolar macrophages: key regulators of pulmonary inflammation 
Lung anatomy 
The respiratory system is an essential organ system that influences whole body 
homeostasis; the import of oxygen and export of carbon dioxide is crucial to maintaining 
the function of other vital organs.  The respiratory system is comprised of the upper 
respiratory tract (mouth, nose, pharynx, and larynx) and the lower respiratory tract 
(trachea and within the lungs, the bronchi, bronchioles and alveoli). The lungs are 
specifically essential to transporting oxygen to the capillaries and rest of the body.  This 
major organ system is organized into 2 lungs that are divided into a total of 5 lobes, a 
likely evolutionary advantage in the event one lung or lobe is damaged.  In humans, the 
right lung is divided into 3 lobes while the left lung is divided into 2 lobes.  In mice, 
however, the lungs have a different anatomical makeup where the right lung is comprised 
of 4 lobes and the left lung is smaller and comprised of a single lobe [1]. Other 
anatomical differences in mice include the close positioning of the epiglottis to the soft 
plate, which restricts breathing solely to the nasal passageways and makes oral breathing 
nearly impossible.  
The lung is intricately organized into a vast tree-like structure subdivided into 
large and small airways.  The larger airways include the trachea, bronchi and bronchioles, 
while the smaller airways include the terminal bronchioles, alveoli ducts and the alveoli.
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As air is breathed in through the nose or mouth it passes through the trachea into the 
bronchi and bronchioles until it reaches the alveoli, the minuscule bulb-shaped ends of 
the airways that are the main functional components of gas exchange. Ninety-five percent 
of the alveolar surface area is covered by large, flat type I epithelial cells, with an 
occasional type II, surfactant-producing epithelial cell. Other cells found within the 
alveolar wall include interstitial cells, as well as endothelial cells that comprise the 
capillaries that are distributed throughout the walls [1].  The fusion of basement 
membranes between the thin, type I epithelial cells and capillary endothelial cells creates 
the alveolar septum where gas exchange occurs.  
Alveolar macrophages (AMs) 
 In humans, the average size of an alveolus is about 0.25mm in diameter, while in 
mice this is much smaller but exact measurements have not been determined.  There is an 
estimated 300 million alveoli within human adult lungs, calculating to an overall surface 
area over 90 m
2 
[2, 3], while in mice, there is an estimated 2.3 million alveoli, resulting in 
an area of 82.2 cm
2 
[4]. With its large surface area and direct connection to the outside 
air, the lungs are continuously exposed to inhaled pathogens and particles and are at risk 
for infection. Innate immune cells, alveolar macrophages (AMs), are strategically located 
with in the alveolar space and are the most abundant antigen presenting cell in the lung 
[5].  AMs monitor the airways for infectious agents, preventing excessive lung 
inflammation, as well as stop pathogens from crossing the alveolar-capillary interface 
into the bloodstream [6]. Under healthy conditions, AMs are 90-95% of airway cells (the 
remaining fraction belonging to lymphocytes) [7-9], and in mice, it is estimated there are 
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a total of 1-2 million AMs distributed within the airspace in the ratio of 1 AM to 3 
alveoli [10]. During fetal development, AMs originate from monocytes [11], but adult 
AMs are thought to be long-lived cells with a half-life of 30 days and minimal self-
renewal in naïve mice [12]. Other studies suggest lung-injury induced loss of AMs 
stimulates local proliferation of AMs and is the main mechanism of repopulation [13-15].  
It is also estimated that in steady-state conditions only 40% of AMs are replaced by 
infiltrating monocytes within 1 year [16]. These long-lived AMs may comprise only 10% 
of the total cells found in the alveoli, yet their function in maintaining a pathogen-free 
environment is critical for lung homeostasis. 
Lung environment determines AM phenotype 
Macrophages were first described in 1892 by Russian scientist Ilya Metchnikoff 
[17], but the isolation of AMs using bronchoalveolar lavage (BAL) was not described 
until 1961 [18]. The alveoli are home to both AMs and interstitial macrophages (IMs), 
but the ease of isolating a pure population of AMs through BAL has directed lung 
immune research toward AM-focused studies [7]. Of note, there is also a population of 
macrophages found in large airways, but at this time it is not known if this population 
differs from AMs. Additionally, it is unclear whether the various methods of AM 
isolation also include interstitial macrophages [19]. For the purpose of these studies, our 
results indicate we have isolated a population of only AMs.   
In mice, it has been shown AMs have a unique phenotype in comparison to IMs, 
as well as other tissue-resident macrophages. Unlike macrophage populations found in 
other organs, AMs express low to negative levels of classic macrophage marker CD11b, 
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high levels classic dendritic cell (DC) marker CD11c, and eosinophil marker sialic 
acid-binding immunoglobulin-like lectin F (Siglec-F), as well as low to negative 
expression of major histocompatibility complex class II (MHC II) and high expression of 
mannose receptor CD206 (Table 1) [20-22].  AM steady-state phenotype can be 
classified as CD11c
+
CD11b
-
Siglec-F
+
F4/80
+
CD206
+
. Guth et al. demonstrated that the 
lung environment rich in granulocyte/macrophage colony-stimulating factor (GM-CSF), 
and to a lesser extent, surfactant protein (SP)-D, both produced by alveolar  
epithelial cells, facilitates the uniqueness of the AM, specifically the expression of 
CD11c [11, 20].  It is important to note that due to this environment, CD11c has also 
been described on IMs, but in contrast to AMs, IMs are CD11b
+
Siglec-F
-
CD206
low/- 
 
(Table 1) [21]. Guth et al. also demonstrated that AMs cultured with medium for 24-48 h 
before activation were able to present antigen in vitro and speculated that freshly isolated 
AMs are not able to present antigen, presumably because of the immunosuppressive 
properties of lingering surfactant proteins [23].  Both SP-A and SP-D have also been 
shown to bind AMs through signal-regulatory protein α (SIRPα) and suppress AM 
phagocytosis. Therefore, in addition to their ability to suppress antigen presentation, it is 
likely these proteins have a significant role in suppressing AM pro-inflammatory 
activation, overall preventing excessive inflammation in the lungs [24, 25]. 
Interestingly, Guth et al. also speculates this unique phenotype parallels that of an 
immature DC cell. Development of macrophages is typically facilitated by CSF-1 and 
DCs by GM-CSF [26], and, similar to immature DCs, but unlike other macrophage  
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Table 1: Comparison of tissue-resident macrophage cell surface markers 
 
Red font indicates unique phenotype markers on both AMs and IMs in the lung, in 
comparison to other tissue-specific macrophage populations. 
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populations, AMs are constantly cleaning up the lung environment through 
macropinocytosis [27]. Other research shows that SP-D binds to immature DCs, but not 
mature DCs, further supporting why this phenotype may be advantageous to managing 
lung inflammation [28].  This combination of a macrophage-dendritic cell phenotype that 
is generated by the lung environment is advantageous for both steady-state and 
inflammatory conditions. The ability of AMs to recognize and respond to non-infectious 
agents and debris without initiating inflammation, but also have the ability to mount a 
pro-inflammatory response to infectious agents, is an efficient function that keeps 
inflammation under control. 
Inhibitory receptors 
In addition to surfactant protein binding to SIRPα, inhibitory receptors, such as 
mannose receptor CD206, macrophage receptor with collagenous structure (MARCO), 
and interleukin (IL)-10 receptor (IL-10R) on AMs are important in regulating 
inflammation.  CD206 on AMs is acquired during lung development [29] and selectively 
binds bacterial glycoproteins and glycolipids.  The interaction of CD206 with 
unopsonized (not targeted for destruction) bacteria suppresses an inflammatory response, 
highlighting a role for this receptor in maintaining tolerance against small amounts of 
infectious agents or commensal bacteria located in the distal airways [30, 31].  In 
humans, scavenger receptor, MARCO, is also important in binding unopsonized inhaled 
particles and bacteria in the lung and aids in the clearance of apoptotic cells [32]. 
Moreover, ligation of IL-10R inhibits pro-inflammatory cytokine release and has been 
shown to indirectly inhibit the toll-like receptor (TLR)-4 signaling pathway [33].  Recent 
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studies by Westphalen et al. also demonstrated the interaction of AMs with the alveolar 
epithelium and the use connexin 43 gap junctions allow AMs to communicate between 
alveoli and suppress lipopolysaccharide (LPS)-induced inflammation [10].  Together, 
these factors manage tolerance in the steady-state lung.  
Activation profiles of AMs 
Preventing excessive inflammation in the lungs is a tightly controlled process and 
is facilitated by many different factors.  The transition from the steady-state to a 
necessary inflammatory state is made possible by the plasticity of macrophages to readily 
activate into a reversible inflammatory profile, depending on factors present within the 
microenvironment. Classification of macrophage activation profiles has varied since the 
early 1990’s.  It was not until recently that the major macrophage research investigators 
collaborated and addressed the confounding classification terminology [34]. This group 
of investigators determined 3 guidelines to use when describing the activation state of 
macrophages. First, identify the model (in vitro versus in vivo) and method of isolation.  
Second, identify the mediators that were used to stimulate macrophage activation. Lastly, 
describe the upregulation or downregulation of cell surface or intracellular markers that 
are associated with specific-mediator induced activation. 
  Prior to these guidelines, our laboratory generalized macrophages into either a 
classical, pro-inflammatory M1 activated macrophage or an alternative, anti-
inflammatory M2 activated macrophage (this included all postulated subsets of M2: M2a, 
M2b and M2c). Figure 1 outlines our generalized classification of M1 and M2 
macrophages. M1 macrophages were characterized by mediators of activation, such as 
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interferon gamma (IFNγ), tumor necrosis factor α (TNFα), and lipopolysaccharide 
(LPS) that activate signal transducer and activator of transcription (STAT) 1 signaling 
and upregulate MARCO, inducible nitric oxide (iNOS, Nos2), IL-6 and TNFα gene 
expression. In contrast, M2 macrophages were summarized as activated by IL-4, IL-10, 
IL-13 and transforming growth factor β (TGFβ) stimulating the STAT3 or STAT6 
signaling cascade, and upregulating gene expression of CD206, IL-4R, IL-10, TGFβ, 
arginase 1 (ARG1), resistin-like α (Retnla, Fizz1), and chitinase 3-like 3 (Chi3l3, Ym1) 
[35]. Thus, the studies herein used these markers for the general classification of AMs in 
our model (Figure 1). 
Initiation and resolution of inflammation 
 AMs produce various pro-inflammatory cytokines in response to inflammatory 
stimuli, including IL-6, TNFα, IL-1β, nitric oxide (NO), reactive oxygen species (ROS), 
and neutrophil chemokine MIP- 2 [36-39]. AM release of IL-1β also stimulates epithelial 
cells to produce large amounts of neutrophil chemokine CXCL8 (homologous to mouse 
KC) that recruits neutrophils into the lung to aid in bacterial clearance [40].  Prolonged 
pro-inflammatory activation of macrophages has been shown to result in tissue damage if 
not regulated [41].  Therefore, lung inflammation needs to be a highly monitored process.  
Resolution of inflammation is achieved through the removal of pathogens by 
neutrophils and AMs, as well as the downregulation of neutrophil chemokines and the 
removal of apoptotic neutrophils, both functions AMs [42].  Specifically, phagocytosis of 
apoptotic cells (termed efferocytosis), such as neutrophils, by macrophages can  
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Figure 1 : Macrophage activation profiles. Tissue resident macrophages express pan 
macrophage cell surface marker F4/80 and retain this marker during their reversible 
activation states. M1 macrophages can be polarized by pro-inflammatory mediators, such 
as IFNγ, TNFα and LPS, subsequently releasing pro-inflammatory cytokines, such as IL-
6 and TNFα.  M1 macrophages also upregulate intracellular iNOS gene expression and 
can be characterized by upregulated levels of MACRO. M2 macrophages are polarized 
by anti-inflammatory mediators IL-4, IL-10, IL-13, and TGFβ to secrete anti-
inflammatory cytokines, such as IL-10 and TGFβ. M2 macrophages can also upregulate 
intracellular ARG1, Fizz, and YM1 gene expression, as well as cell surface markers 
CD206 and IL-4R.  
     Modified from Clària et al., Front. In Immuno 2011 
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downregulate TNFα, NO release and upregulate IL-10 and TGFβ [43-46]. Efferocytosis 
by macrophages also helps facilitate restoration of lung tissue integrity through 
macrophage release of epithelial growth factors platelet derived growth factor (PDGF), 
vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) [47, 48] 
and through their release of prostaglandin E(2), which stimulates endothelial cell 
migration and promotes neoangiogenesis [49]. Additionally, migration of AMs to the 
lung draining lymph nodes or the apoptosis of AMs themselves can promote the 
resolution of inflammation [50, 51]. Overall, AM efferocytosis and apoptosis are both 
important in the restoration and remodeling of injured lung tissue, but they are not 
without consequence. Other studies have also shown that the increase in anti-
inflammatory mediators and a decrease in the number of neutrophils infiltrating into the 
tissue, as a result of efferocytosis by AMs, can lead to an increased risk of secondary 
infection if the lungs are not able to mount a pro-inflammatory response [52]. Taken 
together, the initiation and resolution of inflammation is a closely synchronized process 
that is dependent on AMs and their elegant role in coordinating both pro- and anti-
inflammatory responses.   
 
Binge alcohol consumption paradigm 
Alcohol drinking patterns 
Historically, alcohol has been a common factor in various cultures for thousands 
of years [53, 54]. Fermented beverages have been found as far back 6000 and 7000 BC in 
Iran and China, respectively, and 3000 BC in Egypt [55-57].  The advancement of 
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technology has led to the increased production, variety and wide distribution of alcohol, 
ultimately resulting in the evolution of modern-day drinking patterns [58].  Only 7.4% 
alcohol users are considered alcohol-dependent, revealing that the majority of alcohol 
intake in the United States is through non-dependent patterns of occasional, moderate or 
binge drinking [59]. Moderate drinking is defined as 2 drinks a day for men and 1 drink a 
day for women and has been postulated to have positive health benefits, including 
decreased risk of heart disease, stroke, and diabetes [60].  Interestingly, the consumption 
of alcohol in a binge-like pattern is the most common form of drinking among young 
adults, with half the alcohol consumed by adults being in the form of binge drinks and 
69% of binge drinkers falling into a category of adults 26 years and older [61].  The 
National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines binge drinking 
either as either a blood alcohol concentration (BAC) level greater than or equal to 0.08% 
(80 mg/dL) or by the number of drinks consumed within a 2 hour window, 5 drinks for 
men and 4 drinks for women [62]. One drink is defined by the type of alcohol and 
percentage of alcohol content within each beverage and is equivalent to either 12 oz. 
of.beer (5% alcohol), 8 oz. of malt liquor (7% alcohol) 5 oz. of wine (12% alcohol) or 1.5 
oz of 80-proof liquor (40% alcohol).   
Binge drinking can be correlated with adverse health outcomes, especially 
unintentional injuries, such as vehicle accidents, falls, and burn injury, making alcohol 
the 3
rd
 leading cause of preventable death [63]. Annually, there are about 88,000 alcohol 
related deaths in the United States, two-thirds of which are men [64], while globally, in 
2012, alcohol-related deaths reached 3.3 million a year, representing 6% of all global 
  
 
15 
fatalities [65].  With over 50% of trauma patients presenting a positive BAC at the time 
of hospital admission [66], it is important we understand how alcohol can modulate the 
post-injury cellular and systemic response.  
Alcohol mediates cellular responses 
 The immunosuppressive effects of alcohol consumption have been well 
documented to correlate with increased incidences of infection [67].  Regardless of the 
type of alcohol ingested, in mouse studies, a single exposure of alcohol (acute) alcohol 
consumption can result in the suppression of cellular immune responses [68, 69].  The 
function of various adaptive and innate immune cells, including T cells, DCs, monocytes, 
and macrophages, are affected by alcohol exposure [67].   Ethanol is a small compound 
with a hydrophobic carbon tail that allows itself to easily pass through phospholipid 
bilayers in cell membranes [70]. It can modify lipid membrane properties and well as 
directly interact with transmembrane proteins [71]. Specifically, acute alcohol has been 
shown to increase membrane fluidity and decreased TLR4 migration to the cell surface, 
overall downregulating TLR4-CD14 signaling pathways after LPS stimulation, and 
highlighting a mechanism behind increased susceptibility to infection [72].  
Human DC and monocyte studies have demonstrated acute alcohol can inhibit DC 
and monocyte antigen presentation, as well as T cell proliferation [73, 74].  In murine 
macrophages, acute alcohol exposure in vitro reduces TLR4 signaling and IL-6 
production via the suppression of extracellular-regulated kinase 1 and 2 (ERK1/2) and 
p38 mitogen-activated protein kinase (MAPK) [75]. Additionally, our laboratory has 
shown that in vivo ethanol exposure suppresses both the production of IL-6, TNFα, and 
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IL-12 after in vitro LPS stimulation of alveolar macrophages, as well as suppresses the 
in vitro phagocytosis of Pseudomonas aeruginosa (P. aeruginosa) [8, 76]. Overall, these 
data emphasize the profound affects a single exposure to alcohol can have on the immune 
system.  
Alcohol and the lung 
 Chronic alcohol consumption leads to an increased risk lung infections and a 
decreased ability to clear the infection [77].  Acute ethanol exposure has also been 
described to inhibit inflammatory responses in the lung in response to bacterial infection 
[67]. The literature suggests that one mechanism behind increased incidences of infection 
is the immunosuppression of alveolar macrophage function. Murine studies of chronic 
alcohol exposure and infection showed a decrease in alveolar macrophage phagocytosis, 
while rat studies with acute alcohol exposure revealed a decrease in the production of 
TNFα [78, 79]. Additionally, alcohol abuse has been linked to an increase incidence of 
acute respiratory distress syndrome (ARDS) [80].  ARDS is characterized by an increase 
in tissue edema and permeability to inflammatory cells that can lead to impaired gas 
exchange.  In a murine model of LPS-induced lung injury, acute alcohol exposure in vivo 
increased neutrophil recruitment in to the alveolar space and decreased AM efferocytosis 
of apoptotic cells [81]. It has been postulated that resolution of inflammation in ARDS 
patients is in part impaired due to the effects of alcohol on AMs, once again emphasizing 
the importance of AMs in restoring normal lung function.  
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Burn injury, alcohol and systemic inflammation 
Incidences of burn injury in the Unites States 
 In the United States, there are over 480,000 incidences of burn injures that 
require medical treatment [82].  The 2014 National Burn Repository Report revealed that 
within these incidences of burn injury, 40,000 patients are admitted to the hospital and 
over 3,200 patients per year succumb to either burn injury alone or burn injury and smoke 
inhalation injury. Additionally, fire/flame injuries and scald injuries are the two most 
frequent occurrences of injury, at 43% and 34% [82], respectively. Majority of patients 
had an average burn size under 10% total body surface area (TBSA) and 70% of burn 
patients are adult men. The cost of care for burn injury survivors is about $14,000 for 
every day spent in the hospital, with an average total bill of $86,000 [82].   
Interestingly, pneumonia is the most common complication associated with burn 
injury and incidences of acquiring an infection correlated with an increased number of 
days spent in the hospital. Severe burn, with or without inhalation injury, is a common 
predisposing factor for the development ARDS [83, 84]. Clinical data show 42% of the 
mortality observed in burn patients is due to pulmonary complications [85, 86].  
Respiratory dysfunction in burn patients can be characterized by shallow breathing and 
fluid accumulation in the lung interstitium, leading to heightened vascular resistance and 
an increased effort to breathe [84, 86]. A net result of insufficient gas exchange underlies 
the large percentage of burn fatalities due to pulmonary complications.  Take together, 
these observations emphasize the importance of extreme care given to the lungs after 
burn injury.  
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Intoxication and burn injury 
Of the burn patients hospitalized each year, it speculated that nearly half of this 
population is under the influence of alcohol [87, 88].  Burn patients are already 
immunosuppressed and susceptible to systemic complications, but the addition of alcohol 
at the time of injury increases the chance of morbidity and mortality. Silver et al. 
estimated that patients that present to the emergency room with a positive BAC spend 
twice as many days in the intensive care unit, three times as many days on a ventilator, 
require more fluid resuscitation and 60% more surgical procedures than burn patients that 
were not intoxicated at the time of injury [89]. A longer hospital stay and more days 
intubated on a ventilator leads to an increased risk of pulmonary complications that 
predisposes burn patients to multiple organ failure, with the lungs preceding all other 
organs, as well as a higher chance of mortality [90, 91]. Additionally, research at our 
institution showed that intoxicated burn patients with inhalation injury had a smaller 
percent burn area in comparison to non-intoxicated burn patients. Yet, these patients still 
required the same amount of burn care treatment as patients that were not intoxicated and 
had larger injuries, acquiring a hospital bill of over $200,000 even with a mild injury 
[92]. Thus, the combined insult of being intoxicated at the time of burn injury is worse 
than burn injury alone. 
Gut-Liver-Lung Axis 
Pulmonary complications are proposed to arise as a result of damage in other 
organ systems after burn injury. Multiple organ failure after burn injury is associated with 
overgrowth of gut-derived bacteria and its translocation out of the intestinal lumen and 
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into lymphatic and portal blood systems [93, 94]. In both mice and humans, the 
gastrointestinal system is the first system to interact with alcohol after it is consumed and 
it is the primary site of alcohol absorption.  In animal models, the absorption of alcohol 
by the gut prior to burn injury has been shown to increase intestinal permeability and the 
translocation of bacteria and LPS out of the gut, in comparison to burn injury alone [95-
98].  With the majority of the portal blood supply filtering through the liver, increased 
bacterial burden may result in a greater hepatic response [99, 100].  This, in turn, triggers 
the hepatic production of IL-6, a marker of inflammation that, when found in high 
concentrations in the plasma, has been correlated with increased chance of morbidity and 
mortality in burn patients [101].  The next extensive capillary bed the blood encounters is 
located within the lungs. Heightened IL-6 levels and bacterial byproducts that either 
directly enter the bloodstream or enter the lymph are postulated as a mechanism behind 
exacerbated pulmonary inflammation that is observed after a mouse model of 
intoxication and injury [99] and may highlight why the lungs are one of the first organs to 
fail [84].    
Burn injury-induced lung apoptosis 
Pulmonary inflammation after intoxication and injury associated with similar 
pulmonary characteristics to ARDS in humans, including increased neutrophil 
infiltration, capillary permeability and pulmonary edema [83, 102, 103].  Our laboratory 
and others have established the adverse effect intoxication and injury has on lung tissue 
[99, 104-107].  We have found elevated levels of alveolar wall thickening, neutrophil 
accumulation, neutrophil chemokines KC and MIP-2, and increased pro-inflammatory 
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cytokine IL-6 levels, relative to either ethanol exposure or burn injury alone [99, 104-
107] (Figure 2). The increase in bacteria, LPS and IL-6 into the blood and lymph is likely 
a source of heightened pulmonary inflammation [108, 109]. As described above, AMs 
help coordinate inflammatory processes in the lungs, but their role and activation state in 
pulmonary inflammation after intoxication and injury is not known.  
Another feature of ARDS is the increased apoptosis of epithelial cells in the lung 
tissue, described in both humans and in mouse models [110-112]. Not surprisingly, burn 
injury is associated with increased apoptosis in both lymphoid and parenchymal tissue, 
including the thymus, spleen, and lungs [113-115].  Mesenteric lymph nodes have also 
been highly postulated as likely source of gut-derived factors that initiate inflammation in 
the lungs after burn injury [115, 116].  In a rodent model of 40% TBSA scald injury, an 
increase in apoptotic cells in the lungs was found at 3 h, but a division of the mesenteric 
lymph prior to burn injury decreased lung apoptosis at this time point, in comparison to 
burn injured control counterparts [116]. This further supports the hypothesis that systemic 
inflammatory mediators are responsible for increased pulmonary inflammation after burn 
injury.  In contrast, other studies have assessed apoptosis in the lungs at 3 and 8 h after a 
20% scald injury in mice, but have found varying results on the presence of apoptotic 
cells in the lung tissue [113, 114, 117]. Fukuzuka et al. reported an increase in apoptosis 
in the thymus and spleen 3 and 24 h after burn injury, but not in the lungs and liver [113, 
114].  Using various methods to detect apoptosis, including terminal deoxynucleotidyl 
transferase-dUTP nick end labeling (TUNEL) staining, caspase-3 activity and mRNA 
levels of TNFα and Fas ligand (FasL), their results suggested that the apoptosis observed  
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Figure 2: Pulmonary inflammation after intoxication and injury. In steady-state 
conditions, CD11c
+
Siglec-F
+
CD206
+
(CD11b
-
) AMs maintain tolerance and suppress 
inflammatory responses through inhibitory receptors SIRPα,that binds SP-A and SP-D, 
and mannose receptor CD206.  As a result of heightened levels bacteria/LPS and IL-6 in 
the blood stream after intoxication and injury, there is increased alveolar wall thickening, 
neutrophil accumulation in the interstitium and an increase in neutrophil chemoattractants 
KC and MIP-2, and IL-6 in lung tissue. The activation state and mediators produced by 
AMs and their role in inflammation after intoxication and injury had not been 
determined. Co-illustration credit to C.L. Shults 
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in the lymphoid organs was a result of increased caspse-3 activity and was not 
dependent on LPS or TNFα.  Another study examined apoptosis in the lung at 8 h post-
burn injury and found at this time point there was an increase in caspase-3 activity, but 
not in TUNEL
+
 cells in lung tissue [117]. The range of results of these studies are likely 
due to differences in the model of burn injury, as well as the methods of apoptotic cell 
detection. Of note, these studies failed to identity the cell type undergoing apoptosis in 
any of the organs, including the lung. Since both AMs and epithelial cells are regulators 
of neutrophil recruitment and AMs are also key organizers of resolving inflammation, the 
fate of both of these cells after intoxication and injury is equally important.  
 
Mesenchymal stem cells  
Therapeutic agents in lung injury 
Bone marrow-derived mesenchymal stem cells (MSCs) are a multipotent 
population of stromal cells that are capable of differentiating into osteoblasts, 
chondrocytes and adipocytes [118].  In addition to their differentiating properties, they 
have been characterized as modulators of acute inflammation by virtue of their ability to 
influence the phenotype of macrophages [119]. Exogenous MSC interaction with 
macrophages and their release of paracrine soluble factors have been shown to suppress 
inflammation and polarize macrophages into an M2, anti-inflammatory phenotype [119-
123]. Many studies suggest that the intravenous administration of MSCs results in the 
entrapment of MSCs within the lungs [124-126].  Due to their large size, MSCs become 
trapped within the pulmonary vasculature with only a fraction of these cells passing 
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through and migrating to other organs. Specifically, intravenous administered MSCs 
have been shown to localize in the lungs and interact with AMs, stimulating AM release 
of IL-10 [121].  This property characterizes MSCs as a useful therapeutic in acute lung 
injury. 
Thus far, MSC therapy in burn injury has been focused on wound repair, where 
MSCs are administered near the site of injury [127-130].  Xue et al. demonstrated the 
plasticity of MSCs to differentiate into tissue-specific cells and to promote accelerated 
wound healing, while others have shown an increase in neoangeogenesis and a decrease 
in cellular infiltration at the wound site [130, 131]. Alternative routes of MSC 
administration and their therapeutic applications is an understudied field in burn research 
[129], but their anti-inflammatory properties and the ease of which they lodge in the lung 
after intravenous injections, suggests they would be beneficial to attenuating pulmonary 
inflammation after burn injury. 
In summary, maintaining lung function after intoxication and burn injury is 
critical to promoting survival in burn patients. AMs are key orchestrators in both pro- and 
anti-inflammatory responses in the lung and their role in promoting the resolution of 
inflammation is necessary for the restoration of lung homeostasis.  A disruption in the 
balance of this function can result in excessive inflammatory mediators and injury to the 
lung tissue, including damage to the alveolar-capillary interface and gas exchange. 
Therapeutic agents that specifically target AMs and their function in reducing 
inflammation would be beneficial to the indirect lung damage amassed after burn injury. 
Mesenchymal stem cell’s ability to localize to the lungs and influence an anti-
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inflammatory activation profile by AMs, underline MSCs as a promising therapeutic to 
reduce inflammatory responses in the lung. Deciphering if MSCs can attenuate 
pulmonary inflammation after intoxication and injury will highlight the potential benefits 
of MSCs in other models of trauma injury and systemic inflammation. 
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CHAPTER 3 
 IMPAIRED RESPIRATORY FUNCTION PARALLELS HEIGHTENED 
PULMONARY INFLAMMATION AFTER EPISODIC BINGE ETHANOL 
INTOXICATION AND BURN INJURY 
Abstract 
Clinical data indicate that cutaneous burn injuries covering greater than ten 
percent total body surface area are associated with significant morbidity and mortality, 
where pulmonary complications, including ARDS, contribute to nearly half of all patient 
deaths. Approximately 50% of burn patients are intoxicated at the time of hospital 
admission, which increases days on ventilators by three-fold, and doubles length of 
hospital admittance, compared to non-intoxicated burn patients. The most common 
drinking pattern in the United States is binge drinking, where one rapidly consumes 
alcoholic beverages (4 for women, 5 for men) in 2 hours and an estimated 38 million 
Americans binge drink, often several times per month. Experimental data demonstrate a 
single binge ethanol exposure prior to scald injury, impairs innate and adaptive immune 
responses, thereby enhancing infection susceptibility and amplifying pulmonary 
inflammation, neutrophil infiltration, and edema, and is associated with increased 
mortality. Since these characteristics are similar to those observed in ARDS burn 
patients, our study objective was to determine whether ethanol intoxication and burn 
injury and the subsequent pulmonary congestion affects physiological parameters of lung
  
 
26 
function using non-invasive and unrestrained plethysmography in a murine model 
system. Furthermore, to mirror young adult binge drinking patterns, and to determine the 
effect of multiple ethanol exposures on pulmonary inflammation, we utilized an episodic 
binge ethanol exposure regimen, where mice were exposed to ethanol for a total of 6 days 
(3 days ethanol, 4 days rest, 3 days ethanol) prior to burn injury. Our analyses 
demonstrate mice exposed to episodic binge ethanol and burn injury have higher 
mortality, increased pulmonary congestion and neutrophil infiltration, elevated neutrophil 
chemoattractants, and respiratory dysfunction, compared to burn or ethanol intoxication 
alone. Overall, our study identifies plethysmography as a useful tool for characterizing 
respiratory function in a murine burn model and for future identification of therapeutic 
compounds capable of restoring pulmonary functionality.  
Introduction 
Burn injury is associated with significant morbidity and mortality, with greater 
than 10% of patients succumbing to their injuries when the burn size exceeds 10% of 
their total body surface area [82]. Clinical data suggest that 42% of the mortality 
observed in burn patients is due to pulmonary complications [85, 86]. Severe burn, even 
in the absence of inhalation injury, is a common predisposing factor for the development 
of Acute Respiratory Distress Syndrome (ARDS) [83, 84]. ARDS is associated with rigid 
lungs, hypoxemia, and bi-lateral infiltrates in chest radiographs [132]. Overall, 
respiratory dysfunction in burn patients is characterized by shallow breathing and fluid 
accumulation in the lung interstitium, leading to heightened vascular resistance and an 
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increased effort to breathe [84, 86]. A net result of insufficient gas exchange underlies 
the large percentage of burn fatalities due to pulmonary complications. 
Binge alcohol drinking is an increasingly prevalent activity, affecting an 
estimated 38 million adults in the United States [133].  It is characterized by either the 
number of alcoholic drinks one consumes in 2 hours (4 for women, 5 for men) or by a 
blood alcohol concentration of 0.08%.  Interestingly, approximately 50% of burn patients 
are under the influence of alcohol at the time of hospital admission [88, 89]. Intoxicated 
burn patients have three times as many days on ventilators and an overall twice as long 
hospital stay compared to burn patients who were not intoxicated [89, 134].  This leads to 
an increased risk of pulmonary complications that predisposes burn patients to multiple 
organ failure, with the lungs preceding all other organs, as well as a higher chance of 
mortality [90, 91].  Notably, the vast majority of intoxicated burn patients are binge 
drinkers and not chronic dependent drinkers [59, 135, 136]. Experimental models of 
binge alcohol intoxication and burn injury have demonstrated alterations in innate and 
adaptive immunity that result in the marked immune dysfunction, greater susceptibility to 
infection, and amplified pulmonary inflammation [104-106, 137-143]. Previously, our 
laboratory established that in a mouse model of single-dose binge ethanol exposure and 
burn injury there is amplified neutrophil infiltration, alveolar wall thickening, and edema 
in the lungs when alcohol precedes burn injury [99, 104-107]. Since ARDS is associated 
with similar pulmonary characteristics in humans, including increased neutrophil 
infiltration, capillary permeability and pulmonary edema [83, 102, 103], the objective of 
our study was to determine whether intoxication and burn injury, and the resulting 
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histological pulmonary congestion, affects physiological parameters of lung function 
using a murine model system. 
In these studies, we used non-invasive and unrestrained plethysmography to 
examine the impact of pulmonary congestion caused by burn injury on breathing patterns 
and respiratory function [144]. This system measures the box flow, or the airflow in and 
out of the plethysmography chamber as a result of respiration.  Boyle’s law states that 
there is an inverse relationship between the volume and pressure of a gas when the 
temperature remains constant.  Therefore, using Boyle’s Law and special algorithms, the 
box flow can then be translated to the respiratory flow of an individual animal.   
 The Center for Disease Control (CDC) has reported 1 in 6 adults binge drink at 
least 4 times a month.  Additionally, weekend binge drinking is a pattern observed in 
many cultures [145]. To mirror this drinking pattern, our laboratory used a mouse model 
of episodic binge ethanol intoxication prior to burn injury (adapted from [146], [147-
150]) to assess respiratory physiology and gain an understanding of the effect of 
intoxication on lung function after burn injury. 
Overall, our analyses identify plethysmography as a useful tool for characterizing 
respiratory function in a murine model of ethanol intoxication and burn injury. Our 
studies demonstrate that episodic binge ethanol intoxication prior to burn causes 
increased pulmonary neutrophil infiltration. The timing of neutrophil accumulation in the 
lung parallels the heightened levels of lung neutrophil chemoattractants and is associated 
with respiratory dysfunction, which likely contributes to diminished survival rates.     
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Materials & Methods 
Mice 
Male (C57BL/6) mice were purchased from Jackson Laboratories (Bar Harbor, 
ME) and used at 8-10 weeks old. Mice were housed in sterile micro-isolator cages under 
specific pathogen-free conditions in the Loyola University Chicago Comparative 
Medicine facility. All experiments were conducted in accordance with the Institutional 
Animal Care and Use Committee.  Mice weighing between 22 to 27 g were used in these 
studies.  
Murine Model of Binge Ethanol and Burn Injury 
A murine model of episodic binge ethanol intoxication and burn injury was 
employed using intraperitoneal injections as described previously [138, 150, 151]. 
Animals were given ethanol (1.2g/kg) or saline vehicle at a dose designed to elevate the 
blood alcohol concentration (BAC) to 150 mg/dL at 30 min after ethanol exposure [142]. 
This dose of 150 μl of 20% (v/v) ethanol solution or saline control was given daily for 3 
days consecutively, mice were given 4 days without ethanol, and then given 3 additional 
daily ethanol doses. Thirty minutes following the final ethanol exposure, when the BAC 
was 150 mg/dl, the mice were anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine) 
and their dorsums shaved. The mice were placed in a plastic template exposing 15% of 
the total body surface area and subjected to a scald injury in a 92-95°C water bath or a 
sham injury in room-temperature water [138].  The scald injury results in an insensate, 
full-thickness burn [152].  The mice were then resuscitated with 1.0 ml saline and 
allowed to recover on warming pads.  All experiments were performed between 8 and 9 
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am to avoid confounding factors related to circadian rhythms.  Animals were either 
euthanized at 24 hours or survival was measured out to 7 days post-injury. 
Plethysmography 
Pulmonary function was assessed at 24 hours post-injury by using barometric 
plethysmography (Buxco Research Systems). BAC levels had returned to baseline 
undetectable levels at this time point [76]. Mice were placed in an unrestrained whole 
body barometric plethysmography chamber and allowed to acclimate to the environment 
before lung function parameters [99] were recorded for 10 minutes on a breath-by-breath 
basis. Enhanced pause (Penh), breath frequency (f), tidal volume (TVb) and minute 
volume (MVb) were analyzed. 
Histopathologic Examination of the Lungs 
 The upper right lobe of the lung was inflated with 10% formalin and fixed 
overnight as described previously [104], embedded in paraffin, sectioned at 5 μm, and 
stained with hematoxylin and eosin (H&E).  Sections were evaluated using light 
microscopy (Zeiss AxioVert, Zeiss, Thorndale, CA) and histology photographs were 
taken at 1000x magnification. To measure pulmonary congestion, photographs were 
taken in a blinded fashion of 10 high power fields (400X) per animal and analyzed using 
the Java-based imaging program ImageJ (National Institutes of Health, Bethesda, MD). 
The images were converted to binary to differentiate lung tissue from air space and then 
analyzed for the percent area covered by lung tissue in each field of view as described 
previously [107]. Neutrophils were counted in a blinded fashion in 10 high power fields 
(400X). 
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Measuring Neutrophil Counts by Flow Cytometry 
The upper left lung lobe was removed and cut into small pieces with a razor.  The 
lung tissue was then transferred to a C-tube (Miltenyi Biotec, Auburn, CA) and processed 
using digestion buffer containing 1mg/ml of Collagenase D and 0.1 mg/ml DNase I 
(Roche, Indianapolis, IN) in HBSS and a GentleMACS dissociator (Miltenyi Biotec), 
according to manufacturer’s instructions.  The homogenates were then filtered through 70 
um nylon cell strainers to obtain a single cell suspension. Red blood cells were lysed 
using ACK lysis buffer (Life Technologies, Grand Island, NY). Cells were counted using 
trypan blue to exclude dead cells.  To assess neutrophil numbers, 1x10
6
 lung cells were 
first incubated with anti-CD16/32 (clone 93,eBioscience, San Diego, CA) to block 
unspecific binding to the Fcy II/III receptor.  Cells were then immunostained with rat 
anti-mouse antibodies: CD45 e780 (clone30-F11, eBioscience), CD11b e450 (clone 
M1/70, eBioscience), and Ly6G (Gr-1) PE Cy7-conjugated (clone RB6-8C5, 
eBioscience).  Antibody incubation was carried out for 30 minutes at 4
o
C.  Cells were 
washed and fixed as described [143, 153].  Samples were run on a BD Fortessa cytometer 
(BD Biosciences, San Jose, CA).  Data analysis was performed using Flow Jo FCS 
analysis software (Tree Star Inc., Ashland, OR).  
Cytokine Analysis of Lung Homogenates 
The right middle lung lobe was snap-frozen in liquid nitrogen and then 
homogenized in 1 ml of BioPlex cell lysis buffer according to manufacturer’s protocol 
(BioRad, Hercules, CA). The homogenates were filtered and analyzed for cytokine 
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production using a BioPlex multiplex bead array.  The results were normalized to total 
protein using the BioRad protein assay (BioRad) [106, 107]. 
Statistical Analysis 
 Statistical comparisons were made between the sham vehicle, sham ethanol, burn 
vehicle, and burn ethanol treatment groups. One-way analysis of variance (ANOVA) was 
used with Tukey’s post-hoc test or Bonferroni Multiple Comparisons test and values were 
considered statistically significant when p < 0.05. Data is reported as mean values ± the 
standard error of the mean (SEM). The Gehan-Breslow-Wilcoxon test was used to 
generate comparisons between burn groups in the survival study and Pearson’s 
correlation test was used to generate the correlation coefficient between neutrophil 
numbers and Penh, breath frequency, tidal volume, and minute volume. 
Results 
Binge Ethanol Intoxication Decreases Survival After Burn Injury 
Mice exposed to episodic binge ethanol intoxication and burn injury were 
monitored for survival out to 7 days post-injury. Both sham groups had 100% survival 
regardless of ethanol intoxication (Figure 3).  Survival of burn-injured mice exposed to 
ethanol was significantly lower (48% survival) (p < 0.05) when compared to burn-injured 
mice not exposed to ethanol (84% survival) (p < 0.05). Observed mortality in the 
combined injury group occurred within 72 hours of injury, with 5% succumbing by 24 
hours, 16% mortality between 24 and 48 hours and the majority of death, 31%, occurring 
between 48 and 72 hours. This suggests there is a therapeutic window between time of 
injury and 24 hours to potentially prevent mortality when ethanol precedes burn injury.  
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Figure 3. Decreased survival of mice exposed to ethanol prior to burn injury.  Mice were 
exposed to ethanol or saline as a control for a total of 6 days (3 days ethanol, 4 days rest, 
3 days ethanol) prior to burn injury and monitored for survival out to 7 days post-injury. 
p < 0.05, burn ethanol compared to burn vehicle by Gehan-Breslow-Wilcoxon test. Data 
were combined from 2 independent experiments and are expressed as percent survival. 
N = 4 (sham groups), n = 10-19 (burn groups).   
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Figure 4. Ethanol intoxication impairs post-burn lung function. Mice were placed in an 
unrestrained whole body barometric plethysmography chamber and lung function 
parameters were recorded for 10 minutes.  Penh, p < 0.05 burn ethanol versus all groups, 
p < 0.05 burn vehicle versus sham groups. Breath frequency, p < 0.05 burn ethanol versus 
all groups, p < 0.05 burn vehicle versus sham groups. Tidal volume, p < 0.05 burn 
ethanol compared to sham groups, p < 0.05 burn vehicle compared to sham groups. 
Minute volume, p < 0.05 burn ethanol compared to sham groups, p < 0.05 burn vehicle 
compared to sham groups.  Data were combined from 2 independent experiments. Data 
points shown as individual animals. N = 6-11 animals per group. 
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Intoxication Reduces Lung Function in Mice Subjected  
to Burn Injury 
Lung function was assessed 30 minutes prior to animals being euthanized at 24 
hours post-injury.  Enhanced pause (Penh), a measure of bronchoconstriction and airway 
resistance, revealed that animals that were intoxicated at the time of burn injury had an 
average Penh of 8, compared to sham groups with a Penh of less than 1 and burn injury 
alone with an average Penh of 3 (Figure 4A).  When ethanol intoxication precedes burn 
injury, this corresponds with an 8-fold increase in airway resistance, compared to sham 
groups (p < 0.05), and a 2.5-fold increase, compared to burn injury alone (p < 0.05). 
Moreover, our data reveal that animals with a Penh of 7 or above are at a greater risk for 
mortality.  The frequency of breaths per minute was also significantly decreased in both 
burn groups. Burn injury alone had a 39% decrease in the average number of breaths per 
minute compared to shams (p < 0.05), while intoxicated and burn-injured mice had a 59% 
decrease compared to shams (p< 0.05) and a 33% decrease compared to burn alone (p < 
0.05) (Figure 4B). Additionally, tidal volume, the amount of air that is inhaled and 
exhaled in a single breath, was decreased in both burn groups compared to sham groups 
(p < 0.05) (Figure 4C). Minute volume, the amount of air inhaled and exhaled per minute, 
was also decreased in both burn groups (Figure 4D). Compared to shams, burn injury 
alone had a 60% decrease in the amount of air per minute (p<0.05), while intoxicated and 
burn-injured mice had an 80% decrease (p<0.05).  Furthermore, combined injury had a 
52% decrease compared to burn alone, though this did not reach statistical significance.  
These data indicate burn injury alone induces abnormal breathing patterns, however, 
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when intoxication precedes burn injury, there is a dramatic increase in airway resistance 
and a pronounced reduction in lung function. Overall, intoxicated and burn injured 
animals have a shallow, slower breathing rate than burn injury alone, indicative of overall 
respiratory dysfunction. 
Elevated Pulmonary Neutrophil Infiltration and Congestion  
after Intoxication and Burn Injury 
Similar to the single-dose binge ethanol and burn injury results previously 
reported by our laboratory, [104-107] histochemical analyses of sectioned lung tissue 
demonstrated that episodic binge ethanol intoxication prior to burn injury results in 
increased cellularity and alveolar wall thickening 24 hours post-injury (Figure 5A-C).  
Neutrophils were counted by light microscopy as previously described [104].  When 
intoxication preceded burn injury, there was a 10-fold increase compared to sham groups 
(p < 0.05) and an approximate 1.5-fold increase compared to burn alone (Figure 5B). 
Additionally, these neutrophils were localized to the interstitium and not the alveolar 
space. Pulmonary congestion was quantified using imaging software to measure the area 
of lung tissue in 10 high power fields per animal and is reported as a percentage of the 
entire field of view. Intoxicated and burn injured animals had a significant increase in 
tissue area compared to all other groups (p < 0.05), correlating to a decrease in air space 
and an increase in pulmonary congestion (Figure 5C).  Notably, these changes were 
isolated to the distal airways. There were no apparent changes in the larger airways.  
To further demonstrate that neutrophils were the key cell type contributing to the 
escalated cellularity, flow cytometry was performed. Flow cytometric analysis of cellular  
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Figure 5. Episodic binge ethanol results in similar pulmonary congestion as single dose 
binge ethanol and burn injury.  Lungs were sectioned and stained with H&E and assessed 
for cellular infiltration and alveolar wall thickening. A) Representative sections from 
each treatment group are shown at 1000x. B) Neutrophils were counted by light 
microscopy in H&E-stained lung sections 24 hours after intoxication and burn injury. 
Data are shown as the total number of neutrophils in 10 high power fields (400x). C) 
Quantification of pulmonary congestion 24 hours after injury. * p < 0.05 compared to 
sham groups; # p < 0.05 compared to all groups. Data are presented as mean values ± 
SEM. N = 3-6 animals per group. 
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Figure 6. Ly-6G
+
CD11b
+ 
neutrophils are elevated after episodic binge ethanol and burn 
injury.  Lung tissue was obtained 24 hours post-injury from all treatment groups.  Tissue 
was digested into a single cell suspension and cells were analyzed by flow cytometry. A) 
Representative gating for Ly-6G
+
CD11b
+
 neutrophils (box) of CD45
+
F4/80
-
 cells (data 
not shown) from all four treatment groups.  B) Absolute number of neutrophils in lung 
isolates.  * p < 0.05 versus sham groups.  Data are presented as mean of total neutrophils 
from 100,000 lung cells per group ± SEM.  N = 3-6 animals per group. 
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subsets in the lung revealed dramatically increased CD45
+
CD11b
+
Ly6G
+ 
neutrophil cell 
counts in intoxicated and burn injured mice at 24 hours post-injury, compared to sham 
and isolated burn injury alone (p < 0.05) (Figures 6A&B ). Mice exposed to the 
combined insult had a 7-fold increase (p < 0.05) in neutrophil numbers when compared to 
both sham groups and a 1.5-fold increase when compared to burn-injured animals 
without ethanol intoxication, confirming that neutrophils contribute to increased 
cellularity in the lungs of intoxicated and burn-injured mice. 
It was also observed that the increase in the number of neutrophils corresponded 
to an increase in Penh and decreases in breath frequency, tidal volume and minute 
volume. Pearson’s correlation coefficient was used to determine if there was a linear 
relationship between the number of infiltrating neutrophils and lung function 
measurements. We found a positive correlation between the number of neutrophils and 
Penh (r = 0.9597) and negative correlations between neutrophil numbers and breath 
frequency (r = -0.9866), tidal volume (r = -0.9777) and minute volume (r = -0.9784). 
These data emphasize the potential use of plethysmography as an instrument to determine 
the effect of neutrophil accumulation in lung tissue on overall lung function.  
Ethanol Intoxication Before Burn Injury Enhances Pulmonary KC and Macrophage 
Inflammatory Protein - 2 (MIP-2) Levels 
Since we observed increased neutrophil infiltration, we next sought to examine 
levels of the neutrophil chemoattractants, KC and MIP-2. Similar to our single-dose 
binge ethanol and burn injury findings [104-106], the upregulation of neutrophil  
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Figure 7.  Heighted pulmonary neutrophil chemokine KC and MIP-2 levels after episodic 
binge ethanol and burn injury.  Lung homogenates from all four treatment groups were 
analyzed for levels of A) KC and B) MIP-2. * p < 0.05 versus sham groups; # p < 0.05 
versus all treatment groups. Data are presented as the mean in picograms per milligram of 
protein ± SEM.  N = 3-6 animals per group. 
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chemokines KC and MIP-2 highlight a mechanism behind the increase in pulmonary 
neutrophil accumulation in episodic binge ethanol exposed and burn-injured mice (Figure 
7). Combined injured animals had an 11-fold more KC than both sham groups (p < 0.05) 
and 1.8-fold more KC than burn injury alone (Figure 7A). Additionally, MIP-2 was 
significantly upregulated compared to all treatment groups, with a 6-fold increase in 
MIP-2 compared to sham groups (p < 0.05) and a 2.5-fold increase compared to burn 
injury alone (p < 0.05) (Figure 7B).   
Summary 
Intoxication at the time of burn injury increases bacterial translocation from the 
intestines into the lymphatic system and bloodstream.  Excessive levels of IL-6 and 
endotoxins not removed by the liver may circulate to the vascular bed of the lungs and 
initiate pulmonary inflammation and congestion [95-100].  Prior to this study, it was not 
known how multiple doses of ethanol would affect burn-induced pulmonary 
inflammation.  Ethanol intoxication alone has been shown to suppress immune responses 
in many organs, including the lungs [8, 75, 154, 155].  Whether episodic ethanol 
intoxication before burn injury would yield heightened or diminished pulmonary 
inflammatory effects had yet to be determined. It was also not known how intoxication 
prior to injury affects lung function.  Here, we have demonstrated that episodic binge 
ethanol prior to burn injury causes heightened pulmonary inflammatory responses and 
congestion, paralleling single-dose binge ethanol exposure.  Importantly, we have found 
that these histologic inflammatory responses cause physiological derangements in 
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intoxicated and burn-injured animals, including increased airway resistance and 
abnormal breathing patterns. These findings highlight an underlying mechanism 
contributing to the drastic mortality rate observed in mice exposed to both ethanol and 
burn injury.  
In conclusion, these data emphasize the importance of immediate burn care 
treatment within the few hours after injury, to stabilize breathing patterns and to maintain 
respiratory function, especially when patients are intoxicated at the time of injury.  Non-
invasive, unrestrained whole-body plethysmography will be a useful tool in future animal 
studies to help identify therapeutic reagents that can improve respiratory function in all 
burn patients. 
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CHAPTER 4 
LOSS OF ALVEOLAR MACROPHAGES CORRELATES WITH ELEVATED 
NEUTROPHIL NUMBERS IN THE LUNG FOLLOWING INTOXICATION AND 
BURN INJURY 
 
Abstract 
Clinical evidence reveals that half of all burn patients brought to the emergency 
department are intoxicated at the time of injury.  This combined insult results in 
amplified neutrophil accumulation in the lung and pulmonary edema, with an overall 
increased risk of lung failure and mortality, relative to either insult alone. We and others 
believe that this excessive pulmonary inflammation, that also parallels decreased lung 
function, is attributed, in part, to AM function. Restoration of lung tissue homeostasis is 
dependent on the eradication of neutrophil infiltration and removal of apoptotic cells, 
both major functions of AMs.  With lung function impairment causing a likely decrease 
in gas exchange, we chose to examine the fate of these multi-functional cells. Thirty 
minutes after binge ethanol intoxication, mice were anesthetized and given a 15% total 
body surface area dorsal scald injury. At 24 h, we found a 50% decrease in the number of 
AMs (p<0.05) and 7-fold more TUNEL
+
 apoptotic cells (p<0.05) in the lungs after 
intoxication and injury, relative to control.  Analysis of annexin V and propidium iodide 
on BAL AMs revealed a 2-fold increase in the percent of dead AMs (p<0.05) and a 3-
fold increase in the percent of apoptotic AMs, above that of controls.  Interestingly, AMs 
that were recovered from intoxicated and injured mice had 5-fold more phagocytic AMs, 
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relative to AMs from controls (p<0.05) and also spontaneously produced 5-fold more 
tumor necrosis factor α than controls (p<0.05).  Intratracheal clodronate liposome 
reduction of AMs correlated with a rise in lung neutrophil numbers in intoxicated and 
injured mice, relative to empty liposome treatment. In summary, these data support AMs 
role in managing neutrophil numbers and inflammation in the lung after intoxication and 
burn injury and the significant loss of AMs may delay resolution of inflammation, 
resulting in the elevated mortality rate observed in intoxicated and burn-injured patients. 
Introduction 
 ARDS is a common morbidity among severe burn-injured patients, with or 
without inhalation injury [83, 84]. Infiltration of inflammatory cells and increased 
pulmonary edema lead to impaired gas exchange and increase the risk of pulmonary 
failure [83, 102, 103], resulting in an estimated 42% of the mortality after burn injury 
linked to pulmonary complications [85, 86]. Alcohol is the most abused substance in the 
United States [133] and is a factor in many unintentional injuries, including burn injuries, 
making alcohol the 3
rd
 leading cause of preventable death [63]. The consumption of 
alcohol prior to injury can lead to worsened outcomes and clinical data suggests that 
nearly half of all burn patients that are taken to the emergency room have a positive blood 
alcohol content [88, 89, 92].  Notably, of those who consume alcohol, the majority of the 
drinkers are binge drinkers, not chronic dependent drinkers [59].  
We and others have established in a mouse model of intoxication and burn injury 
that lung inflammation mirrors similarities to the characteristic pathology of ARDS. 
Within the distal airways of the lung we found increased alveolar wall thickening and 
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neutrophil accumulation into the interstitium, that paralleled heightened levels of 
neutrophil chemokines KC and MIP-2, as well as pro-inflammatory cytokine IL-6 levels, 
relative to either ethanol exposure or burn injury alone [99, 104-107, 156].  The increased 
number of neutrophils infiltrating into the lung interstitium correlated to a decrease in 
lung function. This pulmonary inflammation therefore may have causative role in 
increased mortality associated with alcohol exposure prior to burn injury [156].  
  AMs are the lungs first line of defense against inhaled particles or pathogens and 
elegantly coordinate the on-set and resolution of inflammation [157]. The transition from 
steady-state healthy conditions to an inflammatory state is made possible by the plasticity 
of macrophages to readily activate into a reversible inflammatory profile as either a pro-
inflammatory, M1 macrophage or an anti-inflammatory, M2 macrophage, depending on 
mediators present within the microenvironment. AMs have a phenotype distinct from 
other tissue-resident macrophage populations and can be characterized as CD11c
+
CD11b
-
Siglec-F
+
F4/80
+
, with constitutive expression of mannose receptor CD206 and low to 
negative expression of major histocompatibility complex class II (MHC II) [20, 21, 158]. 
The upregulation of specific receptors on AMs can define AM function in different stages 
of inflammation.  Scavenger receptor MARCO is described as a marker of pro-
inflammatory M1 macrophages and aids in the clearance of apoptotic cells (termed 
efferocytosis) [159] [32, 160].  Additionally, CD11b is also an important receptor in 
efferocytosis [161]. During the resolution phase of inflammation, CD206 has been 
characterized as a marker of a M2, anti-inflammatory profile [34, 162-164], thus an up or 
down regulation of CD206 on AMs from baseline levels could suggest a transition to an 
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activated profile. Lastly, M2 marker interleukin (IL)-10 receptor (IL-10R) on AMs is 
also important in regulating inflammation, where the ligation of IL-10R indirectly 
inhibits the TLR4 signaling pathway, decreasing pro-inflammatory cytokine release [33].  
During an inflammatory response in the lung, excessive levels of mediators 
produced by macrophages or neutrophils can result in tissue damage if not properly 
regulated [41].  Therefore, lung inflammation needs to be a highly monitored process.  
Resolution is achieved through pathogen clearance, downregulation of neutrophil 
chemokines and the removal of apoptotic cells, such as neutrophils, all potential functions 
AMs [165]. Specifically, macrophage efferocytosis can down regulate NO release and 
upregulate IL-10 and TGFβ [43-46]. Burn injury and apoptosis studies revealed an 
increase in apoptosis in both lymphoid and parenchymal tissue, including the thymus, 
spleen, and lungs, at 3 and 8 h post-injury; however, the specific cell subsets undergoing 
apoptosis were not analyzed in these studies [113-115]. Moreover, another feature of 
ARDS is the increase in apoptosis of epithelial cells in the lung tissue, described in both 
humans and in mouse models [110-112]. The role of AMs in coordinating on-going 
inflammation and the timely initiation of resolution emphasizes that the activation profile 
and fate of AMs during inflammation is critical to restoring lung homeostasis.  
Since intoxication at the time of injury results in greater pulmonary complications 
and mortality rates than burn injury alone, we chose to examine the role of AMs in only 
intoxicated and burn-injured mice, in comparison to sham vehicle control.  In this study, 
we examined the role of AMs in pulmonary inflammation after intoxication and burn 
injury. Our results suggest that at 24 h after injury there is a 50% reduction in the number 
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of AMs present within the lung tissue, but AMs that were isolated from the tissue 
exhibited an efferocytosis function.  Upregulation of MARCO and CD11b are consistent 
with findings of increased efferocytosis by AMs. Additionally, we found heightened 
numbers of apoptotic cells in the lungs and identified AMs as at least a small population 
of these apoptotic cells. Finally, clodronate liposome reduction of AMs prior to 
intoxication and injury correlated with an increase in neutrophil numbers, in comparison 
to intoxicated, injured and empty liposome treated mice.  We conclude that AMs role in 
clearing apoptotic cells and limiting the number of neutrophils in the lung is subdued by 
an increase in the apoptosis of AMs.   
Materials & Methods 
Mice 
Male (C57BL/6) mice were purchased from Jackson Laboratories (Bar Harbor, 
ME) and used at 8-10 weeks old. Mice were housed in sterile micro-isolator cages under 
specific pathogen-free conditions in the Loyola University Chicago Comparative 
Medicine facility. All experiments were conducted in accordance with the Institutional 
Animal Care and Use Committee.  Mice weighing between 22 to 27 g were used in these 
studies.  
Murine Model of Binge Ethanol and Burn Injury 
A murine model of single dose binge ethanol intoxication and burn injury was 
employed using oral gavage as described previously [138, 150, 151]. Animals were given 
400 μl of 10% (v/v) ethanol solution (1.6 g/kg) or water control by gavage at a dose 
designed to elevate the blood alcohol concentration to 150 mg/dL at 30 min after ethanol 
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exposure [142]. Thirty minutes following the ethanol exposure, the mice were 
anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine) and their dorsum shaved. The 
mice were placed in a plastic template exposing 15% of the total body surface area and 
subjected to a scald injury in a 92-95°C water bath or a sham injury in room-temperature 
water [138].  The scald injury results in an insensate, full-thickness burn [152].  The mice 
were then resuscitated with 1.0 ml saline and allowed to recover on warming pads.  All 
experiments were performed between 8 and 9 am to avoid confounding factors related to 
circadian rhythms. Animals were euthanized at 24 hours.  
Histopathologic Examination of the Lungs 
 The upper right lobe of the lung was inflated with 10% formalin and fixed 
overnight as described previously [104], embedded in paraffin, sectioned at 5 μm, and 
stained with hematoxylin and eosin (H&E).  Sections were evaluated using light 
microscopy (Zeiss AxioVert, Zeiss, Thorndale, CA) and histology photographs were 
taken at 400x magnification. Neutrophils were counted in a blinded fashion in 10 high 
power fields (400X).  
Cytokine Measurements in Lung Homogenates 
The right middle lung lobe was snap-frozen in liquid nitrogen and then 
homogenized in 1 ml of BioPlex cell lysis buffer according to manufacturer’s protocol 
(BioRad, Hercules, CA). The homogenates were filtered and analyzed for cytokine 
production using a BioPlex multiplex bead array [106, 107].  The results were normalized 
to total protein using the BioRad protein assay (BioRad). 
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Isolation of Cells from Lung Tissue  
The upper left lung lobe was removed and cut into small pieces with a razor.  The 
lung tissue was then transferred to a C-tube (Miltenyi Biotec, Auburn, CA) and processed 
using digestion buffer containing 1mg/ml of Collagenase D and 0.1 mg/ml DNase I 
(Roche, Indianapolis, IN) in HBSS and a GentleMACS dissociator (Miltenyi Biotec), 
according to manufacturer’s instructions.  The homogenates were then filtered through 70 
um nylon cell strainers to obtain a single cell suspension [21]. Red blood cells (RBCs) 
were lysed using ACK lysis buffer (Life Technologies, Grand Island, NY). Cells were 
counted using trypan blue to exclude dead cells.   
Bronchoalveolar Lavage 
The lungs of mice were lavaged 5 times with 1 mL of cold PBS to obtain the 
bronchoalveolar lavage (BAL) fluid [76]. All lavage washes were pooled per animal. 
Cells were spun at 1200 rpm for 3 min at 4°C.  RBCs were lysed using ACK lysis buffer, 
washed and spun at 1200 rpm for 3 min at 4°C.  Cells were resuspended up to 400ul in 
PBS and counted using a hemocytometer. Cells were either analyzed by flow cytometry, 
cultured in chamber slides or cytocentrifued onto slides. 
Flow Cytometry Analysis of Alveolar Macrophages 
To assess alveolar macrophages, 1x10
6
 lung cells or 1x10
5
 BAL cells were first 
incubated with anti-CD16/32 (clone 93,eBioscience, San Diego, CA) to block unspecific 
binding to the Fcy II/III receptor.  Cells were then immunostained with rat anti-mouse 
antibodies: CD11c APC-eFluor 780 (clone N418, eBioscience), CD11b eFluor 450 (clone 
M1/70, eBioscience), Siglec-F PE-CF594 (clone E50-2440, BD Biosciences, San Jose, 
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CA), CD206 PE (clone C068C2, Biolegend, San Diego, CA), Ly-6G (Gr-1) PE-Cy7 
(clone RB6-8C5, eBioscience), F4/80 APC (clone BM8, eBioscience), MHC II (I-A/I-E) 
V500 (clone M5/114.15.2, BD Biosciences), TLR4/MD-2 APC (clone MTS510, 
eBioscience), IL-10R PE (clone 1B1.3a, BD Biosciences), MARCO FITC (clone ED31, 
AbD Serotec, Raleigh, NC) [21].  Antibody incubation was carried out for 30 minutes at 
4
o
C.  Cells were washed and fixed as described [143, 153].  MHC II was used as a M1 
marker and CD206 was used a M2 marker [21].  In separate experiments, apoptosis and 
cell death was also assessed on BAL alveolar macrophages using an Alexa Fluor® 488 
Annexin V/Dead Cell Apoptosis Kit (Life Technologies), according to the 
manufacturer’s protocol. Samples were run on a BD Fortessa cytometer (BD 
Biosciences).  Data analysis was performed using Flow Jo FCS analysis software (Tree 
Star Inc., Ashland, OR). BAL alveolar macrophages were also analyzed for apoptosis 
using a CellEvent™ Caspase-3/7 Green Flow Cytometry Kit (Life Technologies), 
according to manufacturer’s protocol, in combination with Siglec-F PE (BD 
Biosciences).  Samples were run on an Amnis ImageStreamX flow cytometer (Millipore, 
Billerica, MA) and analyzed on IDEAS software (Amnis Millipore, Seattle, WA).   
Intracellular Staining of iNOS and ARG1  
BAL cells were isolated and plated at 50,000 cells in 200ul complete medium (RPMI 
without phenol red with 10% FBS and 5% penicillin-streptomycin-glutamine (PSG)) per 
chamber slide well. Slides were incubated 1.5 h at 37
°
C to let macrophages adhere. 
Supernatant was removed and stored at -80
°
C for future cytokine analysis studies using a 
BioPlex multiplex bead array. Cells fixed with 4% PFA for 20 minutes at room 
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temperature and then permeabilized with 0.2% Triton X-100 for 30 min at 37
°
C, 
followed by 10 min at room temperature. To block non-specific binding, cells were 
incubated with superblock for 5mins at room temperature and stained overnight 4
o
C with 
mouse anti-mouse Arginase 1 (ARG1) (Abcam, Cambridge, MA) and rabbit anti-mouse 
inducible nitric oxide synthase (iNOS) (Abcam).  Secondary antibodies donkey anti-
mouse IgG 488 (Abcam) and donkey anti-rabbit IgG 594 were applied for 1.5 h at room 
temperature.  Slides were air dried and mounted with Prolong Gold Dapi (Life 
Technologies).  
Analysis of Alveolar Macrophages 
BAL cells were cytocentrifuged onto slides using a Shandon Cytospin 2. Briefly, 
50,000 BAL cells were resuspended in total of 200ul PBS and cytocentrifuged at 
400RPM for 5 min. Slides were stained with HEMA 3 differential stain and analyzed 
using light microscopy (EVOS, Life Technologies).  Photographs of cells were taken at 
100x and 400x magnification. Phagocytic alveolar macrophages were counted in a 
blinded fashion in 5 high power fields (400X). Additionally, cytocentrifuged cells were 
stained with rabbit anti-mouse active-caspase 3 antibody (Abcam), followed by 
secondary antibody donkey anti-rabbit IgG 594.  Briefly, cells were fixed with 4% 
paraformaldehyde (PFA), permeabilized with 0.1% Triton-100x in 2% BSA and blocked 
with 10% normal donkey serum.  In a humidity chamber, cells were incubated with rabbit 
anti-mouse active-caspase 3 overnight at 4
o
C, followed by donkey anti-rabbit IgG 594 for 
1 h at room temperature. Slides were air dried and mounted with Prolonged Gold Dapi 
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(Life Technologies).  Immunofluorescent photographs were taken at 1000x using a 
Zeiss AxioVert microscope.  
TUNEL Immunofluorescent Staining in Lung Tissue 
The upper right lobe of the lung was inflated with 10% formalin and fixed 
overnight as described previously embedded in paraffin, sectioned at 5 μm [104].  A 
Click-it® Plus in situ terminal deoxynucleotidyl transferase-dUTP nick end labeling 
(TUNEL) Alexa Fluor 488 assay was performed according to manufacturer’s protocol 
(Life Technologies) to detect apoptotic cells. Lung sections were evaluated using 
fluorescent microscopy (EVOS, Life Technologies) and photographs were taken at 100x 
and 400x.  TUNEL
+
 cells were counted in a blinded fashion in 10 low power fields 
(100X) using a Java-based imaging program ImageJ (National Institutes of Health, 
Bethesda, MD). The images were converted to binary to differentiate TUNEL
+
 from non-
fluorescent cells and then analyzed for the number of TUNEL
+
 cells in each field of view. 
Alveolar Macrophage Immunofluorescent Staining for Siglec-F 
The upper left lobe was inflated with 25% optimal cutting temperature (OCT) 
freezing medium, frozen in OCT over dry ice and stored at -80
o
C.  Tissue was 
cryosectioned at 6 μm and sections were air-dried for 1 hour at room temperature. Slides 
were fixed for 5 min in 4% PFA and blocked with superblock for 5 min. In a humidity 
chamber, sections were incubated overnight at 4
o
C with rat anti-mouse purified Siglec-F 
(Clone E50-2440, BD Biosciences), followed by secondary antibody goat anti-rat Alexa 
Fluor®  IgG (H+L) 555 (Life Technologies) for 1 h at room temperature. Slides were air 
dried and mounted with prolonged dapi gold (Life Technologies). For double staining of 
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Siglec-F and TUNEL, slides were first stained for Siglec-F, followed by TUNEL 
staining, according to the manufacturers protocol (Life Technologies).  Sections were 
evaluated using immunofluorescent microscopy (Zeiss AxioVert, Zeiss, Thorndale, CA) 
and photographs were taken at 400x and 1000x magnification.  
Depletion of Alveolar Macrophages 
AMs were depleted using clodronate encapsulated liposomes (Encapsula 
NanoSciences, Brentwood, TN). Briefly, mice were anesthetized (100 mg/kg ketamine 
and 10 mg/kg xylazine) and given intratracheal administration (75ul) of clodronate 
liposomes or control, empty liposomes.  Three days after clodronate administration, mice 
underwent our model of binge ethanol and burn injury and were euthanized at 24 h after 
injury. 
Serum Measurements 
Blood was collected via cardiac puncture and the serum was isolated at stored at   
-80°C.  Serum aliquots were used to measure IL-6 by enzyme linked immunosorbent 
assay (ELISA) (BD Biosciences, Franklin Lakes, NJ). 
Plethysmography 
Pulmonary function was assessed at 24 hours post-injury by using barometric 
plethysmography (Buxco Research Systems). BAC levels had returned to baseline 
undetectable levels at this time point [76]. Mice were placed in an unrestrained whole 
body barometric plethysmography chamber and allowed to acclimate to the environment 
before lung function parameters [99] were recorded for 10 minutes on a breath-by-breath 
basis. Enhanced pause (Penh), breath frequency (f), tidal volume (TVb) and minute 
  
  
54 
volume (MVb) were analyzed. 
Statistical Analysis 
 Statistical comparisons were made between the sham vehicle and burn ethanol 
treatment groups. Unpaired T-test was used and values were considered statistically 
significant when p < 0.05. Data is reported as mean values ± the standard error of the 
mean (SEM).  
Results 
Alterations In Alveolar Macrophage Populations After Intoxication And Injury 
We confirmed the phenotype of AMs obtained through either enzymatic 
dissociation of lung tissue or from the BAL fluid (see Appendix A).  Our observations of 
a decrease in the density of the AM population (Appendix A, Figure 31G), but an 
increase in the granularity of AMs that are present (Appendix A, Figure 32D) after 
intoxication and injury supported the examination of the absolute number and activation 
profile of AMs. Quantification of AMs revealed that in intoxicated and injured mice there 
was a 50% decrease in the number of AMs from dissociated lung tissue (p<0.05) (Figure 
8A), as well as a 50% decrease in the number of BAL cells recovered from BAL fluid 
(p<0.05) (Figure 8B), in comparison to sham mice. While it was not significant, there 
was a 1.5-fold increase in the number of CD11c
+
CD11b
+
F4/80
lo
Siglec-F
+
 intermediate 
AMs after intoxication and injury (Figure 8C). Expression of surface receptors using 
mean fluorescence intensity (MFI) revealed no significant change in the level of MHC II 
(Figure 9A). This was not surprising since we would not expect antigen presentation 
without an active lung infection in the airways. There was also no significant change in  
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Figure 8: A) Decreased number of CD11c
+
CD11b
-
Siglec-F
+
 AMs after intoxication and 
injury. Data are representative of cell counts per 350,000 total lung cells.  B) Number of 
cells recovered from BAL fluid after intoxication and injury.  Lungs were lavaged 5x 
with a total of 5mL of PBS. Total BAL cells were counted and presented as the average 
number of total cells recovered from BAL. C) Number of CD11c
+
CD11b
+
F4/80
lo
Siglec-
F
+
 intermediate AMs in dissociated lung tissue. Data are representative of cell counts per 
350,000 total lung cells.* p < 0.05. By unpaired T-test. Data shown as mean +/- SEM. 
N=4-6 animals per group.  
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Figure 9. AMs upregulate cell surface receptors after intoxication and burn injury. Lung 
tissue was dissociated into a single cell suspension and AMs were gated as 
CD11c
+
CD11b
-
Sigle-F
+ 
and analyzed by flow cytometry. Histogram over lay of average 
MFI on AMs in sham vehicle (blue) and burn ethanol (red) groups and scatter plot graph 
representation of MFI on AMs from individual animals for A) MHC II B) TLR4/MD-2 
C) MARCO D) CD11b E) CD206 and F) IL-10R. * p < 0.05. By unpaired T-test. Data 
are shown as mean ± SEM.  N = 3-6 animals per group. 
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the level of TLR4/MD-2 at 24 h after injury (Figure 9B). However, scatterplot 
representation of TLR4/MD-2 MFI on AMs from individual intoxicated and injured mice 
showed variability in its expression, with a trend toward upregulated TLR4/MD-2, 
further confirmed by a slight increase in the histogram overlay. This suggests that AMs 
may be activated by TLR4 ligands, such as LPS or endotoxins. We also observed a 
significant upregulation of MARCO and CD11b (p <0.05), receptors that are both 
important for efferocytosis (Figure 9 C&D). In contrast, there was no change in the 
expression of M2 markers CD206 or IL-10R (Figure 9 E&F).   
These phenotypic changes towards an inflammatory profile led us to examine the 
intracellular levels of additional M1 and M2 markers, iNOS and ARG1.  BAL cells 
isolated at 24 h post-injury were briefly cultured in chamber slides and 
immunofluorescent staining was used to evaluate these markers (Figure 10A). Results 
indicated there was not an increase in iNOS expression in comparison to ARG1, a 
phenotypic characteristic of pro-inflammatory macrophages (Figure 10B&C). iNOS has 
been shown to be important in killing intracellular bacteria [166], therefore the absence of 
an active lung infection in our model likely would not elicit an upregulation of iNOS by 
AMs.  
Increased lung apoptosis 24 h after intoxication and injury 
AMs comprise only 10% of the total cells found in the alveoli, yet their function 
in maintaining a pathogen-free environment is critical for lung homeostasis. The loss of 
AMs after intoxication and injury led us to investigate the fate of these regulatory cells 24 
h post-injury, predicting that the decrease in AMs correlated to an increase in AM  
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Figure 10. AMs express similar levels of iNOS and ARG1. BAL AMs from each group  
were cultured in chamber slides for 1.5 h.  Adherent cells were fixed and stained for 
iNOS (red), ARG1 (green, punctate staining) and nuclei (blue). A) Representative images 
from each treatment group. Corrected Total Cell Fluorescence (CTCF) was quantified for 
B) iNOS and C) ARG1. Data are shown as mean ± SEM. N=3-4 animals per group.  
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apoptosis.  Using immunofluorescent TUNEL staining, we assessed lung tissue for 
apoptotic cells. We observed numerous fluorescent punctate cells in lung tissue from 
intoxicated and injured mice (Figure 11A) quantification revealed that this group had 7-
fold more apoptotic cells than sham mice (p<0.05) (Figure 11B). We also stained lung 
tissue from intoxicated and injured mice for both Siglec-F and TUNEL to determine if 
AMs were a population of apoptotic cells, but we failed to observe co-localization of 
Siglec-F
+
 and TUNEL
+
 cells in lung tissue (Figure 12A). Using an imaging flow 
cytometer, we examined Siglec-F
+
 BAL AMs for apoptosis marker caspase-3/7 and 
observed Siglec-F
+
 cells were negative for caspase-3/7 expression. Cells with caspse-3/7
lo 
expression exhibited low to no surface expression of Siglec-F, but potentially had 
cytoplasmic expression of Siglec-F. Furthermore, caspase-3/7
hi
 cells did not express 
Siglec-F (Figure 12B-D).  Since > 92% BAL cells are AMs [8], this could suggest AMs 
lose Siglec-F as they undergo apoptosis and this may be the reason why we are unable to 
detect co-localization of the Siglec-F marker and TUNEL in lung tissue. At this time, we 
have yet to use other AM markers to identify TUNEL
+
 cells in lung tissue. The imaging 
flow cytometry data did not reveal a difference in caspase-3/7
+
 cells between treatment 
groups, but since this cytometer acquires images of cells, analysis had to be limited to 
only 500-1000 cells per sample.  The literature also suggests there is not a universal 
marker for apoptosis and it is recommended apoptosis should be measured using various 
methods [167]. 
BAL cells were next analyzed for apoptosis marker, annexin V and dead cell 
marker, propidium iodide (Figure 13A&B). Intoxicated and injured animals had a 2-fold  
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Figure 11. Increased apoptotic cells in the lung after intoxication and injury.  An 
immunofluorescent in situ TUNEL assay was used to identify apoptotic cells in lung 
tissue.  A) Representative images of TUNEL
+
 cells (green) after intoxication and injury, 
nuclei are blue, 200x magnification. B) Average number of apoptotic cells per 10x field 
after intoxication and injury. * p < 0.05. By unpaired T-test. Data are shown as mean ± 
SEM. N=2-4 animals per group.  
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Figure 12. No co-localization of TUNEL
+
 and Siglec-F
+
 cells in lung tissue after 
intoxication and injury.  A) Double staining of  TUNEL
+
 apoptotic cells (green) and 
Siglec-F
+
 alveolar macrophages (red) in lung tissue. 400x magnification.  Representative 
image demonstrating no co-localization between TUNEL
+
 and Siglec-F
+
 cells after 
intoxication and injury. B-D) Siglec-F (purple) and caspase-3/7 (green) staining of BAL 
cells were assessed using an Amnis imaging flow cytometer. B) Siglec-F
+
 cells negative 
for caspase-3/7, C) Siglec-F
lo
 cells with low caspase-3/7 and D) Siglec-F
- 
cells with high 
caspase-3/7.  
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Figure 13. Heightened alveolar macrophage apoptosis and cell death after intoxication 
and injury.  Flow cytometry was used to assess cell death and apoptosis of BAL cells 
using propidium iodide and annexin V staining. Representative gating of propidium 
iodide and annexin V positive BAL cells in A) sham vehicle and B) burn ethanol 
treatment groups. Percent C) dead D) apoptotic or E) total dead and apoptotic cells out of 
total number of alveolar macrophages. *p< 0.05. By unpaired T-test. Data shown as mean 
± SEM. N=4 animals per group.  
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increase in percent of dead cells (p<0.05) (Figures 13C) and a 3-fold increase in the 
percent of apoptotic cells (Figures 13D), in comparison to sham mice. Overall, 
intoxicated and injured animals had a 2.5-fold higher incidence of dead or apoptotic BAL 
cells (p<0.05), in comparison to sham animals (Figures 13E). This translated to 10% of 
BAL cells from sham animals being lost to cell death or apoptosis, while intoxicated and 
injured mice had 25% lost to cell death or apoptosis. With the BAL fluid containing > 
92% AMs, regardless of treatment group, these data suggest AMs are susceptible to 
apoptosis after intoxication and injury. 
TUNEL
+
 cells were also quantified in tissue that had been lavaged to obtain the 
BAL fluid, in comparison to non-lavaged lung tissue.  If alveolar macrophages were 
undergoing apoptosis, then we would predict to see a decrease in the number of apoptotic 
cells after the tissue had been lavaged in intoxicated and injured mice.  Interestingly, 
there was no difference in the number of TUNEL
+
 cells between total lung tissue and 
lavaged lung tissue (data not shown), but flow cytometry analysis of lavaged tissue 
showed lavaging the tissue only removed 5% of AMs, in comparison to non-lavaged 
lung.  The literature suggests that the majority of AMs are sessile and are not easily 
removed from the lungs after lavage [10]. In our laboratory, BAL fluid consistently 
yields less than 200,000 AMs in sham mice and less than 100,000 cells from intoxicated 
and injured mice. With only 1-2 million total AMs in mouse lungs, the removal of less 
than 100,000 cells calculates to the isolation of only 5-10% of total AMs in the lungs.  
This further supports our flow cytometry data that lavaging the lungs only removed 5% 
of AMs, therefore, it is not unusual that the removal of BAL cells from lung tissue would 
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not yield major differences in the number of apoptotic cells, especially since only 25% 
of the removed cells would be dead or apoptotic.  Taken together, these data suggest that 
AMs are only one population of the TUNEL
+
 cells.  Other cells undergoing apoptosis in 
the lungs are likely epithelial and endothelial cells.  
Active efferocytosis by AMs 
Phagocytic removal of apoptotic cells is an important function of alveolar 
macrophage to restore lung tissue to homeostasis.  Loss of AMs and an increase in 
apoptosis by non-AM cell populations led us to question whether the increase in 
apoptotic cells was due to the lack of AMs available to clear apoptotic cells. First, we 
determined whether AMs actively efferocytosed apoptotic cells. Since AMs from 
intoxicated and injured mice displayed more granularity and upregulated efferocytosis-
mediating receptors, we predicted AMs would be more phagocytic.  Analysis of the 
morphology of AMs from both treatment groups revealed that sham animals had healthy, 
uniform alveolar macrophages (Figure 14A&C), while AMs from intoxicated and injured 
animals had more phagocytic alveolar macrophages (Figure 14 B&D-F, arrows). The 
appearance of phagocytic AMs ranged from small translucent vesicles (Figure 14D) to 
larger bodies within AMs (Figure 14E&F).  We also observed blebbing of the cell 
membrane on some cells (Figure 14E, arrow head), which would support an increase in 
apoptosis by AMs, but we were unsure if this was a result of cytocentrifugation and did 
not count these cells.  Quantification of the percent of phagocytic macrophages showed 
20% of AMs from intoxicated and injured mice are in the process of efferocytosis, 
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Figure 14 continued on next page 
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Figure 14. Increased percent of phagocytic alveolar macrophages after intoxication and 
injury.  BAL cells were cytocentrifuged onto slides and stained with a HEMA 3 
differential stain. Images demonstrate the predominance of alveolar macrophages in BAL 
from A) sham vehicle and B) burn ethanol treatment groups. Arrows indicate active 
alveolar macrophages in the process of efferocytosis after intoxication and injury. 400x 
magnification. Higher magnification of BAL cells in C) sham vehicle, and D-F) burn 
ethanol in various stages of phagocytic activity. We postulated these stages were D) 
macropinocytosis E) early stage of engulfment and F) later stage of engulfment. Arrows 
indicate active alveolar macrophages in the process of efferocytosis after intoxication and 
injury and arrow head indicates cell with blebbing membrane. 1000x magnification. G) 
Quantification of the percent of phagocytic cells per 400x field.  Active-caspase-3 (red) 
and dapi (blue) staining of BAL cells was assessed using fluorescent microscopy H) with 
differential interference contrast (DIC) and I) without DIC.  The DIC channel outlines a 
caspase-3
+
 cell engulfed by another cell. *p< 0.05. By unpaired T-test. Data are shown as 
mean ± SEM. N= 3-4 animals per group. 
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a 5-fold increase comparison to sham mice (p<0.05) (Figure 14G).  We predicted the 
larger bodies within AMs were apoptotic cells and confirmed this using antibody against 
active-caspase-3 (Figure 14H-I).  This was further supported by our findings in situ of 
Siglec-F
+
 AMs interacting with small cells with minute nuclei, potentially indicative of 
dead cells (Figure 15A&B).  
Cytokine production by AMs 
To determine cytokine production by AMs after intoxication and injury, 
supernatant was collected from cultured AMs from both sham and intoxicated and injured 
mice.  Results demonstrated that without additional stimulation, AMs from intoxicated 
and injured mice spontaneously produce 5-fold more TNFα than sham animals (p<0.05) 
(Figure 16). Other cytokines, such as IL-6, KC, IL-1β, MCP-1 and IL-10 were not 
present in the supernatant.  These data suggest AMs are not a main source of the IL-6 and 
KC found in the lungs of mice subjected to intoxication and injury. Furthermore, 
cytokine analysis of BAL fluid did not show significant changes in KC, MCP-1 or GM-
CSF (Figure 17). While it was not significant, intoxicated and injured mice did have an 
approximate 3-fold increase in the average amount of IL-6, in comparison to sham mice 
(Figure 17A). These data, taken together with cultured AM cytokine analysis, could 
imply airway cells are a source of elevated lung IL-6.  No change in KC in the airways is 
not surprising considering neutrophil infiltration is into the interstitium and not into the 
alveolar space, suggesting other cells, such as endothelial cells may be a source of lung 
KC.   
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Figure 15. In vivo efferocytosis by Siglec-F
+
 AMs in lung tissue after intoxication and 
injury. Lung tissue from intoxicated and burn injured-mice was stained for Siglec-F
+
 
(red) and assessed for AMs efferocytosis of other cells. Representative image of Siglec-
F
+
 AM in close proximity to small, nucleated cell is shown at A) 400x and B) 1000x. 
White arrows point to small, nucleated cell.  
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Figure 16.  Elevated AM production of TNFα.  AMs were cultured for 1.5 h at 37°C and 
supernatant was removed and assessed for cytokines by multi-plex bead array. Data 
represented as picograms per milliter. * p < 0.05. By unpaired T-test. Data are presented 
as mean ± SEM.  N = 3-6 animals per group.  
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Figure 17.  BAL fluid cytokine and chemokine levels.  Lungs were lavaged 5x with 1mL 
PBS and BAL fluid was analyzed for A) IL-6, B) KC, C) MCP-1 and D) GM-CSF. Data 
represented as picograms per milliter. Not significant by unpaired T-test. Data are 
presented as mean ± SEM.  N = 3-4 animals per group.  
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Neutrophil numbers in the lung after clodronate depletion of AMs 
 The role of AMs in pulmonary inflammation after intoxication and injury was 
further investigated by locally depleting AMs using clodronate liposomes in both sham 
and intoxicated and injured animals. Clodronate or empty liposomes were administered 
i.t. 3 days prior to injury.   Clodronate liposomes specifically reduced CD11c
+
CD11b
-
Siglec-F
+
 AMs from the lungs in both sham and injured mice at 24 h after injury, in 
comparison to empty liposome treated mice (p<0.05) (Figure 18A&B). Examination of 
lung tissue sections revealed that intoxicated and injured mice treated with clodronate 
liposome had 2-fold more neutrophils, in comparison to intoxication, injury and empty 
liposome treated mice (Figure 19C-E).  This increase was not seen in sham mice given 
empty or clodronate liposomes (Figure 19A&B).  Flow cytometry analysis further 
supports these data showing a 1.5-fold increase in CD11b
+
Ly-6G
+
 neutrophils in the 
lungs of intoxicated, injured, and clodronate treated mice, in comparison to those of 
empty liposome treated mice (Figure 19F). This elevation in neutrophil numbers 
significantly correlated to a decrease in AM numbers in intoxicated and injured mice 
treated with clodronate liposome, relative to that of intoxicated injured mice given empty 
liposome (r = -0.8983) (Figure 19G). Interestingly, we did not observe significant 
changes in lung tissue levels of KC after the depletion of AMs (Figure 19H).  This further 
supports the importance of other cells types, such as endothelial cells, as a major source 
of this neutrophil chemokine. Serum levels of IL-6 were also not altered by the depletion 
of AMs (Figure 19I). 
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Figure 18. Clodronate liposome treatment depletes AMs.   Lung tissue was obtained 24 h 
post-injury from all treatment groups.  Tissue was enzymatically dissociated into a single 
cell suspension and cells were analyzed by flow cytometry. A) Representative gating for 
Siglec-F
+
AMs of CD11c
+
CD11b
- 
cells (data not shown) from all four treatment groups.  
B) Absolute number of AMs in lung isolates.  *p < 0.05 versus all groups, by One-way 
ANOVA. # p < 0.05 versus burn ethanol + clodronate liposome, by unpaired T-test. Data 
are presented as mean of number of AMs per 350,000 lung cells ± SEM.  N = 3-6 animals 
per group. 
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Figure 19 continued on next page 
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Figure 19. Assessment of pulmonary inflammation in AM depleted, intoxicated and burn-
injured mice. A-D)  Lungs were sectioned and stained with H&E and assessed for 
cellular infiltration. Representative sections from each treatment group are shown at 
1000x. E) Neutrophils were counted by light microscopy in H&E-stained lung sections 
24 h after intoxication and burn injury. Data are shown as the total number of neutrophils 
in 5 high power fields (400x). Not statistically significant. F) Flow cytometric analysis of 
dissociated lung tissue Ly-6G
+
CD11b
+
 neutrophils. Data representative as absolute 
number of neutrophils per 350,000 cells. G) Pearson correlation of AM cell counts to 
neutrophil cell counts from the lungs of intoxicated and burn injury mice, with or without 
clodronate treatment , r = -0.8983. H) Lung homogenates from all four treatment groups 
were analyzed for levels of KC. I) Serum from all four treatment groups were analyzed 
for IL-6. *p <0.05 versus sham vehicle + empty liposome. Data are presented as mean ± 
SEM. N = 3-6 animals per group. 
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We have established there is a significant correlation between neutrophil infiltration 
and decreased lung function [156].  In these studies we show that there is also a 
significant correlation between the loss of alveolar macrophages and heightened 
neutrophil numbers in lung tissue. We predicted that depletion of AMs with clodronate 
liposomes prior to intoxication and injury would further impair lung function.  In 
contrast, there was no significant difference in Penh, breath frequency, tidal volume, or 
minute volume (Figure 20), in comparison to injured mice treated with empty liposomes.  
Our recent observations of lung function in intoxicated and injured mice were from 
studies in which a multi-day episodic binge ethanol exposure regimen was utilized. 
Repeated exposure to ethanol before injury may result in greater lung impairment than a 
single dose of ethanol exposure. Moreover, in this experiment, numbers of AMs were 
drastically reduced by 75% after just intoxication, injury and empty liposome treatment, 
in comparison to sham mice given empty liposome.  The additional loss of a small 
percentage of remaining AMs after clodronate liposome treatment therefore may not 
result in greater lung impairment.  
 Finally, we analyzed lung tissue for TUNEL
+
 cells. We discovered that clodronate 
treatment alone, 3 days after it was administered, resulted in remnants of apoptotic cells, 
in comparison to empty liposome treated mice (Figure 21A&B). Consistent with our 
previous observations (Figure 21C&E), intoxicated and burn injured mice given empty 
liposomes had more TUNEL
+ 
cells, in comparison to empty liposome treated sham mice. 
Unfortunately, treatment of sham or intoxicated and injured animals with clodronate 
liposomes yielded TUNEL
+
 debris throughout the lung tissue (Figure 21 D&F),  
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Figure 20. Clodronate liposome depletion of AMs does not increase lung impairment. 
Mice were placed in an unrestrained whole body barometric plethysmography chamber 
and lung function parameters were recorded for 10 minutes.  A) Penh, B) Breath 
frequency, C) Tidal volume and D) Minute volume. Data points shown as individual 
animals. Data are presented as mean ± SEM.  N = 2-5 per group. 
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Figure 21. Clodronate liposome increases apoptotic debris in lung tissue.  An 
immunofluorescent in situ TUNEL assay was used to identify apoptotic cells in lung 
tissue. Representative images of TUNEL
+
 cells (green) in each treatment group. Left 
panel, control liposome treated A) unmanipulated C) sham vehicle and E) burn ethanol.  
Right panel, clodronate liposome treated B) unmanipulated D) sham vehicle and F) burn 
ethanol. 200x magnification.  
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Highlighting a limitation of clodronate liposome depletion of AMs to study apoptosis.  
In intoxicated and injured mice treated with clodronate liposome, lung tissue had both 
TUNEL
+
 debris and punctate cells, further suggesting that the increase in apoptotic cells 
is not representative of only AM apoptosis but also of other lung cell types (Figure 21F).   
Summary 
 Higher SSC granularity, altered expression of TLR4/MD-2, and increased 
production of TNFα together suggest AMs from intoxicated and injured mice have an 
activated, pro-inflammatory phenotype. The elevated secretion of TNFα and the 
increased surface expression of MARCO and CD11b on AMs, both important receptors 
in phagocytosis and efferocytosis, coincide with elevated numbers of apoptotic cells in 
lung tissue after injury. Furthermore, morphological analysis revealed a percentage of 
AMs from intoxicated and injured mice could effectively take up apoptotic cells.  We 
determined AMs are a small population of these apoptotic cells, but the majority of 
apoptotic cells are likely epithelial or endothelial cells.  
The literature suggests that efferocytosis by AMs initiates the transition from an 
inflammatory phase towards a resolution phase. Our data revealed there is a 50% 
reduction in the total number of AMs and, of the AMs that were present, less than 20% 
were active in efferocytosis. Minimal AM efferocytosis in the presence of elevated 
numbers of apoptotic cells consequently can hinder the process of transitioning to a 
resolution phase. Clodronate experiments confirmed AMs also have a role in limiting 
neutrophil numbers into the lungs after intoxication and injury.  The negative correlation 
between decreased AM numbers and increased neutrophil numbers proposes elevated 
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neutrophil infiltration after intoxication and injury is a result of AM deficiency in the 
lung tissue. We speculate lack of mediators released in response to efferocytosis by AMs 
(i.e. IL-10 or TGFβ) is responsible for the increase in neutrophil accumulation.  Overall, 
our data demonstrate that both the loss of AMs and a heightened pro-inflammatory 
profile on remaining AMs, may prolong pulmonary inflammation after intoxication and 
injury, underlining a mechanism for impaired lung function and increased incidences of 
mortality.   
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CHAPTER 5 
 
MESENCHYMAL STEM CELLS ATTENUATE PULMONARY INFLAMMATION 
AFTER INTOXICATION AND BURN INJURY 
 
Abstract 
Clinical evidence reveals that 50% of burn patients are under the influence of alcohol at 
the time of hospital admission and that the combined insult of alcohol and burn injury 
causes increased risk of pulmonary complications leading to multiple organ failure and 
death. Our previous work demonstrated that a mouse model of alcohol and burn injury 
resulted in prolonged pulmonary inflammation characterized by amplified neutrophil 
accumulation and dramatic increases in pro-inflammatory cytokines and chemokines 
relative to burn injury and sham groups. Recent studies indicated the role of AMs in 
amplifying pulmonary inflammation after intoxication and injury.  Mesenchymal stem 
cells (MSCs) have been shown to attenuate acute lung inflammation, specifically by their 
ability to modulate the phenotype of AMs. Therefore, we explored exogenous MSCs as a 
post-injury therapy in a mouse model of intoxication and burn injury. Eight week-old 
C57BL/6 male mice were subjected to binge alcohol exposure Thirty minutes following 
the final ethanol exposure, mice were given a 15% total body surface area dorsal scald 
injury. One hour after injury, intoxicated and burn-injured mice were given an 
intravenous injection of CFSE labeled bone marrow-derived MSCs (5x10
5  
i.v.). We 
detected a small percentage of CFSE
+
 MSCs in the lungs at 24 h post injury and assessed 
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lung tissue for pulmonary inflammation. We found that intoxicated and injured mice 
treated with MSCs had a decrease in infiltrating neutrophils into the lungs that paralleled 
reduced neutrophil chemoattractant KC (CXCL1) and pro-inflammatory IL-6 levels in 
lung tissue. Our data suggest that one way in which MSCs attenuated pulmonary 
inflammation is by the activation of anti-inflammatory AMs. Together, these data 
demonstrate that exogenous administration of MSC to mice after intoxication and burn 
injury reduced pulmonary inflammation, highlighting MSCs as therapeutic targets that 
can improve survival in all burn patients. 
Introduction 
Binge drinking is an increasingly prevalent activity in the United States and is the 
most common form of alcohol consumption [61].  It is defined by a blood alcohol 
concentration of 0.08% or by the number of alcoholic drinks an individual has with in a 2 
hour time period (4 for women, 5 for men), and is the most common drinking pattern 
among patients with traumatic injury, including burn injury [66, 87].  Clinical evidence 
reveals that half of the burn patient population is under the influence of alcohol at the 
time of injury [88, 89].  This combined insult results in greater fluid resuscitation, a 
longer hospital stay and an increase in the number of days spent on mechanical 
ventilation, leading to a greater risk pulmonary complications and mortality [89, 92, 168]. 
Our laboratory and others have used a murine model of ethanol intoxication followed by 
a moderate size burn injury to study how intoxication exacerbates inflammation in 
various organ systems, including the lungs. With this combined insult, the lungs display 
characteristics of acute respiratory distress syndrome, including elevated levels of 
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alveolar wall thickening, neutrophil accumulation and increased pro-inflammatory 
cytokine interleukin-6 (IL-6) levels, relative to either ethanol exposure or burn injury 
alone [99, 104-107]. This amplification of pulmonary inflammation has also been 
correlated to a decrease in physiological lung function and an increase in mortality [156].  
The lungs are often the first organs to fail after traumatic injury [84], hence, managing 
the excessive inflammatory response seen after remote injury will likely reduce elevated 
morbidity and mortality in intoxicated and burn-injured patients. 
Resident alveolar macrophages play a critical role in both the onset and resolution 
of pulmonary inflammation [157, 162, 169].  The activation of tissue resident 
macrophages by endogenous danger signals or by the detection of pathogens through 
pattern recognition receptors stimulate macrophages to release pro-inflammatory 
cytokines that initiate the inflammatory process, such interleukin-1β, tumor necrosis 
factor α (TNFα), and interferon-γ [157].  During the course of inflammation, the up 
regulation of anti-inflammatory mediators or the phagocytosis of apoptotic cells by 
macrophages, activate macrophages into an alternative M2, anti-inflammatory phenotype, 
facilitating the resolution of inflammation [51, 52, 170]. Alveolar macrophages are the 
first line of defense against inhaled particles or pathogens.  This environment, with a 
direct connection to open-air, leads to a distinct phenotype with atypical macrophage cell 
surface markers, in comparison to other macrophage populations. Alveolar macrophages 
can be characterized by dendritic cell marker CD11c and eosinophil marker Siglec-F, but 
are negative for classical macrophage marker CD11b [20, 21, 158]. Additionally, the 
constant exposure to inhaled or blood-born pathogens results in alveolar macrophages 
  
  
83 
constitutively expressing mannose receptor CD206 [21, 169], an important receptor that 
assists in the clearance of foreign antigens [171].  CD206 has also been characterized as a 
marker of alternative macrophage activation [34, 162-164].  Thus, an upregulation of 
CD206 on alveolar macrophages from baseline line levels may suggest a transition to an 
M2 phenotype. With the excessive pulmonary inflammation observed after intoxication 
and injury, triggering the anti-inflammatory, resolving and/or reparative macrophage 
phenotype could be critical to restoring lung homeostasis.   
Bone marrow and tissue resident mesenchymal stem cells (MSCs) have been 
characterized as modulators of acute inflammation by virtue of their ability to influence 
the phenotype of macrophages [119]. Exogenous MSC interaction with macrophages and 
their release of paracrine soluble factors have been shown to suppress inflammation and 
polarize macrophages into an alternative, anti-inflammatory phenotype [119-123]. 
Notably, experimental studies using murine models of allergic asthma demonstrated the 
localized benefits of MSC treatment in the lungs. In one murine study, short-term 
localization of exogenous human MSCs (hMSCs) within the lungs was sufficient to 
inhibit allergic inflammation. Through clodronate liposome depletion of alveolar 
macrophages, this study established that the anti-inflammatory effect of MSCs was 
dependent on alveolar macrophages and their indirect role in the upregulation of IL-10 
[172]. Recent reports additionally showed hMSCs can reduce allergic inflammation and 
improve lung function through TGFβ signaling and the upregulation of M2 alveolar 
macrophages, [173]. Additionally, incubating the RAW264.7 macrophage cells line with 
MSC conditioned medium has been shown to induce the expression of the M2 marker 
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CD206 in [174].   Moreover, many studies also suggest the intravenous administration 
of MSCs results in the entrapment of MSCs within the lungs.  Due to their large size, 
MSCs becomes trapped within the pulmonary vasculature with only a fraction of these 
cells passing through and migrating to other organs [124-126]. The resulting reduction in 
capillary flow allows MSCs to secrete anti-inflammatory mediators specifically into the 
lung niche, reducing inflammation [175].   This limitation of MSC therapy, combined 
with the ability of MSCs to attenuate inflammation through the anti-inflammatory 
polarization of macrophages, suggests MSCs would be particularly advantageous to 
attenuating elevated lung inflammation after intoxication and injury. 
The purpose of this study was to determine whether the intravenous infusion of 
exogenous bone marrow-derived MSCs will reduce pulmonary inflammation after 
intoxication and burn injury and if this parallels a shift in alveolar macrophage 
phenotype. Since intoxication at the time of injury results in greater pulmonary 
complications and mortality rates than burn injury alone, we examined the effect of MSC 
treatment on only intoxicated and burn-injured mice, in comparison to sham vehicle 
control. In vitro-expanded MSCs were given intravenously to intoxicated and burn-
injured mice 1 hour after injury. Pulmonary inflammation was assessed by neutrophil 
infiltration, neutrophil chemokine CXCL1 (KC) and IL-6 levels in lung tissue, while 
alveolar macrophage phenotype was analyzed by flow cytometry.  Our results suggest 
MSCs can reduce pulmonary inflammation, possibly by polarizing alveolar macrophage 
to an anti-inflammatory phenotype, highlighting MSCs as a novel therapeutic agent to 
treat lung-specific inflammation in severe burn patients.  
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Materials & Methods 
Mice 
Male (C57BL/6) mice were purchased from Jackson Laboratories (Bar Harbor, 
ME) and used at 8-10 weeks old. Mice were housed in sterile micro-isolator cages under 
specific pathogen-free conditions in the Loyola University Medical Center Comparative 
Medicine facility. All experiments were conducted in accordance with the Institutional 
Animal Care and Use Committee.  Mice weighing between 22 to 27 g were used in these 
studies.  
Mesenchymal Stem Cell Culture 
Gibco® Mouse (C57BL/6) bone marrow (BM)-derived MSCs (Life Technologies, Grand 
Island, NY) were expanded in vitro per manufacturer protocol. Briefly, MSC growth 
medium consisted of 10% FBS and 10mg/ml genatmicin in MEMα Medium with 
GlutaMAX™-I, ribonucleosides and deoxyribonucleosides. MSCs were plated at a 
density of 5,000 cells per cm
2 
in T75 flasks and incubated at 37
o
C, 5% CO2 and 90% 
humidity. Medium was changed every 2 days until cultures were 70-80% confluent. 
MSCs were detached from flasks using pre-warmed trypsin, fluorescently labeled with 
carboxyfluoresceindiacetate, succinimidyl ester (CFSE), following manufacturer protocol 
(Life Technologies) and resuspended in sterile Dulbecco’s phosphate buffered saline 
(PBS) [176]. Additionally, MSCs were analyzed by flow cytometry for MSC markers.  
Briefly, MSCs were incubated with anti-mouse antibodies C-kit APC-eFluor 780 (clone 
ACK2, eBioscience), CD31PE (clone 390, eBioscience), Sca-1 PerCP Cy5.5 (clone D7, 
eBioscience), CD34 eFluor 660 (clone RAM34, eBioscience), and CD44 PE-Cy7 (clone 
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IM7, eBioscience).  Antibody incubation was carried out for 30 minutes at 4
o
C.  Cells 
were washed and fixed as described [143, 153].  Data analysis was performed using Flow 
Jo FCS analysis software (Tree Star Inc., Ashland, OR). Passage 3 cells were used in all 
experiments.  
Murine Model of Binge Ethanol and Burn Injury 
A murine model of single dose binge ethanol intoxication and burn injury was 
employed using oral gavage as described previously [138, 150, 151]. Animals were given 
400 μl of 10% (v/v) ethanol solution (1.6 g/kg) or water control by gavage at a dose 
designed to elevate the blood alcohol concentration to 150 mg/dL at 30 min after ethanol 
exposure [142]. Thirty minutes following the ethanol exposure, the mice were 
anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine) and their dorsums shaved. The 
mice were placed in a plastic template exposing 15% of the total body surface area and 
subjected to a scald injury in a 92-95°C water bath or a sham injury in room-temperature 
water [138].  The scald injury results in an insensate, full-thickness burn [152].  The mice 
were then resuscitated with 1.0 ml saline and allowed to recover on warming pads.  All 
experiments were performed between 8 and 9 am to avoid confounding factors related to 
circadian rhythms.  One hour after injury, intoxicated and burn-injured animals either 
received an intravenous tail vein injection of 5x10
5
 CFSE-labeled MSCs or PBS as a 
control in 200ul [124]. Animals were euthanized at 24 hours.  
Histopathologic Examination of the Lungs 
 The upper right lobe of the lung was inflated with 10% formalin and fixed 
overnight as described previously [104], embedded in paraffin, sectioned at 5 μm, and 
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stained with hematoxylin and eosin (H&E).  Sections were evaluated using light 
microscopy (Zeiss AxioVert, Zeiss, Thorndale, CA) and histology photographs were 
taken at 400x magnification. Neutrophils were counted in a blinded fashion in 10 high 
power fields (400X). The upper left lobe was inflated with 25% OCT freezing medium, 
frozen in OCT over dry ice and store at -80
oC.  Tissue was cryosectioned at 6 μm and 
assessed for CFSE fluorescent MSCs.  
Cytokine Analysis of Lung Homogenates 
The right middle lung lobe was snap-frozen in liquid nitrogen and then 
homogenized in 1 ml of BioPlex cell lysis buffer according to manufacturer’s protocol 
(BioRad, Hercules, CA). The homogenates were filtered and analyzed for cytokine 
production using a BioPlex multiplex bead array.  The results were normalized to total 
protein using the BioRad protein assay (BioRad) [106, 107]. 
Flow Cytometry Analysis of Alveolar Macrophages 
The upper left lung lobe was removed and cut into small pieces with a razor 
blade.  The lung tissue was then transferred to a C-tube (Miltenyi Biotec, Auburn, CA) 
and processed using digestion buffer containing 1mg/ml of Collagenase D and 0.1 mg/ml 
DNase I (Roche, Indianapolis, IN) in HBSS and a GentleMACS dissociator (Miltenyi 
Biotec), according to manufacturer’s instructions (Shults et al. 2015).  The homogenates 
were then filtered through 70 um nylon cell strainers to obtain a single cell suspension. 
Red blood cells were lysed using ACK lysis buffer (Life Technologies, Grand Island, 
NY). Cells were counted using trypan blue to exclude dead cells.  To assess alveolar 
macrophages, 1x10
6
 lung cells were first incubated with anti-CD16/32 (clone 
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93,eBioscience, San Diego, CA) to block unspecific binding to the Fcy II/III receptor.  
Cells were then immunostained with rat anti-mouse antibodies: F4/80 APC (clone BM8, 
eBioscience), CD11b eFluor 450 (clone M1/70, eBioscience), Siglec-F PE-CF594 (clone 
E50-2440, BD Biosciences, San Jose, CA), CD206 PE (clone C068C2, Biolegend, San 
Diego, CA).  CFSE
+
 cells were identified using a FITC channel. Antibody incubation was 
carried out for 30 minutes at 4
o
C.  Cells were washed and fixed as described [143, 153].  
MHC II was used as a M1 marker and CD206 was used a M2 marker [21].  Samples were 
run on a BD Fortessa cytometer (BD Biosciences).  Data analysis was performed using 
Flow Jo FCS analysis software (Tree Star Inc.).  
Serum Measurements 
Blood was collected via cardiac puncture and the serum was isolated at stored at -80°C.  
Serum aliquots were used to measure IL-6 by enzyme linked immunosorbent assay 
(ELISA) (BD Biosciences, Franklin Lakes, NJ) or liver alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST) levels using a DRI-CHEM 7000 (HESKA, 
Loveland, CO).  
TUNEL Immunofluorescent Staining 
The upper right lobe of the lung was inflated with 10% formalin and fixed overnight as 
described previously [104], embedded in paraffin, sectioned at 5 μm.  An in situ TUNEL 
assay was performed according to manufacturer’s protocol (Life Technologies). Sections 
were evaluated using fluorescent microscopy (EVOS, Life Technologies) and TUNEL
+
 
were counted in a blinded fashion in 10 low power fields (100X).   
Statistical Analysis 
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 Statistical comparisons were made between the sham vehicle, burn ethanol + 
PBS, and burn ethanol + MSC treatment groups. One-way analysis of variance 
(ANOVA) was used with Tukey’s post-hoc test and values were considered statistically 
significant when p < 0.05. Data is reported as mean values ± the standard error of the 
mean (SEM).  
Results 
Mesenchymal stem Cells are Present the Lungs 24 h after Administration 
Gibco® Mouse (C57BL/6) BM-derived MSCs were purchased from Life 
Technologies.  These cells were described to have tri-potential differentiation into at least 
osteogenic, adipogenic, and chondogenic lineages, as well as express a flow cytometry 
phenotype of Sca-1
+
CD34
+
CD44
+
CD29
+
c-kit
-
, which is characteristic of BM-derived 
MSCs.  To confirm the phenotype of these MSCs, we analyzed confluent MSCs (passage 
3) using flow cytometry (Figure 22). We found the MSCs were Sca-
1
+
CD34
+
CD44
+
CD29
+
, negative for CD31, and had less than 5% positive for c-kit 
(Figure 22A-F). Additionally, in adoptive transfer experiments, MSCs were labeled with 
CFSE (Figure 23A) and administered to mice an hour after burn injury. At 24 h, CFSE
+
 
MSCs were identified in the lungs of intoxicated and burn injured mice using flow 
cytometry (Figures 23B&C). Lung cells were negatively selected for alveolar 
macrophage/eosinophil marker Siglec-F and granulocyte/neutrophil marker CD11b (data 
not shown), and analyzed for CFSE
+
 cells compared to macrophage/monocyte marker 
F4/80 (Figure 1). Additionally, CFSE
+
 cells were negative for dendritic cell marker 
CD11c (data not shown). Our results indicated there were approximately 100 CFSE
+
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Figure 22. Flow cytometry analysis of MSCs confirms phenotype. A) Representative 
gating (Blue) for MSCs.  B-G) MSCs (red) expression was compared against controls 
(blue) for B) c-kit, C) CD31, D) Sca-1, E) CD34 and F) CD44. G) Immunofluorescent 
staining confirming CD29 expression, in comparison to a Rat IgG2a control antibody. 
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Figure 23. MSCs localize in lung tissue.  CFSE
+
 MSCs were identified in dissociated 
lung tissue from intoxicated and injured mice at 24 h using flow cytometry.  
A) Confirmation of MSCs fluorescence prior to tail vein injection.  B&C) Total 
dissociated lung cells were negatively selected for Siglec-F
 
and CD11b (data not shown), 
followed by the identification of F4/80
- 
CFSE
+
 cells (box) in B) burn ethanol + PBS and 
C) ethanol + MSCs. 
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MSCs recovered per 3.5 x 10
5 
total lung cells. Lack of Siglec-F, CD11b, F4/80 and 
CD11c expression supports the identification of individual CFSE
+
 cells and not CFSE
+
 
cells engulfed by macrophage/monocytes, granulocytes, or dendritic cells. These data 
confirm that MSCs are in a position to attenuate pulmonary inflammation by their ability 
to localize in the lungs and remain there at least 24 h after infusion.   
MSC Treatment Reduces Pulmonary Inflammation after Intoxication and Burn Injury 
As previously shown by our laboratory, histochemical analyses of sectioned lung 
tissue demonstrated that ethanol intoxication prior to burn injury results in a 1.5 fold 
increase in cellularity, primarily by neutrophils, in comparison to burn injury alone at 24 
hours after injury [104-107, 156].  Administration of MSCs 1 hour after injury decreased 
cellular infiltration and reduced pulmonary congestion after intoxication and injury 
(Figure 24A). Neutrophils within the lung interstitium were counted by light microscopy 
as previously described [104].  The increase in neutrophil infiltration into the lungs after 
intoxication and injury was attenuated with MSCs treatment and overall reduced 
neutrophil infiltration by 33% (Figure 24B).   Additionally, the lung, liver, and skin 
(approximate to wound interface) were assessed for the presence of CFSE
+
 MSCs.  At 24 
h after injury we were unable to identify CFSE
+
 cells in either tissue using 
immunofluorescence.  However, we were able to identify CSFE
+
 cells in the lung using 
flow cytometry. Analysis of lung tissue indicated an average of 100 CFSE
+
 MSCs per 
350,000 total cells (~0.3%) (Figure 23C) remained in the lung at 24 h.  Supporting these 
data, Eggenhofer and colleagues found the majority of viable MSCs were within the 
lungs at 1 h and at 24 h, their presence in the lungs was significantly reduced [124].   
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Figure 24.  Histological assessment of pulmonary inflammation.  Lungs were sectioned 
and stained with H&E and assessed for cellular infiltration. A) Representative sections 
from each treatment group are shown at 400x. B) Neutrophils were counted by light 
microscopy in H&E-stained lung sections 24 h after intoxication, injury and MSC 
treatment. Data are shown as the total number of neutrophils in 5 high power fields 
(400x). Not significant. Data are presented as mean values ± SEM. N = 3-4 animals per 
group. Representative of 2 independent experiments. 
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Decreased Pulmonary KC and Interleukin-6 (IL-6) Levels 
Since we observed decreased neutrophil infiltration with MSC treatment, we next 
examined pulmonary neutrophil chemoattractant, KC and pro-inflammatory cytokine IL-
6 levels. Consistent with previous studies, there was an 11-fold increase in KC (p < 0.05) 
in lung tissue, of intoxicated mice subjected to burn injury in comparison to control 
animals (Figure 25A) [104-106, 156] .This paralleled a 5.6 fold increase in IL-6 levels (p 
< 0.05) (Figure 25B). MSC treatment reduced KC levels by a 50% and IL-6 levels by 
70% (Figure 25A&B). These data support our observation that MSC treatment decreases 
neutrophil infiltration into lung tissue, overall reducing pulmonary congestion. 
Surprisingly, we found no difference in the level of the anti-inflammatory interleukin-10 
(IL-10) between experimental groups, even after MSC treatment and reductions in IL-6 
(data not shown).   
Serum IL-6 Attenuated with Mesenchymal Stem Cells 
Dramatic increases in circulating IL-6 levels have been detected with intoxication 
and injury, relative to either insult alone [139] and a high serum level of IL-6 in burn 
injured patients has been correlated with increased chance of morbidity and mortality 
[101]. Here, we also found that intoxication and burn injury significantly upregulates 
serum levels of this cytokine (p < 0.05) and found that treating intoxicated and burn-
injured animals with MSCs reduced serum IL-6 by 50% (Figure 26). The liver is likely 
one of the primary sources of IL-6 after intoxication and injury. We, therefore, analyzed 
levels of liver IL-6, as well as markers of hepatic damage, liver aminotransferases AST 
and ALT.  Consistent with previously data [99, 177], intoxication and burn injury  
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Figure 25.  MSCs attenuate pulmonary KC and IL-6 levels.  Lung homogenates were 
analyzed for levels of A) KC and B) IL-6. * p < 0.05 versus sham vehicle; # p < 0.05 
versus all groups. By One-way ANOVA. Data are presented as fold-change ± SEM.  N = 
3-4 animals per group. Representative of 2 independent experiments. 
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Figure 26. MSCs reduce serum levels of pro-inflammatory IL-6. Serum was collected 
from each treatment group and analyzed for IL-6. Not significant. Data are presented as 
the mean in picograms per milliter ± SEM.  N = 3-6 animals per group. 
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Table 2: MSCs do not alter liver cytokine and serum aminotransferase levels. 
 
 
Liver homogenates were analyzed for levels of IL-6. IL-6 is presented as the mean in 
picograms per milliter ± SEM. Serum was collected from each treatment group and 
analyzed for AST and ALT. AST and ALT are presented as the mean units per liter ± 
SEM. * p < 0.05 versus sham vehicle. N = 3-6 animals per group. 
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elevated hepatic levels of IL-6 (p < 0.05), ALT (p < 0.05), and AST (p < 0.05), relative 
to control animals. While MSC treatment restored pulmonary parameters, it failed to 
diminish the levels of these factors in the liver (Table 2).  Since MSC treatment 
significantly reducing both lung IL-6 and systemic IL-6, but not liver IL-6, this suggests 
that the MSCs have a direct effect on lung tissue.  Additionally, these data propose that 
the liver is not the only source of systemic IL-6 after intoxication and burn injury and that 
the lungs may also contribute to systemic levels. 
Elevated CD206
hi 
Alveolar Macrophages 24 hours  
after Mesenchymal Stem Cell Treatment 
We have shown that the administration of MSCs to intoxicated and injured 
animals reduces inflammation in the lungs, but not on the liver.  We postulated this may 
be due to MSC activation of alveolar macrophages towards an anti-inflammatory 
phenotype [121, 172, 173]. Therefore, we next analyzed alveolar macrophages by flow 
cytometry for M1 and M2 markers, MHC II and CD206, respectively. Lung tissue was 
digested into a single cell suspension and stained for alveolar macrophage cell surface 
markers.  As shown in Chapter 4, Siglec-F
+
CD11c
+
CD11b
-
 alveolar macrophages have 
low to negative levels of MHC II and constitutive expression of CD206 (Figure 27B) 
[21].  To determine if MSCs altered the phenotype of alveolar macrophages in 
intoxicated and burn-injured animals we analyzed alveolar macrophages after 
intoxication, injury and MSC treatment and observed an increase in a population of 
alveolar macrophages with heightened expression of CD206 (Figure 27A-C).  We 
quantified the percent of CD206
hi 
alveolar macrophages out of total alveolar  
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Figure 27. CD206
hi
 AMs are upregulated after MSCs treatment. Lung tissue was 
dissociated into a single cell suspension and cells were analyzed by flow cytometry. A-C) 
Representative gating for CD11c
+
CD11b
-
Siglec-F
+
CD206
hi 
alveolar macrophages (box) 
from each treatment group. D) Percentage of CD206
hi
 cells of total alveolar 
macrophages. E) Scatterplot representation of mean fluorescence intensity (MFI) of 
MHC II on alveolar macrophages from each treatment group. * p < 0.05 versus all 
groups. By One-way ANOVA. Data are presented percentage CD206
hi 
cells per group ± 
SEM.  N = 3-5 animals per group. 
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macrophages and found a 1.5-fold increase (p < 0.05) in these cells after intoxication, 
injury and MSC treatment, in comparison to intoxication and injury alone (Figure 27D).  
However, we found no change in the level of MHC II expression between all treatment 
groups at 24 h (Figure 27E).  This was not surprising considering pulmonary 
inflammation after intoxication and injury likely mirrors sterile inflammation where we 
would not expect antigen presentation.  These findings suggest MSCs may diminish 
pulmonary inflammation through the direct or indirect activation of alveolar macrophages 
into an M2 phenotype, overall highlighting MSCs as a viable therapy to locally suppress 
pulmonary inflammation in intoxicated and burn-injured patients.  
Decreased Apoptosis in Lung Tissue 
The average number of TUNEL
+
 apoptotic cells in lung tissue was quantified after 
intoxication, injury and MSCs.  We found a 33% decrease in the number of TUNEL
+
 
cells with MSC treatment, however, mice treated with MSCs still had a 4.5-fold increase 
in apoptotic cells in comparison to sham (Figure 28A).  We also found no difference in 
the number of alveolar macrophages after MSC treatment (Figure 28B).  This suggests 
that the reduction in pulmonary inflammation as a result of MSC infusion may attenuate 
the cell death of a portion of lung cells, such epithelial or endothelial cells, but not 
alveolar macrophages. The studies herein did not determine how early after injury there is 
a decrease in the alveolar macrophage population, but the literature has shown apoptosis 
in the lungs as early as 3 h after burn alone in rats [116]. One study also demonstrated the 
majority of MSCs are within the lungs at 1 h after administration [124], therefore if we 
inject MSCs 1 h after injury, the majority of MSCs are in the lungs at 2 h after injury and 
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apoptosis in the lungs after intoxication and injury may have already been initiated by 
this time point.   
Summary 
The above studies demonstrate that the intravenous administration of exogenous MSCs 
have the ability to reduce both lung and systemic IL-6, a cytokine that has been described 
to play a causative role in the excessive pulmonary inflammation after intoxication and 
injury [107].  To this end, neutrophil chemokine KC levels and neutrophil infiltration into 
the lungs were also reduced after MSC treatment. Whether this was a direct outcome of 
decreased IL-6 levels was not determined in this study. Additionally, the entrapment of 
MSCs within the lung capillary bed may have led to the activation of alveolar 
macrophages into an anti-inflammatory phenotype resulting in a decrease in both 
systemic IL-6 and pulmonary inflammation, identifying the lungs one source of this pro-
inflammatory cytokine. Taken together, these data suggest that the anti-inflammatory 
properties of MSCs, through either the direct or indirect interaction with resident alveolar 
macrophages may be helpful in initiating the resolution of pulmonary inflammation and 
either decreasing apoptosis or stimulating efferocytosis to remove apoptotic cells after 
intoxication and injury.  These studies highlight MSCs as a useful therapeutic to 
specifically target lung inflammation.  More studies are warranted to determine their 
effectiveness in a clinical application in the context of systemic inflammation. 
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Figure 28. Decreased apoptotic cells in the lung after intoxication, injury and MSC 
treatment.  An immunofluorescent in situ TUNEL assay was used to identify apoptotic 
cells in lung tissue.  A) Average number of apoptotic cells per 10x field.  Not Significant. 
B) Average number AMs per 350,000 lung cells. Not Significant.  Data are shown as 
mean ± SEM. N=3-4 animals per group. 
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CHAPTER 6  
DISCUSSION 
In review, clinical studies indicate patients who are intoxicated at the time of burn 
injury have an increased risk of pulmonary complications and failure.  Previous studies in 
our laboratory described elevated levels of neutrophils, neutrophil chemokines, KC and 
MIP-2, and IL-6 within lung tissue of intoxicated and burn-injured mice, relative to either 
insult alone. However, it had not been determined what underlying mechanism in the 
lung caused these changes or if they affected physiological lung function.  With the 
knowledge that AMs are key orchestrators of both the initiation and resolution of 
inflammation, we hypothesized elevated pulmonary inflammation was a result of 
alterations in the AM population.  To study the role of AMs in pulmonary inflammation 
and the effect of inflammation on lung function after intoxication and injury, we used a 
mouse model of binge ethanol exposure and scald injury.  The results described in this 
dissertation correlate heightened pulmonary inflammation with impaired lung function 
and identify AMs as important regulators of both inflammation and targets of therapeutic 
interventions.  
Lung inflammation can cause physiological derangements in intoxicated and 
burn-injured animals, including increased airway resistance and abnormal breathing 
patterns. Non-invasive, unrestrained whole-body plethysmography is a convenient 
method to evaluate normal breathing patterns in mice [178].  Unlike invasive 
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methods using a tracheotomy and mechanical ventilation to study plethysmography, 
non-invasive techniques do not require anesthesia or surgery. This significantly reduces 
stress and allows individual animals to be assessed multiple times, a useful feature for 
time course studies [178-180].  In non-invasive plethysmography, Penh is a 
dimensionless parameter that has been viewed as a measure of bronchoconstriction and 
airway resistance, though several studies claim Penh is an unreliable measure of 
respiratory mechanics [181, 182].  However, other studies suggest Penh should be used as 
a measure of overall lung function, highlighting changes in respiratory breathing patterns 
[178, 183, 184].  Verheijden, et. al. recently compared non-invasive plethysmography 
(Penh) to invasive plethysmography (Resistance) in a severe model of allergic airway 
inflammation.  Their data revealed an increase in both Penh and resistance with severe 
allergic airway inflammation.  Notably, a Penh of 8 corresponded to a significant increase 
in resistance, compared to controls, suggesting that in severe models of inflammation, 
Penh is a reflective measure of resistance. Additionally, it was determined an increase in 
Penh paralleled an increase in bronchoalveolar lavage cells in the airways [183], 
furthering supporting our data that pulmonary congestion with intoxication and burn 
injury leads to functional lung complications. 
We observed that ethanol intoxication at the time of injury leads to a longer pause 
between breaths (Penh), correlating with a decrease in the frequency of breaths per 
minute. With this data, one would expect this slower breathing pattern, an indicator of 
increased lung resistance, would result in deeper breaths, represented by an increase in 
tidal volume. In contrast, we observed a decrease in tidal volume and minute volume, an 
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indication that the mice are not able to compensate for the increase in lung resistance.  
This breathing pattern may mirror agonal breathing, which is characterized by infrequent, 
shallow breaths and has been observed in severely injured humans. This pattern is 
precipitated by hypoxemia regardless of arterial carbon dioxide levels or pH, which may 
be the case in our injured animals since agonal breathing in humans is typically viewed as 
the terminal stage of respiration, occurring immediately before death [185]. When the 
plethysmography measurements were taken at 24 hours in our experiments, majority of 
the animals appeared either moribund or lethargic in the plethysmography chamber.  
With 47% of death occurring between 24 and 72 hours, the breathing pattern we detected 
in mice at 24 hours strongly suggests it can be characterized as agonal breathing, 
indicating a mechanism behind the large percentage of mortality in the following 48 
hours.  
The location of the dorsal burn injury in this model could also restrict chest wall 
movement during both the inflammatory and the wound healing phases, promoting the 
observed decrease in breaths per minute, overall leading to decreased gas exchange.  
Humans with chest, back or torso circumferential burns have breathing patterns with 
rapid shallow breaths, not slow shallow breaths, as we have observed in our model [86]. 
These differences, however, may be attributed to the immediate care provided to human 
burn patients.  Torso circumferential burns can limit respiration and require a chest 
escharotomy where incisions are made in the burn wound, releasing constricted and non-
elastic damaged tissue, to restore chest movement. The mice in our model do not receive 
circumferential burns, removing the need for escharotomy in the model, but the injury 
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location may still lead to an altered breathing pattern.  Tidal breathing is usually 
interrupted every few minutes by a deep breath or yawn, which is needed to expand 
underinflated alveoli.  Restricted chest wall movement can cause burn patients to lose this 
ability.  Without this interruption in tidal volume, the alveoli eventually collapse in a 
process known as atelectasis, resulting in decreased blood flow, oxygen exchange and the 
ability of the lungs to expand [86, 186].  Our data demonstrate that the loss of lung 
compliance with burn injury, even in the absence of inhalation injury, is further decreased 
when intoxication precedes burn injury. The restricted chest movement and subsequent 
collapse of alveoli may also explain the differences in breathing patterns in our mouse 
model, in comparison to human burn patients. However, the 3-fold increase in Penh with 
burn alone does not correspond to significantly increased mortality rates.  This suggests 
ethanol, not the location of the burn, leads to impaired lung function and elevated 
mortality rates. Overall, these findings highlight pulmonary inflammation as an 
underlying mechanism that contributes to the drastic mortality rate observed in mice 
exposed to both ethanol and burn injury. 
Apoptosis of type I and type II epithelial cells and neutrophil infiltration are 
postulated as two main causes of ARDS [187]. Heighten infiltration or ineffective 
removal of apoptotic neutrophils can prolong the inflammatory response, while damage 
to epithelial cells and the capillary-alveolar interface can lead to increased lung 
permeability.  The resolution of pulmonary inflammation is influenced by the recognition 
of apoptotic cells and efferocytosis by AMs [43, 170].  A defect in this process can 
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substantially prolong the inflammatory response, leading to greater tissue damage. A 
functioning population of AMs is therefore needed to regulate pulmonary inflammation. 
 The studies herein demonstrate intoxication and injury results in increased 
numbers of apoptotic cells in lung tissue 24 h post-injury. AMs from intoxicated and 
injured mice display functional components, MARCO and CD11b, both important in 
efferocytosis.  Morphological analysis of AMs also supports the capacity of a percentage 
of AMs to effectively take up apoptotic cells, even after intoxication and injury. 
Therefore, it does not seem intoxication at the time of injury completely inhibits the 
function of AM efferocytosis. Whether ethanol reduces the percent of efferocytosis after 
burn injury was not determined in this these studies. However, previous studies in our 
laboratory found ethanol exposure decreased AM phagocytosis of P. aeruginosa and that 
this was facilitated by a decrease in macrophage Fcγ- receptor after in vitro or in vivo 
alcohol exposure [8, 76]. Efferocytosis is a separate and distinct process from the 
phagocytosis of pathogens, therefore it is plausible alcohol can have differential effects 
on both of these functions.   
There are two main pathways in the initiation of apoptosis. First, pro-apoptotic 
stimuli can signal the intrinsic pathway of mitochondrial BCL-2 and cytochrome c 
release. Second, activation of death receptors, such as Fas and TNF-family receptors, 
initiate the extrinsic pathway of apoptosis. Both of these pathways lead to caspase-3/7 
activation and the subsequent cleavage of cellular protein and DNA fragmentation that 
results in apoptosis [188].  Here we showed AMs isolated from intoxicated and burn-
injured mice spontaneously produced 5-fold more TNFα, a prominent death receptor 
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activator.  The literature suggests both apoptotic and necrotic cells are TUNEL
+
 [167], 
but only apoptotic cells are caspase-3/7
+
. Our findings of active-caspase-3/7
+
 cells being 
efferocytosed by AMs, supports an apoptosis pathway of cell death, and not necrosis, in 
lung cells after intoxication and injury.  
Clinical data revealed that burn injury alone leads to increased levels of 
endotoxins in the bloodstream, peaking between 7 and 12 hours after injury [108].  
Elevated levels of circulating endotoxin after burn injury has also been correlated to 
increased incidences of multiple organ failure [109].  While the effect of ethanol and burn 
injury on circulating endotoxin levels has not been determine, we postulate that increased 
bacteria translocation from the gut would result in heightened levels of LPS, or other 
bacterial products, into the blood stream.  Previously, our laboratory demonstrated TLR4 
signaling, but not TLR2, contributes to elevated pulmonary inflammation after 
intoxication and injury [106]. LPS, a TLR4 ligand, has been shown to activate endothelial 
cell production of pro-inflammatory mediators, including neutrophil chemokines [189].  
Interestingly, our data indicate AMs and airways cells are not primary sources of KC. 
Taken together, LPS-induced activation of capillary endothelial cells may facilitate 
heightened levels of neutrophil chemokines we have observed in total lung tissue. In 
addition to endotoxins, AM production of TNFα may also have an important role in 
prolonged pulmonary inflammation.  In human studies, TNFα activates endothelial cells 
and induces the upregulation of adhesion molecules and IL-8 and IL-6 secretion, 
resulting in transendothelial migration of neutrophils [190-192]. Furthermore, human 
studies suggest apoptosis of AMs and epithelial cells in acute lung injury is induced by 
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endotoxins and not hypoxemia [193, 194].  Our data revealed there was a trend toward 
an increase in TLR4/MD-2 expression on AMs at 24 h.  We speculate that if endotoxin 
levels peak by 12 h after combined injury, that perhaps endotoxin-induced apoptosis 
occurred long before our 24 h analysis, and is why we observe decreased number of AMs 
in lung tissue.  
Published studies from our laboratory indicate that long myosin light-chain kinase 
(MLCK) activation mediates increased intestinal permeability after intoxication and burn 
injury [97, 98].  Inhibition of MLCK activation, either through membrane permeant 
inhibitor of MLCK (PIK) or studies using MLCK knockout (KO) mice, showed a 
decrease in intestinal damage and bacterial translocation into the mesenteric lymph 
nodes. Preliminary studies examined levels of apoptotic cells in the lungs of intoxicated 
and burn-injured MLCK KO mice.  We found that decreased tight junction disruption 
after intoxication and bury injury resulted in a 75% decrease in apoptotic cells in the 
lung, in comparison to wild type counterparts (p <0.05) (Figure 29). These data support 
our hypothesis that systemic mediators, such as LPS or endotoxins, influence pulmonary 
inflammation and apoptosis. Future studies are warranted to compare the role of AMs in 
inflammation in MLCK KO mice to wild type mice.   
The literature suggests that efferocytosis by AMs initiates the transition from an 
inflammatory phase towards a resolution phase by stimulating the release of IL-10 and 
TGFβ [43-46]. TGFβ has specifically been shown to inhibit TNFα-induced, IL-8 
dependent migration of neutrophils through the endothelium [195].  We did not examine 
levels of TGFβ, but this would be an interesting future direction for these studies. We  
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Figure 29: Decreased number of apoptotic cells in the lung after intoxication and injury in 
MLCK KO mice.  An immunofluorescent in situ TUNEL assay was used to identify 
apoptotic cells in lung tissue. Average number of apoptotic cells per 10x field after 
intoxication and injury.  *p < 0.05 versus sham vehicle WT, #p < 0.05 versus burn 
ethanol WT by One Way ANOVA.  Data are shown as mean ± SEM. N=3-4 animals per 
group.  
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have analyzed lung IL-10, but have not seen changes in this cytokine 24 h after 
intoxication and burn injury.  We also did not detect a change in the IL-10R expression, 
suggesting if exogenous IL-10 were administered, it may be able to activate an 
inflammatory phenotype on AMs. Loss of AMs, in addition to minimal AM efferocytosis 
of the abundant apoptotic cells, may result in deficient levels of anti-inflammatory 
mediators that can initiate the resolution phase.  Thus, this can prolong the pro-
inflammatory phase. The heightened expression of scavenger receptor MARCO and 
production of TNFα by AMs supports a pro-inflammatory phenotype. Excessive 
inflammatory mediator production has been shown to inhibit apoptosis of neutrophils and 
prolong their stay in tissue [196].  Our laboratory also demonstrated intoxication, prior to 
burn injury and infection, decreased in neutrophil apoptosis and prolonged their stay in 
the airways [143].  These factors support an extended pro-inflammatory phase that can 
result in tissue damage and impair lung function.  Collectively, these data also indicate 
AMs 24 h post-injury may be activated by LPS. In response, they may upregulate 
MARCO, express both ARG1 and iNOS, and secrete TNFα.  Using recent macrophage 
nomenclature guidelines these data suggest we can potentially classify AMs from 
intoxicated and injury mice as M(LPS) [34] (Figure 30). 
Clodronate experiments confirmed AMs also have a role in limiting neutrophil 
numbers into the lungs after intoxication and injury.  The negative correlation between 
decreased AM numbers and increased neutrophil numbers proposes elevated neutrophil 
accumulation after intoxication and injury is a result of AM deficiency in the lung tissue. 
Our data show that both the loss of AMs and a heightened pro-inflammatory profile on  
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Figure 30: AMs have a pro-inflammatory M(LPS) phenotype after intoxication and 
injury. In steady-state conditions, AMs maintain tolerance and suppress inflammatory 
responses through inhibitory receptors CD206 and SIRPα, that binds SP-A and SP-D.  As 
a result of heightened levels bacteria/LPS and IL-6 in the blood stream after intoxication 
and injury, there is increased alveolar wall thickening, neutrophil accumulation into the 
interstitium and an increase in neutrophil chemoattractants KC and MIP-2, and IL-6 in 
lung tissue. The studies indicate AMs acquired an M(LPS) phenotype. We postulated 
LPS activates through TLR4/MD-2. Co-illustration credit C.L. Shults 
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remaining AMs, may prolong pulmonary inflammation after intoxication and injury, 
underlining a mechanism for impaired lung function and increased incidences of 
mortality.   
Kinetic studies of AM life-span reveal AMs are long-lived cells with a half-life of 
30 days and minimal self-renewal in steady-state lung conditions [12]. During lung 
injury, loss of AMs results in the local proliferation of AMs and is the main mechanism 
of repopulation [13-15].  In Appendix A (Figure 31&33-34), we identified a population 
of intermediate AMs. Quantification of these cells after injury demonstrated a 1.5-fold 
increase in this population (Figure 8C), indicating intermediate AMs may be actively 
trying to repopulate loss of AMs in the alveolar space. The rate of repopulation after 
injury and function of efferocytosis was not determined, but these activities would be an 
interesting study to determine the effect of alcohol on the repopulation of AMs after 
injury.   
Our studies emphasize the imperative role of AMs in pulmonary inflammation 
after intoxication and burn injury and the restoration of these multi-functional AMs could 
be critical to re-establishing lung homeostasis and improving lung function. The 
identification of local lung therapeutic agents that specifically target AMs may be 
beneficial to attenuating pulmonary inflammation, overall reducing mortality in burn 
patients.  The data in this dissertation highlight MSCs a useful therapy to specifically 
treat pulmonary inflammation.   Intravenous administration of exogenous MSCs were 
demonstrated to have the ability to reduce both lung and systemic IL-6, a cytokine that 
has been described to play a causative role in the excessive pulmonary inflammation after 
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intoxication and injury [107].  To this end, neutrophil chemokine KC levels and 
neutrophil infiltration into the lungs were also reduced after MSC treatment. Whether this 
was a direct outcome of decreased IL-6 levels was not determined in this study. However, 
the literature implies that MSC production of anti-inflammatory mediators, such as IL-10 
and TGFβ, can down regulate pro-inflammatory mediators, such as IL-6. In our study, we 
did not observe increased levels of lung IL-10, but Lee et al. demonstrated the anti-
inflammatory factor, tumor necrosis factor-α induced protein 6,which is secreted by 
MSCs trapped in the lungs can enter the bloodstream and reduce inflammation at the 
primary site of injury [175]. In our intoxication and injury model, it is possible MSC 
therapy attenuated pulmonary inflammation in more than one way. The secretion of anti-
inflammatory mediators by MSCs into circulation may localize to the burn injury, 
dampening the release of IL-6, thereby decreasing systemic IL-6 levels and pulmonary 
inflammation. Additionally, the entrapment of MSCs within the lung capillary bed allows 
MSCs to activate alveolar macrophages to an anti-inflammatory phenotype, further 
contributing to the reduction of lung inflammation. Alternatively, MSC attenuation of 
pulmonary inflammation through alveolar macrophages may result in a decrease in 
systemic IL-6, identifying the lungs one source that contributes to elevated serum levels 
of this pro-inflammatory cytokine.  
To our knowledge, clinical and experimental MSC therapy in burn injury has 
focused on wound repair, through either the topical transplantation or injections of MSCs 
near the site of injury [127-130].  Xue et al. demonstrated the plasticity of MSCs to 
differentiate into tissue-specific cells and to promote accelerated wound healing, while 
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others have shown an increase in neoangiogenesis and a decrease in cellular infiltration 
at the wound site [130, 131]. Thus far, alternative routes of MSC administration and their 
therapeutic applications is an understudied field in burn research [129]. We choose an 
intravenous method of MSC administration in attempt to localize MSCs and their anti-
inflammatory properties to the lungs and believe that our study is the first to investigate 
the effects of intravenous administered MSCs to target pulmonary inflammation after 
intoxication and burn injury. We found a small percentage CFSE
+
 MSCs in the lungs 24 
h after burn injury using flow cytometry, at a ratio of 100 CFSE
+
 MSCs per 350,000 total 
cells (~0.3%) (Figure 23C). However, we could not identify CFSE+ cells in the lung 
tissue.   The small percentage of MSCs in the lungs at the time point could be due to a 
various factors.  While the majority of intravenous MSCs are localized to the lungs, 
regardless of experimental model, bone fracture studies suggest viable MSCs are able to 
home to the site of injury and promote fracture healing. These studies used 
bioluminescent trafficking and confirmed a large percentage of MSCs get trapped in the 
lungs 1 day after transfer, but a portion of MSCs home to the bone fracture site by 3 to 14 
days after administration [197-199].  This delay in migration from the lungs to the site of 
injury may support why we do not see MSCs near the burn wound at this 24 h time point.  
Furthermore, intoxication at the time of bone fracture did not inhibit the migration of 
MSCs given 24 h after injury [200]. Bioluminescence is a very sensitive technique that 
shows the general location of labeled MSCs within a test subject, but the visualization of 
individual fluorescently labeled cells may be more difficult to find within the several 
million lung alveoli.  Additionally, burn injury alone results in an increase in capillary 
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permeability and tissue edema, with a great need for fluid resuscitation [201], while 
intoxicated and burn-injured patients require an even greater amount of fluid resuscitation 
[89].  Our laboratory found that intoxication at the time of injury increases post-burn 
dehydration, even after fluid resuscitation, while also causing a shift in fluid 
compartments that results in greater ischemic end-organ damage [202].  The increase in 
capillary permeability and loss of fluid from the vascular space may highly influence the 
fate of infused MSCs. The large size of MSCs may not only trap them within the lung 
capillary bed, but also retain them within constrained vasculature of intoxicated and burn-
injured mice.  It is also possible the migration aptitude of the Gibco® MSCs differs from 
freshly isolated primary bone marrow-derived MSCs.  However, published studies have 
confirmed the immunosuppressive ability of this cell line [203].  Overall, we can 
conclude that even in the presence of acute dehydration and ischemia, MSCs are able to 
exhibit an anti-inflammatory effect on the lungs, while also reducing systemic IL-6.    
In conclusion, even though AMs may only be a small percentage of cells in the 
lungs, their function and presence has a huge impact on normal lung function.  These data 
presented in this dissertation support our hypothesis that intoxication and burn injury 
results in the loss of AMs through apoptosis, leading to elevated levels of neutrophil 
infiltration and impaired lung function. Finally, AMs diverse functions and their 
changeable activation state present an opportune therapeutic target to help control 
pulmonary inflammation in all burn patients.  
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Results 
Lung tissue was dissociated into a single cell suspension from both sham vehicle 
and burn ethanol treatment groups and analyzed by flow cytometry [21].  Total live lung 
cells were gated (Figure 31A) and examined for expression of CD11b and CD11c cell 
surface markers (Figure 31B).  Using these 2 markers we were able to subdivide lung 
cells into 4 different populations, including AMs (Figure 31B, R1), intermediate 
AMs/CD11b
+
 DCs (Figure 31B, R2), granulocytes (neutrophils) (Figure 31B, R3), and 
lymphocytes/non-leukocytes (Figure 31B, R4), regardless of injury.  While our main 
focus was on the characterization of AMs, we confirmed the phenotype of all 4 
populations and assessed whether intoxication and injury altered the frequency of these 
individual subsets. First, forward scatter (FSC-cell size) and side scatter (SSC-
granularity) plots were analyzed from each treatment group (Figure 31C&F).  With 
intoxication and injury, we visually noted the appearance of a population of cells within 
total lung (Figure 31F, white dashed circle). Based on data presented in Chapter 3, as 
well as previous data by our laboratory, we predicted this population of cells was 
infiltrating neutrophils.  To identify AMs, we first analyzed total live cells for 
CD11c
+
CD11b
- 
(Figure 31D&G) and noticed a decrease in the density of this population.  
Further analysis of alveolar macrophages confirmed their expression of Siglec-F (Figure 
31E&H). Within CD11c
+
CD11b
- 
population we also can identify  
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Figure 31. Flow cytometry analysis of leukocyte populations in lung tissue.  Lung tissue 
was obtained 24 hours post-injury and enzymatically dissociated into a single cell 
suspension. Lung cells were stained for leukocyte cell markers. A) Total lung cells were 
gated to include large myeloid cells (polygon gate) and exclude smaller lymphocytes and 
dead cells. B) Summary of individual cell populations within the total lung gate using a 
CD11c versus CD11c gating method.  (R1) CD11c
+
CD11b
-
 AMs (R2) CD11c
+
CD11b
+
 
intermediate AMs and CD11b
+
 DCs (R3) CD11c
-
CD11b
-
 lymphocytes/non-leukocytes 
and (R4) CD11c
-
CD11b
+
 granulocytes (neutrophils). C-H) Representative gating of AMs 
from both sham vehicle and burn ethanol groups. Flow profiles in sham vehicle were 
selected for C) total lung cells (polygon gate), then D) CD11c
+
CD11b
-
 cells (black gate), 
then E) Siglec-F
+
 (CD11c
+
) cells (black gate), small black arrows indicate DCs within the 
CD11c
+
CD11b
-
 population. Flow profiles in burn ethanol were similarly selected for F) 
total lung cells (polygon gate-white dash circle indicates infiltrating cells), then G) 
CD11c
+
CD11b
-
 cells (black gate), then H) Siglec-F
+
 (CD11c
+
) cells (black gate). 
Changes in the density of cell populations indicate changes in the quantity of cells in a 
population.  
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CD11c
+
Siglec-F
-
 DCs.  Using a backgating tool we, we examined where 
CD11c
+
CD11b
+
Siglec-F
+
 AMs were located within total lung cells in both treatment 
groups (Figure 32A&D).  AMs in sham vehicle varied in size (FSC) and granularity 
(SSC), with the majority of AMs falling between 50-150K SSC (Figure 32A). However, 
AMs from intoxicated and burn injured mice showed an increase in SSC, majority of 
cells ranging from 100-225K (Figure 32D), suggesting combined injury activates AMs.  
We further show CD11c
+
CD11b
-
Siglec-F
+
 cells are F4/80
+
 (Figure 32C&F).  
Additionally, we examined Siglec-F
+
 cells and found a population of 
CD11c
+
CD11b
+
Siglec-F
+
 cells adjacent on the plot to AMs (Figure 32B&E). Eosinophils 
can be eliminated because they are Siglec-F
+
, but not CD11c
+
, therefore, we hypothesized 
this additional population of Siglec-F
+
 cells were interstitial macrophages.  
 Analysis of CD11c
+
CD11b
+
 cells (Figure 33) revealed that the majority of the 
cells from sham animals had a wide range of FSC and SSC (Figure 33A), while this 
population from intoxication and injured mice had an increase in SSC (Figure 33C).  We 
next analyzed this population for F4/80 and Siglec-F expression in both treatment groups. 
Using fluorescent minus one controls we established a F4/80
-
Siglec-F
-
 and a 
F4/80
lo
Sigle-F
+
population of cells (Figure 34A). F4/80
-
Siglec-F
-
 also expressed MHC II 
(Figure 34B), while F4/80
lo
Siglec-F
+
 expressed similar levels of CD206 as AMs (Figure 
34C). The literature suggests these CD11c
+
CD11b
+
 cells are an intermediate macrophage 
population that replenish alveolar macrophages [204].  However, we believe we have 
shown that CD11c
+
CD11b
+
 cells are representative of F4/80
-
Siglec-F
-
MHC II
+
 “CD11b+ 
DCs” and F4/80loSiglec-F+CD206+ intermediate AMs. We are hesitant to call  
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Figure 32. Forward scatter and side scatter characteristics of AMs. Forward scatter (FSC) 
is a measure of cell size and side scatter (SSC) is a measure of granularity. Data 
representative of dissociated lung tissue from (A-C) sham vehicle and (D-F) burn ethanol 
mice. A&D) CD11c
+
CD11b
-
Sigle-F
+ 
AMs (red) were analyzed for FSC and SSC in total 
lung cells. B&E) Location of Siglec-F
+
 cell populations within CD11c
 
and CD11b
 
gating 
(red). There are two Siglec-F
+
 populations of cells, CD11b
- 
and CD11b
+
. C&F) 
Confirmation of F4/80 expression on
 
CD11c
+
CD11b
-
Sigle-F
+ 
AMs (red), in comparison 
to a fluorescent minus one control (black).  
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Figure 33. Forward scatter and side scatter characteristics of CD11b
+
CD11c
+
 cells. Data 
representative of dissociated lung tissue from A&B) sham vehicle and C&D) burn 
ethanol mice. A&C) CD11c
+
CD11b
+
cells (red) were analyzed for FSC and SSC in total 
lung cells. B&D) Gating of CD11c
+
CD11b
+ 
cells (red) that were analyzed for FSC versus 
SSC in A&C.  
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Figure 34. Characterization of CD11b
+
CD11c
+
 cells. CD11b
+
CD11c
+
 cells from 
dissociated lung tissue were analyzed in sham vehicle and burn ethanol mice for Siglec-F 
and F4/80 expression. A) Two populations were identified, Siglec-F
+
F4/80
lo
 intermediate 
AMs (magenta gate) and Siglec-F
-
F4/80
-
 DCs (green gate). B) Expression levels of MHC 
II on both intermediate AMs (magenta) and DCs (green). MHC II is expressed on Siglec-
F
-
F4/80
-
 DCs, but not on Siglec-F
+
F4/80
lo
 intermediate AMs. C) Expression levels of 
CD206 on intermediate AMs (magenta) in comparison to CD11c
+
CD11b
-
Sigle-F
+ 
AMs 
(blue). CD206 levels on intermediate AMs are similar to AMs.   
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intermediate AMs interstitial macrophages because 1) we did not assess their location in 
the tissue and 2) it is thought that interstitial AMs do not express Siglec-F [21].  
Additionally, clodronate depletion of AMs also eliminated intermediate AMs, but not 
DCs, further confirming that these are two distinct populations (Figure 35). We originally 
hypothesized the DC population were monocytes, but according to Misharin et al., 
monocytes in the lung are not MHC II
+
 [21].  
 The location of CD11c-CD11b+ cells was also assessed in total lung cells (Figure 
36A&D), confirming that the infiltrating population observed with intoxication and 
injury was CD11c
-
CD11b
+
Ly-6G
+
 neutrophils (Figure 31F & 36A-C) and we have 
already established in Chapter 3 that there is a significant increase in CD11b
+
Ly-6G
+
 
neutrophils after intoxication and injury. Eosinophils were not assessed, but they would 
likely fall in the CD11c
-
CD11b
+ 
population during an allergic stimuli.  Lastly, CD11c
-
CD11b
-
 cells were characterized as F4/80
-
Ly-6G
-
Siglec-F
-
 lymphocytes or non-
leukocytes. Based on where they fall in the FSC and SSC plot, these cells likely are a mix 
of lymphocytes, epithelial, endothelial cells or dead cells (Figure 36D&E).  
 In separate experiments, BAL cells were also obtained and their phenotype was 
compared against AMs from dissociated lung tissue (Figure 37).  BAL cells were 
phenotyped as CD11c
+
CD11b
+
Siglec-F
+
F4/80
+
 (Figure 37D) and these cells represented 
>92% of total BAL cells, highlighting BAL cells as a mainly pure population of AMs, 
regardless of treatment.  The small scattering of cells that would be CD11c
+
CD11b
+ 
suggests BAL may also contain intermediate AMs. More studies on this are needed to 
confirm these observations. We further analyzed the baseline expression of  
  
  
[126] 
 
Figure 35. Clodronate liposome depletes CD11b
+
CD11c
+
Siglec-F
+
F4/80
lo
 intermediate 
AMs. Total lung cells from dissociated lung tissue were analyzed in sham vehicle and 
burn ethanol mice after empty control and clodronate liposome treatment. Analysis of 
intermediate AMs (magenta gate) and DCs (green gate) revealed clodronate liposome 
selectively depleted only CD11b
+
CD11c
+
Siglec-F
+
F4/80
lo
 intermediate AMs, confirming 
their macrophage lineage.  
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Figure 36. Forward scatter and side scatter characteristics of CD11b
+
CD11c
- 
and CD11b
-
CD11c
- 
cells. Data representative of dissociated lung tissue from burn ethanol. A) 
CD11b
+
CD11c
- 
(red) were analyzed for FSC and SSC in total lung cells. White dashed 
circle indicates infiltrating population after intoxication and injury. B) Gating of CD11c
-
CD11b
+ 
cells (red) that were analyzed for FSC versus SSC in A. C) Confirmation of Ly-
6G expression on
 
CD11c
-
CD11b
+ 
cells (red), in comparison to a fluorescent minus one 
control. This confirmed a neutrophil phenotype. D) CD11b
-
CD11c
- 
(red) were analyzed 
for FSC and SSC in total lung cells. E) Gating of CD11c
-
CD11b
- 
cells (red) that were 
analyzed for FSC versus SSC in D. These small cells are lymphocytes, non-leukocytes, or 
dead cells.  
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Figure 37. Comparison of AMs from dissociated lung or BAL fluid in sham vehicle. 
Lungs were either enzymatically dissociated into a single cell suspension or they were 
lavaged 5x with 1 mL PBS and cells stained for AM markers. A-C) Representative gating 
of AMs in BAL fluid.  Flow profiles were selected for A) total lung cells (polygon gate), 
then B) CD11c
+
CD11b
-
 cells (black gate), then C) Siglec-F
+
(CD11c
+
) cells (black gate). 
D) Histogram display of surface receptor fluorescent intensity on AMs from both 
dissociated lung and BAL fluid, confirming the CD11c
+
CD11b
-
Sigle-F
+ 
F4/80
+
 AM 
phenotype (red) in comparison to fluorescent minus one (FMO) controls (black).  A FMO 
is where cells are stained for every antibody except one to determine fluorescence 
crossover.  This is done for each antibody. 
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M1 markers, MARCO and MHC II, and M2 marker CD206 on both dissociated lung  
AMs and BAL AMs from sham mice (Figure 38).  There was no change in the expression 
of MARCO or MHC II in sham animals and consistent with the literature, AMs 
constitutively express CD206 [21, 169].  In summary, the nearly pure population AMs in 
the BAL fluid can also be identified in dissociated lung tissue, emphasizing that both of 
both BAL and dissociated lung tissue will be useful source for our AM-focused studies. 
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Figure 38. Baseline expression of activation receptors on AMs from dissociated lung and 
BAL-derived AMs in sham vehicle. Lungs were either enzymatically dissociated into a 
single cell suspension or they were lavaged 5x with 1 mL PBS and cells stained for AM 
markers. Histogram display of baseline surface receptor fluorescent intensity on sham 
vehicle CD11c
+
CD11b
-
Sigle-F
+
 AMs (red) from both dissociated lung and BAL fluid in 
comparison to fluorescent minus one (FMO) controls (black).  
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APPENDIX B 
DETAILED METHODS DESCRIPTION 
Intoxication and Burn Injury Protocol 
Materials 
Hot plate 
Water basins 
Animal clippers with #40 surgical clip comb 
Thermometer 
1cc syringes with 27 gauge needle 
3cc syringes with 20 gauge oral gavage needle 
0.9% normal saline (sterile) 
Burn injury template (check for proper size according to weight of mice) 
Ketamine 
Xylazine 
Ethanol 
Procedure 
1. Fill two water basins with deionized water and heat one until 92-95°C, leaving the 
other at room temperature. 
2. Tail mark and weigh the mice. 
3. Gavage mice with 400ul of ethanol mixed in water at the desired dose or water 
alone.  Allow 2-3 minutes between cages so there is time to shave and burn the 
mice at their scheduled time.
 
 
4. Thirty (30) min. after ethanol administration, anesthetize the mice by injecting a 
mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) in sterile saline by i.p. 
injection. 
5.  As soon as they are asleep (approx. 5 min. after anesthesia injection), thoroughly 
shave the backs of the mice (Oster animal clippers with #40 comb). 
6. One at a time, place animals in appropriate burning template to give a 14-16% 
total body surface area scald injury according to their weight (see chart in 
procedure room), and proceed with the burn injury (or sham – dunking mice in 
room temp water). Make sure the shaved part of the back is “sealed” on the 
burning template by gently pressing the mouse down into the template. 
7. Hold the template containing the animal in the water for 7 seconds. Quickly blot 
the mouse’s back on paper towels. Removing as much hot water as possible from 
the animal prevents further scalding.  Put the mouse back in a clean cage.  
8.  As soon as possible after the injury, resuscitate each mouse with 1.0 ml of 0.9% 
sterile saline (i.p.), pre-warmed in 37C water bath, or on warming pads.   
9. Keep cages on heating pads for the next 3-4 hours.to help the mice recover from 
procedure.  Mice can be returned to the mouse room once they are walking and 
fairly alert. 
10. Place some food pellets on the bottom of each cage; the mice can’t stretch their 
necks as easily to reach for food after burn injury.  Replace water bottles. 
 
Solutions: 
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Ketamine/Xylazine: Diluted with 0.9% saline, 100 mg/kg ketamine, 10 mg/kg xylazine, 
70.0 uL/mouse i.p. (see Ketamine/Xylazine protocol for how to make)  
Ethanol:  
1) 20% solution is the final concentration, made from the 95% stock ethanol 
(marked for use in mice only). Dilute with water from the drinking fountain.   
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Plethysmography 
Materials 
Mice 
Barometric plethysmography apparatus 
Mini screwdriver 
1cc syringe with tubing 
Timer 
Procedure 
2) Turn on computer and the 3 Buxco plethysmography machines. 
3) Make sure all 4 chambers (1-4) are connected to machine. 
4) Under Home, select calibration (wrench symbol) on the Loyola WBP file. 
Calibrate all 4 chambers according to instructions. Close stop cock (turn to side) 
at the top of each chamber during calibration. Re-open stop cock when chamber is 
finished being calibrated. Use mini screw driver to adjust calibration setting and a 
1cc syringe attached to tubing to inject air into the chamber. Make sure to re-
attach tubing to chamber after syringe is removed. 
5) After calibration, select Basline and then Loyola WBP. 
6) Enter in animal numbers and place mice into each chamber, making sure 
chambers are completely closed, stop cock is facing up and all connections are 
secure. 
7) Under Session, select “Acknowledge All Sites”. 
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8) Mice will have 5 min of acclimation, followed by 10 min of data recording. Set 
timer for 15 min per mouse set. 
9) After 15 min, remove mice and put next set of mice into chambers. 
10) Under Session, select “Load New Subjects”. Enter in animal numbers for new set 
of mice. Repeat steps 6-8 until all mice are done. 
11) When finished recording data, under File select “End Session”. Make sure each 
animal recording is selected and save data. 
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Lung Tissue Dissociation 
Materials 
Collagenase D 
DNase I 
2% BSA/PBS 
HBSS, no phenol red 
gentleMACS C tubes  
70 µm cell strainers 
50mL conical tubes 
gentleMACS Dissociator 
Incubator 
Centrifuge 
Procedure 
1. Modified from Miltenyi Biotec’s Lung Dissociation Kit protocol. 
2. Prepare to digest lung lobe in 2mg/mL Collagenase D and 0.1mg/mL DNase I. 
3. Prepare digestion buffer by dissolving the following into HBSS:  
a. Collagense D: 100mg in 2ml in 15mL (100ul of this into 2.4mL is 
2mg/mL). 
b. DNase I: 10mg in 1ml (25ul of this into 2.4mL is 0.1mg/mL). 
4. Remove lungs from mice and place upper left lobe into C tube with 2.4mL HBSS. 
Add in 100ul prepared Collegenase D and 25ul DNase I. 
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5. Close C tube tightly until you hear a snap and attach it upside down into slot on 
the gentleMacs Dissociator. 
6. Run gentleMACS program m_lung_01. Detach C tube from dissociator. 
7. Incubate samples in incubator at 37°C for 20-25 min, manually mixing samples 
every 5 min. 
8. Remove tubes from incubator and use a pipet to gentle break up dissociated tissue 
until it’s a single cell suspension (Do not use program m_lung_02. It is too harsh 
on cells). 
9. Perform brief 15 s centrifugation to collect sample at bottom of the tube. 
10. Resuspend sample and filter through a 70 µm cell strainer into a 50mL conical 
tube. Wash strainer with 2.5mL HBSS. 
11. Discard strainer and centrifuge cells for 10 min at 300xg. Remove supernatant. 
12. Resuspend in 2% BSA/PBS and count cells. 
13. Cells are now ready for flow cytometry analysis. 
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Bronchoalveolar Lavage 
Materials 
Cold 1x PBS 
60 Tubing 
1cc syringe with 20g needle 
25g needle 
15mL conical tube 
50mL conical tube 
Procedure 
1. Attach tubing to a 20g gauge needle with ¼ inch of tubing extended from needle. 
2. Euthanize mouse and expose trachea and lungs. Using a 25g needle, gently pierce 
the trachea below the first collangenous ring, Insert tubing (that is attached to 
needle and syringe) into the trachea. 
3. Lavage lungs 5 times with .8-.9 ml of cold PBS (keep PBS in 50mL conical tube 
in ice bucket). 
4. Pool all washes per animal into a 15mL conical tube 
5. Spin cells 1200 rpm 3min 4° C. 
6. Removed supernatant (~5mL) and store at at -80ºC for future cytokine analysis 
studies. 
7. Resuspend in 500ul RBC Lysis Buffer (ACK lysis buffer) and incubate 4 min on 
ice. 
8. Add 5ml PBS to quench reaction and spin cells 1200 rpm 3 min. 
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9. Resuspend to 400ul in PBS and count cells. 
10. Cells are ready for flow cytometry staining, chamber slide incubation or 
cytocentrifugation onto slides. 
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Flow Cytometry of Alveolar Macrophages 
Materials 
Antibodies 
FACS Buffer: 1x PBS + 2% BSA 
1x PBS 
Eppindorf tubes 
Plastic FACS tubes 
Pipets 
Centrifuge 
Ice  
Refrigerator or cold room 
Waste container 
Foil 
Procedure 
1. Obtain and count lung cells or BAL cells.  
2. Add 1x106 lung cells or 1x105 BAL cells to eppindorf tubes. 
3. Centrifuge at 1200rpm  at 4oC for 5min. 
4. Decant supernatant by gently “dumping” it into a waste container. 
5. Block unspecific binding to the Fcy II/III receptor using anti-CD16/32 for 20 min 
at 4
o
C on ice. 
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6. Without washing cells, directly add in 50ul of primary antibodies diluted in FACS 
buffer for 30 min at 4
o
C on ice in the dark. (Titer antibodies to determine 
appropriate concentrations). 
7. Wash 2x with FACS buffer. 
8. Transfer cells to FACS tubes and immediately run unfixed cells resuspended in 
400ul PBS on the BD Fortessa cytometer OR fix cells with 500ul 1% PFA for 15 
min on ice. Wash with PBS and store in refrigerator at 4
o
C overnight covered in 
foil and analyze samples the next day. 
Controls: 
9. Unstained Cells (from both sham vehicle and burn ethanol groups). 
10. Fluorescence Minus One Control (FMO): Each fluorochrome needs 1 sample with 
all fluorochromes, except for that 1 fluorochrome.  
Antibodies to characterize alveolar macrophages: 
CD11c APC-eFluor 780 (clone N418, eBioscience) 
CD11b eFluor 450 (clone M1/70, eBioscience) 
F4/80 APC (clone BM8, eBioscience) 
Siglec-F PE-CF594 (clone E50-2440, BD Biosciences, San Jose, CA) 
CD206 PE (clone C068C2, Biolegend, San Diego, CA) 
Ly-6G (Gr-1) PE-Cy7 (clone RB6-8C5, eBioscience) 
MHC II BD Horizon V500 (BD Biosciences)  
TLR4/MD-2 APC (clone MTS510, eBioscience) 
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MARCO FITC (Abd Serotec),  
CD71 PerCP-eFluor 710 (clone R17217, eBiosciences) 
IL-10R PE (clone 1B1.3a, BD Bioscience 
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Siglec-F Immunofluorescent Staining 
1. Section OCT frozen lung tissue at 6µm onto slides. 
2. Airdry slides for 1 hour at room temperature. 
3. Fix slides 5 min in 4% PFA (15ml 16% PFA + 45ml cold PBS in a coplin jar) in 
the hood.  
4. Wash 3x with 1x cold PBS for 5 min. Pour PBS into coplin jar, then gently put 
slides in PBS. Pouring PBS over slides in jar can cause delicate tissue to dislodge 
from slide. 
5. Block with superblock for 5 min (no longer or can ruin tissue). 
6. ‘Dip” rinse slides (dip slides in PBS-don’t leave in PBS). 
7. In a humidity chamber, incubate sections overnight at 4oC with rat anti-mouse 
purified Siglec-F (Clone E50-2440, BD Biosciences) at 10ug/ml diluted in 
antibody diluent (Immco). 
8. Wash 3x with 1x cold PBS for 5 min each. 
9. Incubate sections with secondary antibody goat anti-rat Alexa Fluor® 555 anti-rat 
IgG (H+L) (Life Technologies)1:500 diluted in antibody diluent for 1 h at room 
temperature. 
10. Wash 3x with 1x cold PBS for 5 min each. 
11. Air slides dry and mount with prolonged dapi gold (Life Technologies). 
 
 
 
  
  
[145] 
Active-Caspase 3 Staining 
Materials 
Humidity chamber 
Coplin jars 
1x PBS 
Fixation : 4% Paraformaldehyde (PFA) in 1x PBS 
Permeabilization: 0.1% Triton X-100 in 2% BSA/PBS 
Blocking Reagent: 10% normal donkey serum + 0.1% Triton-100x 
Antibody diluent: 2% BSA/PBS 
Prolong Gold Dapi mounting medium 
Procedure 
1. Isolate BAL cells. Centrifuge 300g for 3 minutes.  Lyse RBCs with ACK lysis 
buffer for 4 mins on ice.  Wash cells.  Resuspend each pellet in 300ul media 
and count by putting 10ul directly onto hemocytometer.  After counting, 
measure exactly how much media each sample was resuspended in. 
2. BAL cells were cytocentrifuged (50,000 cells/200ul PBS or complete 
medium) onto slides at 400RPM for 5 min. 
3. Fix slides 5 min in 4% PFA (made in cold PBS) in coplin jars in the hood.  
4. Wash 3x with 1x cold PBS for 5 min.  
5. In humidity chamber, permiabilize with 0.1% Triton-100x in 2% BSA/PBS 
for 30 min at room temperature. 
6. Wash 3x with 1x cold PBS for 5 min.  
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7. Block with 10% normal donkey serum (NDS) + 0.1% Triton-100x for 20 
minutes at room temperature. Tap off serum. 
8. Incubate slides overnight at 4oC with rabbit anti-active-caspase 3 (Abcam) at 
10ug/ml diluted in 2% BSA/PBS. 
9. Wash 3x with 1x cold PBS for 5 min each. 
10. Incubate sections with secondary antibody donkey anti-rabbit 594 (Life 
Technologies) diluted in 2%BSA/PBS for 45 min at room temperature. 
11. Wash 3x with 1x cold PBS for 5 min each. 
12. Air slides dry and mount with prolonged dapi gold (Life Technologies). 
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ImageJ Analysis of Lung Tissue Histology 
Materials 
Lung H&E slides 
Microscope with camera 
ImageJ program 
Procedure 
1. Save 10 high power images per animal as jpeg files in a separate folder for each 
animal.   
2. Import folder as an “Image Sequence” in the ImageJ program. 
3. Convert to 8-bit and adjust contrast and threshold if necessary.  Must apply the same 
settings to all sets of images. 
4. Convert to binary. 
5. Set measurements to be captured with threshold as area fraction. 
6. Select “measure” and record. 
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ImageJ Analysis of TUNEL
+
 Cells 
Materials 
Lung slides stained with TUNEL 
Microscope with camera 
ImageJ program 
Procedure 
7. Save 10 high power images per animal as jpeg files in a separate folder for each 
animal.   
8. Import folder as an “Image Sequence” in the ImageJ program. 
9. Convert to 8-bit and adjust contrast and threshold if necessary.  Must apply the same 
settings to all sets of images. 
10. Convert to binary. 
11. Set measurements to be captured with threshold as area fraction. 
12. Select analyze and “analyze particles”  and set measurements to be captured: 
a. Size 5-infinity 
b. Circularity 0-100 
13. Generate results and save data cell counts of TUNEL+ cells. 
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Clodronate Depletion of Alveolar Macrophages 
Materials 
Clodronate liposome 
Control liposome  
1cc syringe with 30g needle 
50 Tubing 
200ul pipet 
Ketamine  
Xylazine 
Board and rubber band 
Procedure 
1. Bring clodronate and control liposomes (Encapsula NanoSciences, Brentwood, 
TN) to room temperature. Gently mix vial contents (do not vortex). 
2. Weigh and tail mark mice. 
3. Anesthetized  mice with100 mg/kg ketamine and 10 mg/kg xylazine. 
4. Mice were suspended 
5. Using a 200ul pipet, take 75ul of liposomes and pipet it into a 1cc syringe. 
Attached needle with tubing to syringe and intratracheally administer liposomes. 
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Mesenchymal Stem Cells Tail Vein Injection 
Materials 
Wooden box with small hole in the side 
27 gauge needle with syringe 
Heating Pad 
Ethanol (70% v/v) 
PBS 
MSCs (1x10
5
/200ul pre-warmed PBS) 
Procedure 
1. Place animal cage on warming pad. 
2. Bend needle to a 120° angle with the syringe. 
3. Place mouse under Styrofoam housing, pulling tail through the side hole. 
4. Wet the tail with ethanol and rub proximal portion of the tail until a lateral tail vein is 
visible. 
5. Insert needle into lateral vein and slowly inject MSCs or saline control. 
 
 
 
 
 
 
 
  
  
151 
REFERENCES 
1. Treuting, P.M.a.D., S.M., Comparative Anatomy and Histology: A Mouse and 
Human Atlas. 2011: Academic Press. 
2. Burns, A.R., C.W. Smith, and D.C. Walker, Unique structural features that 
influence neutrophil emigration into the lung. Physiol Rev, 2003. 83(2): p. 309-
36. 
3. Kopf, M., C. Schneider, and S.P. Nobs, The development and function of lung-
resident macrophages and dendritic cells. Nat Immunol, 2015. 16(1): p. 36-44. 
4. Knust, J., M. Ochs, H.J. Gundersen, and J.R. Nyengaard, Stereological estimates 
of alveolar number and size and capillary length and surface area in mice lungs. 
Anat Rec (Hoboken), 2009. 292(1): p. 113-22. 
5. Fels, A.O. and Z.A. Cohn, The alveolar macrophage. J Appl Physiol (1985), 
1986. 60(2): p. 353-69. 
6. Bowden, D.H., The alveolar macrophage. Environ Health Perspect, 1984. 55: p. 
327-41. 
7. van oud Alblas, A.B. and R. van Furth, Origin, Kinetics, and characteristics of 
pulmonary macrophages in the normal steady state. J Exp Med, 1979. 149(6): p. 
1504-18. 
8. Karavitis, J., E.L. Murdoch, C. Deburghgraeve, L. Ramirez, and E.J. Kovacs, 
Ethanol suppresses phagosomal adhesion maturation, Rac activation, and 
subsequent actin polymerization during FcgammaR-mediated phagocytosis. Cell 
Immunol, 2012. 274(1-2): p. 61-71. 
9. Ely, K.H., T. Cookenham, A.D. Roberts, and D.L. Woodland, Memory T cell 
populations in the lung airways are maintained by continual recruitment. J 
Immunol, 2006. 176(1): p. 537-43. 
10. Westphalen, K., G.A. Gusarova, M.N. Islam, M. Subramanian, T.S. Cohen, A.S. 
Prince, and J. Bhattacharya, Sessile alveolar macrophages communicate with 
alveolar epithelium to modulate immunity. Nature, 2014. 506(7489): p. 503-6. 
  
  
152     
11. Guilliams, M., I. De Kleer, S. Henri, S. Post, L. Vanhoutte, S. De Prijck, K. 
Deswarte, B. Malissen, H. Hammad, and B.N. Lambrecht, Alveolar macrophages 
develop from fetal monocytes that differentiate into long-lived cells in the first 
week of life via GM-CSF. J Exp Med, 2013. 210(10): p. 1977-92. 
12. Murphy, J., R. Summer, A.A. Wilson, D.N. Kotton, and A. Fine, The prolonged 
life-span of alveolar macrophages. Am J Respir Cell Mol Biol, 2008. 38(4): p. 
380-5. 
13. Tarling, J.D., H.S. Lin, and S. Hsu, Self-renewal of pulmonary alveolar 
macrophages: evidence from radiation chimera studies. J Leukoc Biol, 1987. 
42(5): p. 443-6. 
14. Landsman, L. and S. Jung, Lung macrophages serve as obligatory intermediate 
between blood monocytes and alveolar macrophages. J Immunol, 2007. 179(6): p. 
3488-94. 
15. Hashimoto, D., A. Chow, C. Noizat, P. Teo, M.B. Beasley, M. Leboeuf, C.D. 
Becker, P. See, J. Price, D. Lucas, M. Greter, A. Mortha, S.W. Boyer, E.C. 
Forsberg, M. Tanaka, N. van Rooijen, A. Garcia-Sastre, E.R. Stanley, F. Ginhoux, 
P.S. Frenette, and M. Merad, Tissue-resident macrophages self-maintain locally 
throughout adult life with minimal contribution from circulating monocytes. 
Immunity, 2013. 38(4): p. 792-804. 
16. Maus, U.A., S. Janzen, G. Wall, M. Srivastava, T.S. Blackwell, J.W. Christman, 
W. Seeger, T. Welte, and J. Lohmeyer, Resident alveolar macrophages are 
replaced by recruited monocytes in response to endotoxin-induced lung 
inflammation. Am J Respir Cell Mol Biol, 2006. 35(2): p. 227-35. 
17. Metchnikoff, E., Leçons Sur La Pathologie Comparée De L' inflammation. Paris: 
Masson, 1892. 
18. Myrvik, Q., E.S. Leake, and B. Fariss, Studies on pulmonary alveolar 
macrophages from the normal rabbit: a technique to procure them in a high state 
of purity. J Immunol, 1961. 86: p. 128-32. 
19. Hussell, T. and T.J. Bell, Alveolar macrophages: plasticity in a tissue-specific 
context. Nat Rev Immunol, 2014. 14(2): p. 81-93. 
20. Guth, A.M., W.J. Janssen, C.M. Bosio, E.C. Crouch, P.M. Henson, and S.W. 
Dow, Lung environment determines unique phenotype of alveolar macrophages. 
Am J Physiol Lung Cell Mol Physiol, 2009. 296(6): p. L936-46. 
  
  
153     
21. Misharin, A.V., L. Morales-Nebreda, G.M. Mutlu, G.R. Budinger, and H. 
Perlman, Flow cytometric analysis of macrophages and dendritic cell subsets in 
the mouse lung. Am J Respir Cell Mol Biol, 2013. 49(4): p. 503-10. 
22. Zaynagetdinov, R., T.P. Sherrill, P.L. Kendall, B.H. Segal, K.P. Weller, R.M. 
Tighe, and T.S. Blackwell, Identification of myeloid cell subsets in murine lungs 
using flow cytometry. Am J Respir Cell Mol Biol, 2013. 49(2): p. 180-9. 
23. Wright, J.R., Immunoregulatory functions of surfactant proteins. Nat Rev 
Immunol, 2005. 5(1): p. 58-68. 
24. Janssen, W.J., K.A. McPhillips, M.G. Dickinson, D.J. Linderman, K. Morimoto, 
Y.Q. Xiao, K.M. Oldham, R.W. Vandivier, P.M. Henson, and S.J. Gardai, 
Surfactant proteins A and D suppress alveolar macrophage phagocytosis via 
interaction with SIRP alpha. Am J Respir Crit Care Med, 2008. 178(2): p. 158-67. 
25. Gardai, S.J., Y.Q. Xiao, M. Dickinson, J.A. Nick, D.R. Voelker, K.E. Greene, and 
P.M. Henson, By binding SIRPalpha or calreticulin/CD91, lung collectins act as 
dual function surveillance molecules to suppress or enhance inflammation. Cell, 
2003. 115(1): p. 13-23. 
26. Chitu, V. and E.R. Stanley, Colony-stimulating factor-1 in immunity and 
inflammation. Curr Opin Immunol, 2006. 18(1): p. 39-48. 
27. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia, Dendritic cells use 
macropinocytosis and the mannose receptor to concentrate macromolecules in 
the major histocompatibility complex class II compartment: downregulation by 
cytokines and bacterial products. J Exp Med, 1995. 182(2): p. 389-400. 
28. Brinker, K.G., E. Martin, P. Borron, E. Mostaghel, C. Doyle, C.V. Harding, and 
J.R. Wright, Surfactant protein D enhances bacterial antigen presentation by 
bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol, 2001. 
281(6): p. L1453-63. 
29. Jones, C.V., T.M. Williams, K.A. Walker, H. Dickinson, S. Sakkal, B.A. 
Rumballe, M.H. Little, G. Jenkin, and S.D. Ricardo, M2 macrophage polarisation 
is associated with alveolar formation during postnatal lung development. Respir 
Res, 2013. 14: p. 41. 
30. Charlson, E.S., K. Bittinger, A.R. Haas, A.S. Fitzgerald, I. Frank, A. Yadav, F.D. 
Bushman, and R.G. Collman, Topographical continuity of bacterial populations 
in the healthy human respiratory tract. Am J Respir Crit Care Med, 2011. 184(8): 
p. 957-63. 
  
  
154     
31. Zhang, J., S.D. Tachado, N. Patel, J. Zhu, A. Imrich, P. Manfruelli, M. Cushion, 
T.B. Kinane, and H. Koziel, Negative regulatory role of mannose receptors on 
human alveolar macrophage proinflammatory cytokine release in vitro. J Leukoc 
Biol, 2005. 78(3): p. 665-74. 
32. Palecanda, A., J. Paulauskis, E. Al-Mutairi, A. Imrich, G. Qin, H. Suzuki, T. 
Kodama, K. Tryggvason, H. Koziel, and L. Kobzik, Role of the scavenger 
receptor MARCO in alveolar macrophage binding of unopsonized environmental 
particles. J Exp Med, 1999. 189(9): p. 1497-506. 
33. Curtale, G., M. Mirolo, T.A. Renzi, M. Rossato, F. Bazzoni, and M. Locati, 
Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent 
microRNA-146b. Proc Natl Acad Sci U S A, 2013. 110(28): p. 11499-504. 
34. Murray, P.J., J.E. Allen, S.K. Biswas, E.A. Fisher, D.W. Gilroy, S. Goerdt, S. 
Gordon, J.A. Hamilton, L.B. Ivashkiv, T. Lawrence, M. Locati, A. Mantovani, 
F.O. Martinez, J.L. Mege, D.M. Mosser, G. Natoli, J.P. Saeij, J.L. Schultze, K.A. 
Shirey, A. Sica, J. Suttles, I. Udalova, J.A. van Ginderachter, S.N. Vogel, and 
T.A. Wynn, Macrophage activation and polarization: nomenclature and 
experimental guidelines. Immunity, 2014. 41(1): p. 14-20. 
35. Sica, A. and A. Mantovani, Macrophage plasticity and polarization: in vivo 
veritas. J Clin Invest, 2012. 122(3): p. 787-95. 
36. Kelley, J., Cytokines of the lung. Am Rev Respir Dis, 1990. 141(3): p. 765-88. 
37. Monton, C. and A. Torres, Lung inflammatory response in pneumonia. Monaldi 
Arch Chest Dis, 1998. 53(1): p. 56-63. 
38. Cakarova, L., L.M. Marsh, J. Wilhelm, K. Mayer, F. Grimminger, W. Seeger, J. 
Lohmeyer, and S. Herold, Macrophage tumor necrosis factor-alpha induces 
epithelial expression of granulocyte-macrophage colony-stimulating factor: 
impact on alveolar epithelial repair. Am J Respir Crit Care Med, 2009. 180(6): p. 
521-32. 
39. Herold, S., W. von Wulffen, M. Steinmueller, S. Pleschka, W.A. Kuziel, M. 
Mack, M. Srivastava, W. Seeger, U.A. Maus, and J. Lohmeyer, Alveolar 
epithelial cells direct monocyte transepithelial migration upon influenza virus 
infection: impact of chemokines and adhesion molecules. J Immunol, 2006. 
177(3): p. 1817-24. 
40. Marriott, H.M., K.A. Gascoyne, R. Gowda, I. Geary, M.J. Nicklin, F. Iannelli, G. 
Pozzi, T.J. Mitchell, M.K. Whyte, I. Sabroe, and D.H. Dockrell, Interleukin-1beta 
  
  
155     
regulates CXCL8 release and influences disease outcome in response to 
Streptococcus pneumoniae, defining intercellular cooperation between pulmonary 
epithelial cells and macrophages. Infect Immun, 2012. 80(3): p. 1140-9. 
41. Sindrilaru, A., T. Peters, S. Wieschalka, C. Baican, A. Baican, H. Peter, A. 
Hainzl, S. Schatz, Y. Qi, A. Schlecht, J.M. Weiss, M. Wlaschek, C. Sunderkotter, 
and K. Scharffetter-Kochanek, An unrestrained proinflammatory M1 macrophage 
population induced by iron impairs wound healing in humans and mice. J Clin 
Invest, 2011. 121(3): p. 985-97. 
42. Korns, D., S.C. Frasch, R. Fernandez-Boyanapalli, P.M. Henson, and D.L. 
Bratton, Modulation of macrophage efferocytosis in inflammation. Front 
Immunol, 2011. 2: p. 57. 
43. Voll, R.E., M. Herrmann, E.A. Roth, C. Stach, J.R. Kalden, and I. Girkontaite, 
Immunosuppressive effects of apoptotic cells. Nature, 1997. 390(6658): p. 350-1. 
44. Kim, S., K.B. Elkon, and X. Ma, Transcriptional suppression of interleukin-12 
gene expression following phagocytosis of apoptotic cells. Immunity, 2004. 21(5): 
p. 643-53. 
45. Ariel, A. and C.N. Serhan, New Lives Given by Cell Death: Macrophage 
Differentiation Following Their Encounter with Apoptotic Leukocytes during the 
Resolution of Inflammation. Front Immunol, 2012. 3: p. 4. 
46. Freire-de-Lima, C.G., Y.Q. Xiao, S.J. Gardai, D.L. Bratton, W.P. Schiemann, and 
P.M. Henson, Apoptotic cells, through transforming growth factor-beta, 
coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid 
and NO synthesis in murine macrophages. J Biol Chem, 2006. 281(50): p. 38376-
84. 
47. Morimoto, K., H. Amano, F. Sonoda, M. Baba, M. Senba, H. Yoshimine, H. 
Yamamoto, T. Ii, K. Oishi, and T. Nagatake, Alveolar macrophages that 
phagocytose apoptotic neutrophils produce hepatocyte growth factor during 
bacterial pneumonia in mice. Am J Respir Cell Mol Biol, 2001. 24(5): p. 608-15. 
48. Granata, F., A. Frattini, S. Loffredo, R.I. Staiano, A. Petraroli, D. Ribatti, R. 
Oslund, M.H. Gelb, G. Lambeau, G. Marone, and M. Triggiani, Production of 
vascular endothelial growth factors from human lung macrophages induced by 
group IIA and group X secreted phospholipases A2. J Immunol, 2010. 184(9): p. 
5232-41. 
  
  
156     
49. Brecht, K., A. Weigert, J. Hu, R. Popp, B. Fisslthaler, T. Korff, I. Fleming, G. 
Geisslinger, and B. Brune, Macrophages programmed by apoptotic cells promote 
angiogenesis via prostaglandin E2. FASEB J, 2011. 25(7): p. 2408-17. 
50. Kirby, A.C., M.C. Coles, and P.M. Kaye, Alveolar macrophages transport 
pathogens to lung draining lymph nodes. J Immunol, 2009. 183(3): p. 1983-9. 
51. Janssen, W.J., L. Barthel, A. Muldrow, R.E. Oberley-Deegan, M.T. Kearns, C. 
Jakubzick, and P.M. Henson, Fas determines differential fates of resident and 
recruited macrophages during resolution of acute lung injury. Am J Respir Crit 
Care Med, 2011. 184(5): p. 547-60. 
52. Medeiros, A.I., C.H. Serezani, S.P. Lee, and M. Peters-Golden, Efferocytosis 
impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 
signaling. J Exp Med, 2009. 206(1): p. 61-8. 
53. McGovern, P.E., A. Mirzoian, and G.R. Hall, Ancient Egyptian herbal wines. 
Proc Natl Acad Sci U S A, 2009. 106(18): p. 7361-6. 
54. Legras, J.L., D. Merdinoglu, J.M. Cornuet, and F. Karst, Bread, beer and wine: 
Saccharomyces cerevisiae diversity reflects human history. Mol Ecol, 2007. 
16(10): p. 2091-102. 
55. McGovern, P.E., J. Zhang, J. Tang, Z. Zhang, G.R. Hall, R.A. Moreau, A. Nunez, 
E.D. Butrym, M.P. Richards, C.S. Wang, G. Cheng, Z. Zhao, and C. Wang, 
Fermented beverages of pre- and proto-historic China. Proc Natl Acad Sci U S 
A, 2004. 101(51): p. 17593-8. 
56. McGovern, P.E., The beginnings of wine making and viniculture in the ancient 
Near East and Egypt. Expedition, 1997. 39: p. 3-21. 
57. Cavalieri, D., P.E. McGovern, D.L. Hartl, R. Mortimer, and M. Polsinelli, 
Evidence for S. cerevisiae fermentation in ancient wine. J Mol Evol, 2003. 57 
Suppl 1: p. S226-32. 
58. Jernigan, D.H., Applying commodity chain analysis to changing modes of alcohol 
supply in a developing country. Addiction, 2000. 95 Suppl 4: p. S465-75. 
59. Howland, J. and R. Hingson, Alcohol as a risk factor for injuries or death due to 
fires and burns: review of the literature. Public Health Rep, 1987. 102(5): p. 475-
83. 
  
  
157     
60. Dufour, M.C., What is moderate drinking? Defining "drinks" and drinking levels. 
Alcohol Res Health, 1999. 23(1): p. 5-14. 
61. Naimi, T.S., R.D. Brewer, A. Mokdad, C. Denny, M.K. Serdula, and J.S. Marks, 
Binge drinking among US adults. JAMA, 2003. 289(1): p. 70-5. 
62. NIAAA, NIAAA council approves definition of binge drinking. NIAAA Newletter 
2004. 
63. Mokdad, A.H., J.S. Marks, D.F. Stroup, and J.L. Gerberding, Correction: actual 
causes of death in the United States, 2000. JAMA, 2005. 293(3): p. 293-4. 
64. Stahre, M., J. Roeber, D. Kanny, R.D. Brewer, and X. Zhang, Contribution of 
excessive alcohol consumption to deaths and years of potential life lost in the 
United States. Prev Chronic Dis, 2014. 11: p. E109. 
65. Organization, W.H., Global status report on alcohol and health 2014. 
66. Savola, O., O. Niemela, and M. Hillbom, Alcohol intake and the pattern of 
trauma in young adults and working aged people admitted after trauma. Alcohol 
Alcohol, 2005. 40(4): p. 269-73. 
67. Szabo, G. and P. Mandrekar, A recent perspective on alcohol, immunity, and host 
defense. Alcohol Clin Exp Res, 2009. 33(2): p. 220-32. 
68. Winkler, C., B. Wirleitner, K. Schroecksnadel, H. Schennach, and D. Fuchs, Beer 
down-regulates activated peripheral blood mononuclear cells in vitro. Int 
Immunopharmacol, 2006. 6(3): p. 390-5. 
69. Mandrekar, P., D. Catalano, B. White, and G. Szabo, Moderate alcohol intake in 
humans attenuates monocyte inflammatory responses: inhibition of nuclear 
regulatory factor kappa B and induction of interleukin 10. Alcohol Clin Exp Res, 
2006. 30(1): p. 135-9. 
70. Patra, M., E. Salonen, E. Terama, I. Vattulainen, R. Faller, B.W. Lee, J. 
Holopainen, and M. Karttunen, Under the influence of alcohol: the effect of 
ethanol and methanol on lipid bilayers. Biophys J, 2006. 90(4): p. 1121-35. 
71. Ingolfsson, H.I. and O.S. Andersen, Alcohol's effects on lipid bilayer properties. 
Biophys J, 2011. 101(4): p. 847-55. 
  
  
158     
72. Dolganiuc, A., G. Bakis, K. Kodys, P. Mandrekar, and G. Szabo, Acute ethanol 
treatment modulates Toll-like receptor-4 association with lipid rafts. Alcohol Clin 
Exp Res, 2006. 30(1): p. 76-85. 
73. Szabo, G., D. Catalano, B. White, and P. Mandrekar, Acute alcohol consumption 
inhibits accessory cell function of monocytes and dendritic cells. Alcohol Clin 
Exp Res, 2004. 28(5): p. 824-8. 
74. Mandrekar, P., D. Catalano, A. Dolganiuc, K. Kodys, and G. Szabo, Inhibition of 
myeloid dendritic cell accessory cell function and induction of T cell anergy by 
alcohol correlates with decreased IL-12 production. J Immunol, 2004. 173(5): p. 
3398-407. 
75. Goral, J., M.A. Choudhry, and E.J. Kovacs, Acute ethanol exposure inhibits 
macrophage IL-6 production: role of p38 and ERK1/2 MAPK. J Leukoc Biol, 
2004. 75(3): p. 553-9. 
76. Karavitis, J., E.L. Murdoch, C.R. Gomez, L. Ramirez, and E.J. Kovacs, Acute 
ethanol exposure attenuates pattern recognition receptor activated macrophage 
functions. J Interferon Cytokine Res, 2008. 28(7): p. 413-22. 
77. Boe, D.M., R.W. Vandivier, E.L. Burnham, and M. Moss, Alcohol abuse and 
pulmonary disease. J Leukoc Biol, 2009. 86(5): p. 1097-104. 
78. Brown, L.A., F.L. Harris, X.D. Ping, and T.W. Gauthier, Chronic ethanol 
ingestion and the risk of acute lung injury: a role for glutathione availability? 
Alcohol, 2004. 33(3): p. 191-7. 
79. Nelson, S., G. Bagby, and W.R. Summer, Alcohol suppresses lipopolysaccharide-
induced tumor necrosis factor activity in serum and lung. Life Sci, 1989. 44(10): 
p. 673-6. 
80. Moss, M., B. Bucher, F.A. Moore, E.E. Moore, and P.E. Parsons, The role of 
chronic alcohol abuse in the development of acute respiratory distress syndrome 
in adults. JAMA, 1996. 275(1): p. 50-4. 
81. Boe, D.M., T.R. Richens, S.A. Horstmann, E.L. Burnham, W.J. Janssen, P.M. 
Henson, M. Moss, and R.W. Vandivier, Acute and chronic alcohol exposure 
impair the phagocytosis of apoptotic cells and enhance the pulmonary 
inflammatory response. Alcohol Clin Exp Res, 2010. 34(10): p. 1723-32. 
82. ABA, American Burn Association National Burn Repository: 2014 Report. 
Chicago, IL. 2014. 
  
  
159     
83. Liffner, G., Z. Bak, A. Reske, and F. Sjoberg, Inhalation injury assessed by score 
does not contribute to the development of acute respiratory distress syndrome in 
burn victims. Burns, 2005. 31(3): p. 263-8. 
84. Turnage, R.H., F. Nwariaku, J. Murphy, C. Schulman, K. Wright, and H. Yin, 
Mechanisms of pulmonary microvascular dysfunction during severe burn injury. 
World J Surg, 2002. 26(7): p. 848-53. 
85. Phillips, A.W. and O. Cope, Burn therapy. II. The revelation of respiratory tract 
damage as a principal killer of the burned patient. Ann Surg, 1962. 155: p. 1-19. 
86. Achauer, B.M., P.A. Allyn, D.W. Furnas, and R.H. Bartlett, Pulmonary 
complications of burns: the major threat to the burn patient. Ann Surg, 1973. 
177(3): p. 311-9. 
87. Brezel, B.S., J.M. Kassenbrock, and J.M. Stein, Burns in substance abusers and 
in neurologically and mentally impaired patients. J Burn Care Rehabil, 1988. 
9(2): p. 169-71. 
88. Grobmyer, S.R., S.P. Maniscalco, G.F. Purdue, and J.L. Hunt, Alcohol, drug 
intoxication, or both at the time of burn injury as a predictor of complications and 
mortality in hospitalized patients with burns. J Burn Care Rehabil, 1996. 17(6 Pt 
1): p. 532-9. 
89. Silver, G.M., J.M. Albright, C.R. Schermer, M. Halerz, P. Conrad, P.D. 
Ackerman, L. Lau, M.A. Emanuele, E.J. Kovacs, and R.L. Gamelli, Adverse 
clinical outcomes associated with elevated blood alcohol levels at the time of burn 
injury. J Burn Care Res, 2008. 29(5): p. 784-9. 
90. Ciesla, D.J., E.E. Moore, J.L. Johnson, J.M. Burch, C.C. Cothren, and A. Sauaia, 
The role of the lung in postinjury multiple organ failure. Surgery, 2005. 138(4): p. 
749-57; discussion 757-8. 
91. Hollingsed, T.C., J.R. Saffle, R.G. Barton, W.B. Craft, and S.E. Morris, Etiology 
and consequences of respiratory failure in thermally injured patients. Am J Surg, 
1993. 166(6): p. 592-6; discussion 596-7. 
92. Davis, C.S., T.J. Esposito, A.G. Palladino-Davis, K. Rychlik, C.R. Schermer, R.L. 
Gamelli, and E.J. Kovacs, Implications of alcohol intoxication at the time of burn 
and smoke inhalation injury: an epidemiologic and clinical analysis. J Burn Care 
Res, 2013. 34(1): p. 120-6. 
  
  
160     
93. Baron, P., L.D. Traber, D.L. Traber, T. Nguyen, M. Hollyoak, J.P. Heggers, and 
D.N. Herndon, Gut failure and translocation following burn and sepsis. J Surg 
Res, 1994. 57(1): p. 197-204. 
94. Deitch, E.A., The role of intestinal barrier failure and bacterial translocation in 
the development of systemic infection and multiple organ failure. Arch Surg, 
1990. 125(3): p. 403-4. 
95. Choudhry, M.A., S.N. Rana, M.J. Kavanaugh, E.J. Kovacs, R.L. Gamelli, and 
M.M. Sayeed, Impaired intestinal immunity and barrier function: a cause for 
enhanced bacterial translocation in alcohol intoxication and burn injury. 
Alcohol, 2004. 33(3): p. 199-208. 
96. Kavanaugh, M.J., C. Clark, M. Goto, E.J. Kovacs, R.L. Gamelli, M.M. Sayeed, 
and M.A. Choudhry, Effect of acute alcohol ingestion prior to burn injury on 
intestinal bacterial growth and barrier function. Burns, 2005. 31(3): p. 290-6. 
97. Zahs, A., M.D. Bird, L. Ramirez, M.A. Choudhry, and E.J. Kovacs, Anti-IL-6 
antibody treatment but not IL-6 knockout improves intestinal barrier function and 
reduces inflammation after binge ethanol exposure and burn injury. Shock, 2013. 
39(4): p. 373-9. 
98. Zahs, A., M.D. Bird, L. Ramirez, J.R. Turner, M.A. Choudhry, and E.J. Kovacs, 
Inhibition of long myosin light-chain kinase activation alleviates intestinal 
damage after binge ethanol exposure and burn injury. Am J Physiol Gastrointest 
Liver Physiol, 2012. 303(6): p. G705-12. 
99. Chen, M.M., A. Zahs, M.M. Brown, L. Ramirez, J.R. Turner, M.A. Choudhry, 
and E.J. Kovacs, An alteration of the gut-liver axis drives pulmonary 
inflammation after intoxication and burn injury in mice. Am J Physiol 
Gastrointest Liver Physiol, 2014. 307(7): p. G711-8. 
100. Emanuele, N.V., M.A. Emanuele, M.O. Morgan, D. Sulo, S. Yong, E.J. Kovacs, 
R.D. Himes, and J.J. Callaci, Ethanol potentiates the acute fatty infiltration of 
liver caused by burn injury: prevention by insulin treatment. J Burn Care Res, 
2009. 30(3): p. 482-8. 
101. Meduri, G.U., S. Headley, G. Kohler, F. Stentz, E. Tolley, R. Umberger, and K. 
Leeper, Persistent elevation of inflammatory cytokines predicts a poor outcome in 
ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of 
outcome over time. Chest, 1995. 107(4): p. 1062-73. 
  
  
161     
102. Dancey, D.R., J. Hayes, M. Gomez, D. Schouten, J. Fish, W. Peters, A.S. Slutsky, 
and T.E. Stewart, ARDS in patients with thermal injury. Intensive Care Med, 
1999. 25(11): p. 1231-6. 
103. Steinvall, I., Z. Bak, and F. Sjoberg, Acute respiratory distress syndrome is as 
important as inhalation injury for the development of respiratory dysfunction in 
major burns. Burns, 2008. 34(4): p. 441-51. 
104. Patel, P.J., D.E. Faunce, M.S. Gregory, L.A. Duffner, and E.J. Kovacs, Elevation 
in pulmonary neutrophils and prolonged production of pulmonary macrophage 
inflammatory protein-2 after burn injury with prior alcohol exposure. Am J 
Respir Cell Mol Biol, 1999. 20(6): p. 1229-37. 
105. Bird, M.D., M.O. Morgan, L. Ramirez, S. Yong, and E.J. Kovacs, Decreased 
pulmonary inflammation after ethanol exposure and burn injury in intercellular 
adhesion molecule-1 knockout mice. J Burn Care Res, 2010. 31(4): p. 652-60. 
106. Bird, M.D., A. Zahs, C. Deburghgraeve, L. Ramirez, M.A. Choudhry, and E.J. 
Kovacs, Decreased pulmonary inflammation following ethanol and burn injury in 
mice deficient in TLR4 but not TLR2 signaling. Alcohol Clin Exp Res, 2010. 
34(10): p. 1733-41. 
107. Chen, M.M., M.D. Bird, A. Zahs, C. Deburghgraeve, B. Posnik, C.S. Davis, and 
E.J. Kovacs, Pulmonary inflammation after ethanol exposure and burn injury is 
attenuated in the absence of IL-6. Alcohol, 2013. 47(3): p. 223-9. 
108. Dobke, M.K., J. Simoni, J.L. Ninnemann, J. Garrett, and T.J. Harnar, 
Endotoxemia after burn injury: effect of early excision on circulating endotoxin 
levels. J Burn Care Rehabil, 1989. 10(2): p. 107-11. 
109. Yao, Y.M., Z.Y. Sheng, H.M. Tian, Y. Yu, Y.P. Wang, H.M. Yang, Z.R. Guo, 
and W.Y. Gao, The association of circulating endotoxaemia with the development 
of multiple organ failure in burned patients. Burns, 1995. 21(4): p. 255-8. 
110. Bardales, R.H., S.S. Xie, R.F. Schaefer, and S.M. Hsu, Apoptosis is a major 
pathway responsible for the resolution of type II pneumocytes in acute lung 
injury. Am J Pathol, 1996. 149(3): p. 845-52. 
111. Guinee, D., Jr., E. Brambilla, M. Fleming, T. Hayashi, M. Rahn, M. Koss, V. 
Ferrans, and W. Travis, The potential role of BAX and BCL-2 expression in 
diffuse alveolar damage. Am J Pathol, 1997. 151(4): p. 999-1007. 
  
  
162     
112. Kitamura, Y., S. Hashimoto, N. Mizuta, A. Kobayashi, K. Kooguchi, I. Fujiwara, 
and H. Nakajima, Fas/FasL-dependent apoptosis of alveolar cells after 
lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med, 
2001. 163(3 Pt 1): p. 762-9. 
113. Fukuzuka, K., C.K. Edwards, 3rd, M. Clare-Salzler, E.M. Copeland, 3rd, L.L. 
Moldawer, and D.W. Mozingo, Glucocorticoid-induced, caspase-dependent 
organ apoptosis early after burn injury. Am J Physiol Regul Integr Comp 
Physiol, 2000. 278(4): p. R1005-18. 
114. Fukuzuka, K., J.J. Rosenberg, G.C. Gaines, C.K. Edwards, 3rd, M. Clare-Salzler, 
S.L. MacKay, L.L. Moldawer, E.M. Copeland, 3rd, and D.W. Mozingo, Caspase-
3-dependent organ apoptosis early after burn injury. Ann Surg, 1999. 229(6): p. 
851-8; discussion 858-9. 
115. Magnotti, L.J., J.S. Upperman, D.Z. Xu, Q. Lu, and E.A. Deitch, Gut-derived 
mesenteric lymph but not portal blood increases endothelial cell permeability and 
promotes lung injury after hemorrhagic shock. Ann Surg, 1998. 228(4): p. 518-
27. 
116. Magnotti, L.J., D.Z. Xu, Q. Lu, and E.A. Deitch, Gut-derived mesenteric lymph: a 
link between burn and lung injury. Arch Surg, 1999. 134(12): p. 1333-40; 
discussion 1340-1. 
117. Lutmer, J., D. Watkins, C.L. Chen, M. Velten, and G. Besner, Heparin-binding 
epidermal growth factor-like growth factor attenuates acute lung injury and 
multiorgan dysfunction after scald burn. J Surg Res, 2013. 185(1): p. 329-37. 
118. Ma, S., N. Xie, W. Li, B. Yuan, Y. Shi, and Y. Wang, Immunobiology of 
mesenchymal stem cells. Cell Death Differ, 2014. 21(2): p. 216-25. 
119. Kim, J. and P. Hematti, Mesenchymal stem cell-educated macrophages: a novel 
type of alternatively activated macrophages. Exp Hematol, 2009. 37(12): p. 1445-
53. 
120. Maggini, J., G. Mirkin, I. Bognanni, J. Holmberg, I.M. Piazzon, I. Nepomnaschy, 
H. Costa, C. Canones, S. Raiden, M. Vermeulen, and J.R. Geffner, Mouse bone 
marrow-derived mesenchymal stromal cells turn activated macrophages into a 
regulatory-like profile. PLoS One, 2010. 5(2): p. e9252. 
121. Nemeth, K., A. Leelahavanichkul, P.S. Yuen, B. Mayer, A. Parmelee, K. Doi, 
P.G. Robey, K. Leelahavanichkul, B.H. Koller, J.M. Brown, X. Hu, I. Jelinek, 
R.A. Star, and E. Mezey, Bone marrow stromal cells attenuate sepsis via 
  
  
163     
prostaglandin E(2)-dependent reprogramming of host macrophages to increase 
their interleukin-10 production. Nat Med, 2009. 15(1): p. 42-9. 
122. Dayan, V., G. Yannarelli, F. Billia, P. Filomeno, X.H. Wang, J.E. Davies, and A. 
Keating, Mesenchymal stromal cells mediate a switch to alternatively activated 
monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol, 
2011. 106(6): p. 1299-310. 
123. Aggarwal, S. and M.F. Pittenger, Human mesenchymal stem cells modulate 
allogeneic immune cell responses. Blood, 2005. 105(4): p. 1815-22. 
124. Eggenhofer, E., V. Benseler, A. Kroemer, F.C. Popp, E.K. Geissler, H.J. Schlitt, 
C.C. Baan, M.H. Dahlke, and M.J. Hoogduijn, Mesenchymal stem cells are short-
lived and do not migrate beyond the lungs after intravenous infusion. Front 
Immunol, 2012. 3: p. 297. 
125. Fischer, U.M., M.T. Harting, F. Jimenez, W.O. Monzon-Posadas, H. Xue, S.I. 
Savitz, G.A. Laine, and C.S. Cox, Jr., Pulmonary passage is a major obstacle for 
intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev, 
2009. 18(5): p. 683-92. 
126. Schrepfer, S., T. Deuse, H. Reichenspurner, M.P. Fischbein, R.C. Robbins, and 
M.P. Pelletier, Stem cell transplantation: the lung barrier. Transplant Proc, 2007. 
39(2): p. 573-6. 
127. Yagi, H., A. Soto-Gutierrez, Y. Kitagawa, A.W. Tilles, R.G. Tompkins, and M.L. 
Yarmush, Bone marrow mesenchymal stromal cells attenuate organ injury 
induced by LPS and burn. Cell Transplant, 2010. 19(6): p. 823-30. 
128. Xue, L., Y.B. Xu, J.L. Xie, J.M. Tang, B. Shu, L. Chen, S.H. Qi, and X.S. Liu, 
Effects of human bone marrow mesenchymal stem cells on burn injury healing in 
a mouse model. Int J Clin Exp Pathol, 2013. 6(7): p. 1327-36. 
129. Huang, L. and A. Burd, An update review of stem cell applications in burns and 
wound care. Indian J Plast Surg, 2012. 45(2): p. 229-36. 
130. Rasulov, M.F., A.V. Vasilchenkov, N.A. Onishchenko, M.E. Krasheninnikov, 
V.I. Kravchenko, T.L. Gorshenin, R.E. Pidtsan, and I.V. Potapov, First 
experience of the use bone marrow mesenchymal stem cells for the treatment of a 
patient with deep skin burns. Bull Exp Biol Med, 2005. 139(1): p. 141-4. 
  
  
164     
131. Rasulov, M.F., V.T. Vasilenko, V.A. Zaidenov, and N.A. Onishchenko, Cell 
transplantation inhibits inflammatory reaction and stimulates repair processes in 
burn wound. Bull Exp Biol Med, 2006. 142(1): p. 112-5. 
132. Ashbaugh, D.G., D.B. Bigelow, T.L. Petty, and B.E. Levine, Acute respiratory 
distress in adults. Lancet, 1967. 2(7511): p. 319-23. 
133. CDC, Vital Signs: Binge Drinking Prevalence, Frequency, and Intensity Among 
Adults. Morbidity and Mortality Weekly Report, 2012. 61(1): p. 14-19. 
134. Hadjizacharia, P., T. O'Keeffe, D.S. Plurad, D.J. Green, C.V. Brown, L.S. Chan, 
D. Demetriades, and P. Rhee, Alcohol exposure and outcomes in trauma patients. 
Eur J Trauma Emerg Surg, 2011. 37(2): p. 169-175. 
135. Smith, G.S. and J.F. Kraus, Alcohol and residential, recreational, and 
occupational injuries: a review of the epidemiologic evidence. Annu Rev Public 
Health, 1988. 9: p. 99-121. 
136. Schermer, C.R., Alcohol and injury prevention. J Trauma, 2006. 60(2): p. 447-51. 
137. Kawakami, M., B.R. Switzer, S.R. Herzog, and A.A. Meyer, Immune suppression 
after acute ethanol ingestion and thermal injury. J Surg Res, 1991. 51(3): p. 210-
5. 
138. Faunce, D.E., M.S. Gregory, and E.J. Kovacs, Effects of acute ethanol exposure 
on cellular immune responses in a murine model of thermal injury. J Leukoc Biol, 
1997. 62(6): p. 733-40. 
139. Faunce, D.E., M.S. Gregory, and E.J. Kovacs, Acute ethanol exposure prior to 
thermal injury results in decreased T-cell responses mediated in part by increased 
production of IL-6. Shock, 1998. 10(2): p. 135-40. 
140. Messingham, K.A., D.E. Faunce, and E.J. Kovacs, Alcohol, injury, and cellular 
immunity. Alcohol, 2002. 28(3): p. 137-49. 
141. Choudhry, M.A., K.A. Messingham, S. Namak, A. Colantoni, C.V. Fontanilla, 
L.A. Duffner, M.M. Sayeed, and E.J. Kovacs, Ethanol exacerbates T cell 
dysfunction after thermal injury. Alcohol, 2000. 21(3): p. 239-43. 
142. Murdoch, E.L., H.G. Brown, R.L. Gamelli, and E.J. Kovacs, Effects of ethanol on 
pulmonary inflammation in postburn intratracheal infection. J Burn Care Res, 
2008. 29(2): p. 323-30. 
  
  
165     
143. Murdoch, E.L., J. Karavitis, C. Deburghgraeve, L. Ramirez, and E.J. Kovacs, 
Prolonged chemokine expression and excessive neutrophil infiltration in the lungs 
of burn-injured mice exposed to ethanol and pulmonary infection. Shock, 2011. 
35(4): p. 403-10. 
144. Irvin, C.G. and J.H. Bates, Measuring the lung function in the mouse: the 
challenge of size. Respir Res, 2003. 4: p. 4. 
145. Lundqvist, C., C. Alling, R. Knoth, and B. Volk, Intermittent ethanol exposure of 
adult rats: hippocampal cell loss after one month of treatment. Alcohol Alcohol, 
1995. 30(6): p. 737-48. 
146. Callaci, J.J., D. Juknelis, A. Patwardhan, M. Sartori, N. Frost, and F.H. Wezeman, 
The effects of binge alcohol exposure on bone resorption and biomechanical and 
structural properties are offset by concurrent bisphosphonate treatment. Alcohol 
Clin Exp Res, 2004. 28(1): p. 182-91. 
147. Przybycien-Szymanska, M.M., Y.S. Rao, and T.R. Pak, Binge-pattern alcohol 
exposure during puberty induces sexually dimorphic changes in genes regulating 
the HPA axis. Am J Physiol Endocrinol Metab, 2010. 298(2): p. E320-8. 
148. Przybycien-Szymanska, M.M., N.N. Mott, and T.R. Pak, Alcohol dysregulates 
corticotropin-releasing-hormone (CRH) promoter activity by interfering with the 
negative glucocorticoid response element (nGRE). PLoS One, 2011. 6(10): p. 
e26647. 
149. Vaagenes, I.C., S.Y. Tsai, S.T. Ton, V.A. Husak, S.O. McGuire, T.E. O'Brien, 
and G.L. Kartje, Binge ethanol prior to traumatic brain injury worsens 
sensorimotor functional recovery in rats. PLoS One, 2015. 10(3): p. e0120356. 
150. Qin, Y., J.L. Hamilton, M.D. Bird, M.M. Chen, L. Ramirez, A. Zahs, E.J. Kovacs, 
and L. Makowski, Adipose inflammation and macrophage infiltration after binge 
ethanol and burn injury. Alcohol Clin Exp Res, 2014. 38(1): p. 204-13. 
151. Messingham, K.A., C.V. Fontanilla, A. Colantoni, L.A. Duffner, and E.J. Kovacs, 
Cellular immunity after ethanol exposure and burn injury: dose and time 
dependence. Alcohol, 2000. 22(1): p. 35-44. 
152. Faunce, D.E., J.N. Llanas, P.J. Patel, M.S. Gregory, L.A. Duffner, and E.J. 
Kovacs, Neutrophil chemokine production in the skin following scald injury. 
Burns, 1999. 25(5): p. 403-10. 
  
  
166     
153. Boehmer, E.D., J. Goral, D.E. Faunce, and E.J. Kovacs, Age-dependent decrease 
in Toll-like receptor 4-mediated proinflammatory cytokine production and 
mitogen-activated protein kinase expression. J Leukoc Biol, 2004. 75(2): p. 342-
9. 
154. Happel, K.I. and S. Nelson, Alcohol, immunosuppression, and the lung. Proc Am 
Thorac Soc, 2005. 2(5): p. 428-32. 
155. Gamble, L., C.M. Mason, and S. Nelson, The effects of alcohol on immunity and 
bacterial infection in the lung. Med Mal Infect, 2006. 36(2): p. 72-7. 
156. Shults, J.A., Curtis, B.J., Chen, M.C., O'Halloran, E.B., Ramirez, L., and Kovacs, 
E.J., Impaired Respiratory Function and Heightened Pulmonary Inflammation in 
Episodic Binge Ethanol Intoxication and Burn Injury. Alcohol, 2015. In Press. 
157. Herold, S., K. Mayer, and J. Lohmeyer, Acute lung injury: how macrophages 
orchestrate resolution of inflammation and tissue repair. Front Immunol, 2011. 2: 
p. 65. 
158. von Garnier, C., L. Filgueira, M. Wikstrom, M. Smith, J.A. Thomas, D.H. 
Strickland, P.G. Holt, and P.A. Stumbles, Anatomical location determines the 
distribution and function of dendritic cells and other APCs in the respiratory 
tract. J Immunol, 2005. 175(3): p. 1609-18. 
159. deCathelineau, A.M. and P.M. Henson, The final step in programmed cell death: 
phagocytes carry apoptotic cells to the grave. Essays Biochem, 2003. 39: p. 105-
17. 
160. Rogers, N.J., M.J. Lees, L. Gabriel, E. Maniati, S.J. Rose, P.K. Potter, and B.J. 
Morley, A defect in Marco expression contributes to systemic lupus 
erythematosus development via failure to clear apoptotic cells. J Immunol, 2009. 
182(4): p. 1982-90. 
161. Chen, J., S. Namiki, M. Toma-Hirano, S. Miyatake, K. Ishida, Y. Shibata, N. 
Arai, K. Arai, and Y. Kamogawa-Schifter, The role of CD11b in phagocytosis 
and dendritic cell development. Immunol Lett, 2008. 120(1-2): p. 42-8. 
162. Porcheray, F., S. Viaud, A.C. Rimaniol, C. Leone, B. Samah, N. Dereuddre-
Bosquet, D. Dormont, and G. Gras, Macrophage activation switching: an asset 
for the resolution of inflammation. Clin Exp Immunol, 2005. 142(3): p. 481-9. 
163. Roszer, T., Understanding the Mysterious M2 Macrophage through Activation 
Markers and Effector Mechanisms. Mediators Inflamm, 2015. 2015: p. 816460. 
  
  
167     
164. Stein, M., S. Keshav, N. Harris, and S. Gordon, Interleukin 4 potently enhances 
murine macrophage mannose receptor activity: a marker of alternative 
immunologic macrophage activation. J Exp Med, 1992. 176(1): p. 287-92. 
165. Ariel, A., I. Maridonneau-Parini, P. Rovere-Querini, J.S. Levine, and H. Muhl, 
Macrophages in inflammation and its resolution. Front Immunol, 2012. 3: p. 324. 
166. Chakravortty, D. and M. Hensel, Inducible nitric oxide synthase and control of 
intracellular bacterial pathogens. Microbes Infect, 2003. 5(7): p. 621-7. 
167. Henson, P.M. and R.M. Tuder, Apoptosis in the lung: induction, clearance and 
detection. Am J Physiol Lung Cell Mol Physiol, 2008. 294(4): p. L601-11. 
168. Raff, T., G. Germann, and U. Barthold, Factors influencing the early prediction 
of outcome from burns. Acta Chir Plast, 1996. 38(4): p. 122-7. 
169. Aggarwal, N.R., L.S. King, and F.R. D'Alessio, Diverse macrophage populations 
mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol 
Physiol, 2014. 306(8): p. L709-25. 
170. Fadok, V.A., D.L. Bratton, A. Konowal, P.W. Freed, J.Y. Westcott, and P.M. 
Henson, Macrophages that have ingested apoptotic cells in vitro inhibit 
proinflammatory cytokine production through autocrine/paracrine mechanisms 
involving TGF-beta, PGE2, and PAF. J Clin Invest, 1998. 101(4): p. 890-8. 
171. Taylor, P.R., L. Martinez-Pomares, M. Stacey, H.H. Lin, G.D. Brown, and S. 
Gordon, Macrophage receptors and immune recognition. Annu Rev Immunol, 
2005. 23: p. 901-44. 
172. Mathias, L.J., S.M. Khong, L. Spyroglou, N.L. Payne, C. Siatskas, A.N. 
Thorburn, R.L. Boyd, and T.S. Heng, Alveolar macrophages are critical for the 
inhibition of allergic asthma by mesenchymal stromal cells. J Immunol, 2013. 
191(12): p. 5914-24. 
173. Song, X., S. Xie, K. Lu, and C. Wang, Mesenchymal stem cells alleviate 
experimental asthma by inducing polarization of alveolar macrophages. 
Inflammation, 2015. 38(2): p. 485-92. 
174. Gao, S., F. Mao, B. Zhang, L. Zhang, X. Zhang, M. Wang, Y. Yan, T. Yang, J. 
Zhang, W. Zhu, H. Qian, and W. Xu, Mouse bone marrow-derived mesenchymal 
stem cells induce macrophage M2 polarization through the nuclear factor-
kappaB and signal transducer and activator of transcription 3 pathways. Exp 
Biol Med (Maywood), 2014. 239(3): p. 366-75. 
  
  
168     
175. Lee, R.H., A.A. Pulin, M.J. Seo, D.J. Kota, J. Ylostalo, B.L. Larson, L. Semprun-
Prieto, P. Delafontaine, and D.J. Prockop, Intravenous hMSCs improve 
myocardial infarction in mice because cells embolized in lung are activated to 
secrete the anti-inflammatory protein TSG-6. Cell Stem Cell, 2009. 5(1): p. 54-63. 
176. Weir, C., M.C. Morel-Kopp, A. Gill, K. Tinworth, L. Ladd, S.N. Hunyor, and C. 
Ward, Mesenchymal stem cells: isolation, characterisation and in vivo fluorescent 
dye tracking. Heart Lung Circ, 2008. 17(5): p. 395-403. 
177. Chen, M.M., J.L. Palmer, J.A. Ippolito, B.J. Curtis, M.A. Choudhry, and E.J. 
Kovacs, Intoxication by intraperitoneal injection or oral gavage equally 
potentiates postburn organ damage and inflammation. Mediators Inflamm, 2013. 
2013: p. 971481. 
178. Glaab, T., C. Taube, A. Braun, and W. Mitzner, Invasive and noninvasive 
methods for studying pulmonary function in mice. Respir Res, 2007. 8: p. 63. 
179. Bates, J.H. and C.G. Irvin, Measuring lung function in mice: the phenotyping 
uncertainty principle. J Appl Physiol (1985), 2003. 94(4): p. 1297-306. 
180. Milton, P.L., H. Dickinson, G. Jenkin, and R. Lim, Assessment of respiratory 
physiology of C57BL/6 mice following bleomycin administration using barometric 
plethysmography. Respiration, 2012. 83(3): p. 253-66. 
181. Adler, A., G. Cieslewicz, and C.G. Irvin, Unrestrained plethysmography is an 
unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J 
Appl Physiol (1985), 2004. 97(1): p. 286-92. 
182. Hoymann, H.G., Invasive and noninvasive lung function measurements in 
rodents. J Pharmacol Toxicol Methods, 2007. 55(1): p. 16-26. 
183. Verheijden, K.A., P.A. Henricks, F.A. Redegeld, J. Garssen, and G. Folkerts, 
Measurement of airway function using invasive and non-invasive methods in mild 
and severe models for allergic airway inflammation in mice. Front Pharmacol, 
2014. 5: p. 190. 
184. Bates, J., C. Irvin, V. Brusasco, J. Drazen, J. Fredberg, S. Loring, D. Eidelman, 
M. Ludwig, P. Macklem, J. Martin, J. Milic-Emili, Z. Hantos, R. Hyatt, S. Lai-
Fook, A. Leff, J. Solway, K. Lutchen, B. Suki, W. Mitzner, P. Pare, N. Pride, and 
P. Sly, The use and misuse of Penh in animal models of lung disease. Am J Respir 
Cell Mol Biol, 2004. 31(3): p. 373-4. 
  
  
169     
185. Guntheroth, W.G. and I. Kawabori, Hypoxic apnea and gasping. J Clin Invest, 
1975. 56(6): p. 1371-7. 
186. McCutcheon, F.H., Atmospheric respiration and the complex cycles in 
mammalian breathing mechanisms. J Cell Physiol, 1953. 41(2): p. 291-303. 
187. Galani, V., E. Tatsaki, M. Bai, P. Kitsoulis, M. Lekka, G. Nakos, and P. 
Kanavaros, The role of apoptosis in the pathophysiology of Acute Respiratory 
Distress Syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract, 
2010. 206(3): p. 145-50. 
188. Hengartner, M.O., The biochemistry of apoptosis. Nature, 2000. 407(6805): p. 
770-6. 
189. Dauphinee, S.M. and A. Karsan, Lipopolysaccharide signaling in endothelial 
cells. Lab Invest, 2006. 86(1): p. 9-22. 
190. Pober, J.S. and R.S. Cotran, Cytokines and endothelial cell biology. Physiol Rev, 
1990. 70(2): p. 427-51. 
191. Collins, T., Endothelial nuclear factor-kappa B and the initiation of the 
atherosclerotic lesion. Lab Invest, 1993. 68(5): p. 499-508. 
192. Huber, A.R., S.L. Kunkel, R.F. Todd, 3rd, and S.J. Weiss, Regulation of 
transendothelial neutrophil migration by endogenous interleukin-8. Science, 
1991. 254(5028): p. 99-102. 
193. Bingisser, R., C. Stey, M. Weller, P. Groscurth, E. Russi, and K. Frei, Apoptosis 
in human alveolar macrophages is induced by endotoxin and is modulated by 
cytokines. Am J Respir Cell Mol Biol, 1996. 15(1): p. 64-70. 
194. Z'Graggen B, R., J. Tornic, B. Muller-Edenborn, L. Reyes, C. Booy, and B. Beck-
Schimmer, Acute lung injury: apoptosis in effector and target cells of the upper 
and lower airway compartment. Clin Exp Immunol, 2010. 161(2): p. 324-31. 
195. Smith, W.B., L. Noack, Y. Khew-Goodall, S. Isenmann, M.A. Vadas, and J.R. 
Gamble, Transforming growth factor-beta 1 inhibits the production of IL-8 and 
the transmigration of neutrophils through activated endothelium. J Immunol, 
1996. 157(1): p. 360-8. 
196. Lee, A., M.K. Whyte, and C. Haslett, Inhibition of apoptosis and prolongation of 
neutrophil functional longevity by inflammatory mediators. J Leukoc Biol, 1993. 
54(4): p. 283-8. 
  
  
170     
197. Granero-Molto, F., J.A. Weis, M.I. Miga, B. Landis, T.J. Myers, L. O'Rear, L. 
Longobardi, E.D. Jansen, D.P. Mortlock, and A. Spagnoli, Regenerative effects of 
transplanted mesenchymal stem cells in fracture healing. Stem Cells, 2009. 27(8): 
p. 1887-98. 
198. Kang, J.W., K.D. Park, Y. Choi, D.H. Baek, W.S. Cho, M. Choi, J.H. Park, K.S. 
Choi, H.S. Kim, and T.M. Yoo, Biodistribution and in vivo efficacy of genetically 
modified human mesenchymal stem cells systemically transplanted into a mouse 
bone fracture model. Arch Pharm Res, 2013. 36(8): p. 1013-22. 
199. Lee, S.W., P. Padmanabhan, P. Ray, S.S. Gambhir, T. Doyle, C. Contag, S.B. 
Goodman, and S. Biswal, Stem cell-mediated accelerated bone healing observed 
with in vivo molecular and small animal imaging technologies in a model of 
skeletal injury. J Orthop Res, 2009. 27(3): p. 295-302. 
200. Obermeyer, T.S., D. Yonick, K. Lauing, S.R. Stock, R. Nauer, P. Strotman, R. 
Shankar, R. Gamelli, M. Stover, and J.J. Callaci, Mesenchymal stem cells 
facilitate fracture repair in an alcohol-induced impaired healing model. J Orthop 
Trauma, 2012. 26(12): p. 712-8. 
201. Demling, R.H., The burn edema process: current concepts. J Burn Care Rehabil, 
2005. 26(3): p. 207-27. 
202. Chen, M.M., E.B. O'Halloran, J.A. Ippolito, M.A. Choudhry, and E.J. Kovacs, 
Alcohol potentiates postburn remote organ damage through shifts in fluid 
compartments mediated by bradykinin. Shock, 2015. 43(1): p. 80-4. 
203. Djouad, F., P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, D. Noel, and C. 
Jorgensen, Immunosuppressive effect of mesenchymal stem cells favors tumor 
growth in allogeneic animals. Blood, 2003. 102(10): p. 3837-44. 
204. Duan, M., W.C. Li, R. Vlahos, M.J. Maxwell, G.P. Anderson, and M.L. Hibbs, 
Distinct macrophage subpopulations characterize acute infection and chronic 
inflammatory lung disease. J Immunol, 2012. 189(2): p. 946-55. 
 
 
 
 171 
 
VITA 
 Jill Ann (Ippolito) Shults was born in Chicago, IL on August 10, 1984 to 
James and Diane Ippolito. In June of 2006, she received a Bachelor of Science in Biology 
from DePaul University (Chicago, IL). At DePaul, Jill was awarded an undergraduate 
research assistant grant and her first laboratory research experience was under the 
guidance of Dr. Phillip E. Funk. After graduation, Jill spent four years working in the 
laboratory of Dr. Pamela L. Witte as a research specialist at Loyola University Chicago. 
 In August of 2010, Jill joined the Integrative Cell Biology Program at Loyola 
University Chicago (Maywood, IL).  Shortly thereafter, she joined the laboratory of Dr. 
Elizabeth J. Kovacs where she studied the effect of alcohol on post-burn pulmonary 
inflammation. While at Loyola, Jill received a pre-doctoral fellowship from a National 
Institutes of Health Institutional Training Grant and a pre-doctoral Ruth L. Kirchstein 
National Research Service Award from the National Institutes of Health. 
In June 2014, Jill married fellow graduate student, Cody Lee Shults, who completed 
his Ph.D. in the laboratory of Dr. Toni R. Pak.  Jill plans to continue with immunology 
research and is currently in the process of applying for post-doctoral positions.   
 
